Processing 00000000.tx.1: Evidence That Intramolecular Associations between Presenilin Domains Are Obligatory for Endoproteolytic Processing* Carlos A. 

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "That Intramolecular Associations between Presenilin Domains"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0004083:Associations [Mental Process]
   719 E C0439849:Association [Qualitative Concept]
   719 E C0596306:Association [Phenomenon or Process]
   719 E C0699792:association [Social Behavior]

Phrase: "Are"

Phrase: "Obligatory for Endoproteolytic Processing"

Phrase: "* Carlos A."
Processing 00000000.tx.2: Saura, Taisuke Tomita, Frances Davenport, Christie L. 

Phrase: "Saura,"

Phrase: "Taisuke Tomita,"

Phrase: "Frances Davenport,"

Phrase: "Christie L."
Processing 00000000.tx.3: Harris, Takeshi Iwatsubo, and Gopal Thinakaran From the Department of Pathology and the Division of Neuropathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2196and the Department of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo 113-0033,Japan  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Mutations in genes encoding presenilins (PS1 and PS2) cosegregate with the majority of early onset cases of familial Alzheimer's disease. 

Phrase: "Harris,"

Phrase: "Takeshi Iwatsubo,"

Phrase: "and"

Phrase: "Gopal Thinakaran From the Department of Pathology"

Phrase: "and"

Phrase: "the Division of Neuropathology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1293097:Division [Therapeutic or Preventive Procedure]
   770   C2919030:Division [Organization]
   770   C2919031:Division [Activity]

Phrase: "The Johns Hopkins University School of Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0036375:School [Manufactured Object,Organization]
   748   C0041740:University [Manufactured Object,Organization]

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "Maryland 21205-2196and"

Phrase: "the Department of Neuropathology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0587493:Neuropathology department [Health Care Related Organization]
   770   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Neuroscience,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027910:Neuroscience [Biomedical Occupation or Discipline]
  1000   C1552241:Neuroscience [Professional or Occupational Group]
  1000   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "Graduate School of Pharmaceutical Sciences,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0870614:graduate school [Manufactured Object,Organization]
   760   C0036375:School [Manufactured Object,Organization]
   760   C0588053:Graduate [Population Group]
   760   C1547183:Graduate [Idea or Concept]

Phrase: "University of Tokyo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040371:Tokyo [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Tokyo 113-0033,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040371:Tokyo [Geographic Area]

Phrase: "Japan  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Mutations in genes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   841   C0596611:gene mutations [Genetic Function]
   790   C0026882:Mutations [Genetic Function]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2"

Phrase: ")"

Phrase: "cosegregate with the majority of early onset cases of familial Alzheimer's disease."
Meta Candidates (Total=22; Excluded=3; Pruned=0; Remaining=19)
   819   C0338445:Familial Alzheimer's disease of early onset [Disease or Syndrome]
   798   C0750901:Alzheimer's disease with early onset [Disease or Syndrome]
           Alzheimer Disease, Early Onset
   770   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   766   C0814120:early disease onset [Disease or Syndrome]
   753   C0002395:Alzheimer's Disease [Disease or Syndrome]
   753   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C1833334:Early-onset [Finding]
   751   C0277558:Familial disease [Disease or Syndrome]
   751   C0277793:disease onset [Temporal Concept]
   751   C0679245:early disease [Temporal Concept]
   736   C0012634:Disease [Disease or Syndrome]
   736   C0015576:familial [Family Group]
   736   C0241888:Familial [Functional Concept]
   736   C0332162:Onset [Qualitative Concept]
   736   C0680220:majority [Social Behavior]
   736   C0868928:Cases [Functional Concept]
   736   C1279919:Early [Temporal Concept]
   736   C1533148:Cases [Quantitative Concept]
   715 E C0344339:disease family [Finding]
   703 E C1706255:CASE [Medical Device]
   703 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.4: PS1 and PS2 are polytopic membrane proteins that undergo endoproteolytic cleavage to generate stable NH2- and COOH-terminal derivatives (NTF and CTF, respectively). 

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2"

Phrase: "are"

Phrase: "polytopic membrane proteins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0025255:Membrane [Tissue]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "that"

Phrase: "undergo"

Phrase: "endoproteolytic cleavage to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]

Phrase: "generate"

Phrase: "stable NH2-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0002508:NH2 [Organic Chemical]
   861   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "COOH-terminal derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0243072:derivatives [Chemical Viewed Structurally]
   793 E C1527240:Derivative [Functional Concept]

Phrase: "(NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "CTF,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.5: Several lines of evidence suggest that the endoproteolytic derivatives are likely the functional units of PS in vivo. 

Phrase: "Several lines of evidence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205132:lines [Spatial Concept]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the endoproteolytic derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "are"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "the functional units of PS"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0439148:Units [Quantitative Concept]
   760   C1519795:Units [Quantitative Concept]
   726 E C1704753:Unit [Manufactured Object]
   726 E C1880519:Unit [Quantitative Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.6: In the present report, we examine the disposition of PS NTF and CTF assemblies in stable mouse N2a neuroblastoma cell lines expressing human PS polypeptides. 

Phrase: "In the present report,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "examine"

Phrase: "the disposition of PS NTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0743223:Disposition [Idea or Concept]
   760   C1705555:Disposition [Idea or Concept]

Phrase: "and"

Phrase: "CTF assemblies in stable mouse N2a neuroblastoma cell lines"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C0598084:cell assembly [Cell Function]
   737   C1707720:Terminal Assembly [Manufactured Object]
   704   C1706853:Assembly [Activity]
   704   C1879748:Assembly [Manufactured Object]

Phrase: "expressing"

Phrase: "human PS polypeptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.7: We show that exogenous expression of PS1 NTFs neither assemble with endogenous CTF nor exhibit dominant negative inhibitory effects on the endogenous PS1 cleavage and the accumulation of derivatives. 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that exogenous expression of PS1 NTFs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "neither"

Phrase: "assemble with endogenous CTF"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0205088:Terminal [Temporal Concept]
   753   C0205227:Endogenous [Functional Concept]
   753   C0332255:fragments [Functional Concept]
   753   C0486805:Fragments [Body Substance]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   753   C1706853:Assemble [Activity]
   719 E C1708096:Fragment [Qualitative Concept]

Phrase: "nor"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "dominant negative inhibitory effects on the endogenous PS1 cleavage"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "the accumulation of derivatives."
Processing 00000000.tx.8: In cells co-expressing PS1 and PS2, PS1- and PS2-derived fragments do not form mixed assemblies. 

Phrase: "In cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "co-expressing"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2,"

Phrase: "PS1-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2-derived fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "mixed assemblies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]
Processing 00000000.tx.9: In contrast, cells expressing a chimeric PS1/PS2 polypeptide form stable PS1 NTF-PS2 CTF assemblies. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "a chimeric PS1/PS2 polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "stable PS1 NTF-PS2 CTF assemblies."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1707720:Terminal Assembly [Manufactured Object]
   760   C1706853:Assembly [Activity]
   760   C1879748:Assembly [Manufactured Object]
Processing 00000000.tx.10: Moreover, expression of chimeric PS1/PS2 polypeptides harboring a familial early onset AD-linked mutation (M146L) elevates the production of A42 peptides. 

Phrase: "Moreover,"

Phrase: "expression of chimeric PS1/PS2 polypeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "a familial early onset AD-linked mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0026882:Mutation [Genetic Function]
   799   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(M146L"

Phrase: ")"

Phrase: "elevates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:elevate [Qualitative Concept]

Phrase: "the production of A42 peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]
Processing 00000000.tx.11: Our results provide evidence that assembly of structural domains contained within NH2- and COOH-terminal regions of PS occur prior to endoproteolytic cleavage.  

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that assembly of structural domains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1706853:Assembly [Activity]
   760   C1879748:Assembly [Manufactured Object]

Phrase: "contained within NH2-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0002508:NH2 [Organic Chemical]
   790   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   790   C0332256:contained [Functional Concept]
   790   C2700400:Contained [Activity]

Phrase: "and"

Phrase: "COOH-terminal regions of PS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]

Phrase: "occur prior to endoproteolytic cleavage."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0332152:Prior to [Temporal Concept]
           Prior
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   760   C2826257:PRIOR [Event]
Processing 00000000.tx.12: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Alzheimer's disease (AD),1 a progressive neurodegenerative disorder, is the most common cause of dementia in the elderly. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD),1"

Phrase: "a progressive neurodegenerative disorder,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1864985:Progressive disorder [Finding]
   901   C0524851:Neurodegenerative Disorder [Disease or Syndrome]
   827   C0012634:Disorder [Disease or Syndrome]

Phrase: "is"

Phrase: "the most common cause of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015127:cause [Functional Concept]
   753   C1524003:Cause [Conceptual Entity]

Phrase: "in the elderly."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001792:Elderly [Population Group]
  1000   C1999167:elderly [Population Group]
Processing 00000000.tx.13: AD is characterized pathologically by the presence of senile plaques and neurofibrillary tangles in the brains of affected individuals (1). 

Phrase: "AD"

Phrase: "is"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "pathologically by the presence of senile plaques"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   778   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   748   C0392079:Senile [Finding]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   714 E C0011389:Plaque [Disease or Syndrome]
   714 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "neurofibrillary tangles in the brains of affected individuals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   737 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.14: The predominant constituent of senile plaque is 40-43-amino acid -amyloid peptides (A), which are derived from proteolytic processing of a type I integral membrane glycoprotein, called the amyloid precursor protein (APP) (Ref. 2; reviewed in Ref. 3). 

Phrase: "The predominant constituent of senile plaque"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0729650:constituent [Substance]

Phrase: "is"

Phrase: "40-43-amino acid -amyloid peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "are"

Phrase: "derived from proteolytic processing of a type I integral membrane glycoprotein,"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   756   C0025248:Membrane Glycoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0441729:Type I [Classification]
   756   C1514570:Proteolytic Processing [Molecular Function]
   754   C1547386:Processing type [Idea or Concept]
   738   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]
   738   C0021966:I- [Inorganic Chemical]
   738   C0025255:Membrane [Tissue]
   738   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0332307:Type [Qualitative Concept]
   738   C0443238:Integral [Quantitative Concept]
   738   C0596901:Membrane [Cell Component]
   738   C0597304:Proteolytic [Molecular Function]
   738   C1441547:Derived [Qualitative Concept]
   738   C1547052:*Type [Quantitative Concept]
   738   C1706182:Membrane [Manufactured Object]
   738   C1709694:Processing [Activity]
   738   C1947941:proteolytic [Enzyme]
   738   C3245521:derived [Idea or Concept]

Phrase: "called"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0679006:Call [Mental Process]
   966   C1947967:Call [Functional Concept]

Phrase: "the amyloid precursor protein (APP)"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(Ref. 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ";"

Phrase: "reviewed in Ref. 3"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.15: Approximately 10% of all cases of AD, classified as familial early onset AD (FAD) (age of onset <60 years), is caused by autosomal dominant inheritance of mutations in genes encoding APP (for a review, see Ref. 4), presenilin 1(PS1) (5) and presenilin 2(PS2) (6-8). 

Phrase: "Approximately 10% of all cases of AD,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0332232:Approximately [Qualitative Concept]
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "classified as familial early onset AD (FAD) (age of onset"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   795   C1835401:Early age of onset [Finding]
   777   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   760   C1833334:Early-onset [Finding]
   739   C0001779:Age [Organism Attribute]
   739   C0008902:Classified [Classification]
   739   C0015576:familial [Family Group]
   739   C0241888:Familial [Functional Concept]
   739   C0332162:Onset [Qualitative Concept]
   739   C1279919:Early [Temporal Concept]
   739   C3247466:FAD [Pharmacologic Substance]

Phrase: "<60 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "is"

Phrase: "caused by autosomal dominant inheritance of mutations"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   814   C0443147:Autosomal dominant inheritance [Intellectual Product]
           Autosomal dominant
   778   C0678942:dominant inheritance [Genetic Function]
   774   C0678944:autosomal inheritance [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   748   C0242538:Inheritance [Quantitative Concept]
   748   C0596142:autosomal [Cell Component]
   748   C0728826:Inheritance [Functional Concept]
   748   C1527180:Dominant [Functional Concept]
   714   C0015127:cause [Functional Concept]
   714   C1524003:Cause [Conceptual Entity]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "("

Phrase: "for a review,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Ref. 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "presenilin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: ")"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "presenilin 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(PS2"

Phrase: ")"

Phrase: "(6-8"

Phrase: ")."
Processing 00000000.tx.16: Expression of FAD-linked APP mutations leads to increased production of highly fibrillogenic A species ending at residue 42(or 43) (A42) (reviewed in Ref. 3). 

Phrase: "Expression of FAD-linked APP mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "leads to increased production of highly fibrillogenic"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   774   C0861064:increased lead [Finding]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0033268:production [Occupational Activity]
   748   C0181586:leads [Medical Device]
   748   C0205217:Increased [Quantitative Concept]
   748   C0205250:Highly [Qualitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]

Phrase: "ending at residue 42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0444930:ending [Spatial Concept]
   770   C1709915:Residue [Conceptual Entity]
   770   C1882936:RESIDUE [Phenomenon or Process]
   770   C2746065:Ending [Temporal Concept]

Phrase: "("

Phrase: "or"

Phrase: "43"

Phrase: ")"

Phrase: "(A42"

Phrase: ")"

Phrase: "("

Phrase: "reviewed in Ref. 3"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.17: In addition, expression of FAD-linked PS1 and PS2 variants alters APP processing in a manner that leads to elevated production of A42 (9-14). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "expression of FAD-linked PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "PS2 variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "APP processing in a manner"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0033666:protein processing [Molecular Function]
   748   C1709694:Processing [Activity]

Phrase: "that"

Phrase: "leads to elevated production of A42"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0033268:production [Occupational Activity]
   753   C0181586:leads [Medical Device]
   753   C0205250:Elevated [Qualitative Concept]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3163633:Elevated [Qualitative Concept]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(9-14"

Phrase: ")."
Processing 00000000.tx.18: Thus, genetic mutations in all the three genes that cosegregate with FAD increase the production of the pathogenic A42 peptides. 

Phrase: "Thus,"

Phrase: "genetic mutations in all"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0026882:genetic mutations [Genetic Function]
           Mutations
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "the three genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "that"

Phrase: "cosegregate with FAD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3247466:FAD [Pharmacologic Substance]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the production of the pathogenic A42 peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033268:production [Occupational Activity]
Processing 00000000.tx.19: The role that PS plays in facilitating proteolytic cleavage of APP at the -secretase site is not known, but PS1-deficient neurons exhibit selective defects in the production of A (15, 16). 

Phrase: "The role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "that PS"

Phrase: "plays in facilitating proteolytic cleavage of APP"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0597304:Protein Cleavage [Molecular Function]
           Proteolytic
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0010813:cleavage [Cell Function]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0032214:Play [Daily or Recreational Activity]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C0600138:Plays [Finding]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1330957:cleavage [Cell Function]
   742   C1709634:Precursor [Idea or Concept]
   742   C1947941:proteolytic [Enzyme]

Phrase: "at the -secretase site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: ","

Phrase: "but"

Phrase: "PS1-deficient neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "selective defects in the production of A (15,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0243067:defects [Functional Concept]
   711 E C1457869:Defect [Functional Concept]
   711 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.20: PS1 and PS2 (PS) are homologous polytopic membrane proteins (17) that are subject to endoproteolytic cleavage (12, 18-20). 

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2 (PS)"

Phrase: "are"

Phrase: "homologous polytopic membrane proteins"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   886   C1512488:Homologous Protein [Amino Acid, Peptide, or Protein]
   861   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0025255:Membrane [Tissue]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0596901:Membrane [Cell Component]
   812   C1706182:Membrane [Manufactured Object]
   741 E C0205287:Membranous [Qualitative Concept]

Phrase: "(17"

Phrase: ")"

Phrase: "that"

Phrase: "are subject to endoproteolytic cleavage"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C0681850:Subject [Group]
   760   C1330957:cleavage [Cell Function]
   760   C1550501:{Subject} [Idea or Concept]
   760   C1551058:Are [Quantitative Concept]
   760   C1706203:Subject [Idea or Concept]
   760   C2349001:Subject [Human]
   760   C2697811:Subject [Functional Concept]

Phrase: "(12,"

Phrase: "18-20"

Phrase: ")."
Processing 00000000.tx.21: In previous efforts, we documented that PS1-derived 28-kDa NH2-terminal (NTF) and 17-kDa COOH-terminal fragments (CTF) are the preponderant PS1-related species that accumulate in vivo (18). 

Phrase: "In previous efforts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015264:Effort [Organism Function]

Phrase: "we"

Phrase: "documented"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "that PS1-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "derived"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "28-kDa NH2-terminal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0002508:NH2 [Organic Chemical]
   812   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   812   C0205088:Terminal [Temporal Concept]
   812   C1705314:Terminal [Manufactured Object]
   812   C1705315:Terminal [Spatial Concept]

Phrase: "(NTF)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "17-kDa COOH-terminal fragments (CTF)"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0332255:fragments [Functional Concept]
   804   C0486805:Fragments [Body Substance]
   771 E C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "the preponderant PS1-related species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1705920:Species [Conceptual Entity]

Phrase: "that"

Phrase: "accumulate"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.22: The PS NTF and CTF accumulate to 1:1 stoichiometry, and the absolute levels of PS-derived fragments are established by a highly regulated and saturable mechanism such that overproduction of human PS fragments led to diminution of mouse PS fragments (18). 

Phrase: "The PS NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "accumulate to 1"

Phrase: ":"

Phrase: "1 stoichiometry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597526:Stoichiometry [Quantitative Concept]

Phrase: "and"

Phrase: "the absolute levels of PS-derived fragments"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "established by a highly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205250:Highly [Qualitative Concept]
   770   C0443211:Established [Qualitative Concept]
   770   C1272684:Established [Qualitative Concept]

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "saturable mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "such"

Phrase: "that overproduction of human PS fragments"

Phrase: "led to diminution of mouse PS fragments"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0332255:fragments [Functional Concept]
   748   C0332511:Diminution [Qualitative Concept]
   748   C0486805:Fragments [Body Substance]
   748   C1708698:LED [Manufactured Object]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C1522538:Lead [Functional Concept]
   714 E C1708096:Fragment [Qualitative Concept]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.23: In transfected cells overexpressing PS, only a small fraction of full-length PS is converted into stable fragments (t1/2>12h); 

Phrase: "In transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "PS,"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a small fraction of full-length PS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1264633:Fraction of [Quantitative Concept]
           Fraction
   774   C1442089:Length Fraction [Quantitative Concept]
   748   C1554103:Fraction [Idea or Concept]

Phrase: "is"

Phrase: "converted into stable fragments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205360:Stable [Qualitative Concept]
   770   C0332255:fragments [Functional Concept]
   770   C0486805:Fragments [Body Substance]
   770   C1547311:Stable [Intellectual Product]
   737 E C1708096:Fragment [Qualitative Concept]

Phrase: "(t1/2>12h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0456695:/12h [Temporal Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.24: excess full-length PS polypeptides are rapidly degraded (t1/2~1h) (18, 21-25). 

Phrase: "excess full-length PS polypeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "are"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "(t1/2~1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442450:1H [Temporal Concept]

Phrase: ")"

Phrase: "(18,"

Phrase: "21-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450347:21/25 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.25: Moreover, accumulation of PS1 and PS2 fragments are coordinately regulated, providing strong evidence that association with limiting cellular components regulates the abundance of PS fragments (21). 

Phrase: "Moreover,"

Phrase: "accumulation of PS1"

Phrase: "and"

Phrase: "PS2 fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "coordinately"

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: ","

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "strong evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that association with limiting cellular components"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "regulates"

Phrase: "the abundance of PS fragments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2346714:Abundance [Qualitative Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.26: More recently, using in situ chemical cross-linking and co-immunoprecipitation approaches, we demonstrated that the NTF and CTF of either PS1 or PS2 can be coisolated (26). 

Phrase: "More recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "in situ chemical"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220806:Chemical [Chemical]
   827   C3272558:Chemical [Intellectual Product]
   734   C0444498:In situ [Spatial Concept]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "co-immunoprecipitation approaches,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0449445:Approaches [Spatial Concept]
   827   C1292724:Approaches [Functional Concept]
   734   C1449705:Co-Immunoprecipitation [Laboratory Procedure]

Phrase: "we"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "CTF of either PS1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0332255:fragments [Functional Concept]
   753   C0486805:Fragments [Body Substance]
   719 E C1708096:Fragment [Qualitative Concept]

Phrase: "or"

Phrase: "PS2"

Phrase: "can"

Phrase: "be"

Phrase: "coisolated"

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.27: The accumulated data support our view that the more stable endoproteolytic derivatives are the biologically functional forms of PS. 

Phrase: "The accumulated data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "our"

Phrase: "view"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "that"

Phrase: "the more stable endoproteolytic derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0243072:derivatives [Chemical Viewed Structurally]
   779 E C1527240:Derivative [Functional Concept]

Phrase: "are"

Phrase: "the biologically functional forms of PS."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]
Processing 00000000.tx.28: Arguing against this notion, Citron et al. 

Phrase: "Arguing against this notion,"

Phrase: "Citron et al."
Processing 00000000.tx.29: (27) reported that expression of a truncated PS1 species corresponding to the human PS1 NTF with a FAD mutation failed to increase A42 production; 

Phrase: "(27"

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that expression of a truncated PS1 species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "corresponding to the human PS1 NTF"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0086418:Human [Human]
   753   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   753   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1418985:PS1 [Gene or Genome]
   753   C2986918:PS1 [Gene or Genome]

Phrase: "with a FAD mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "A42 production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: ";"
Processing 00000000.tx.30: the authors suggested that the pathogenic effect of mutant PS is elicited by the full-length molecule and not the endoproteolytic derivatives. 

Phrase: "the authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the pathogenic effect of mutant PS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "elicited by the full-length molecule"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0449265:Elicited by [Qualitative Concept]
           elicited
   753   C0443225:Full [Qualitative Concept]
   753   C0567416:Molecule [Substance]
   753   C1444754:Length [Quantitative Concept]
   753   C1706316:LENGTH [Research Activity]

Phrase: "and"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the endoproteolytic derivatives."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]
Processing 00000000.tx.31: In this report, we examine the assembly of PS1 and PS2 derivatives in stable mouse N2a neuroblastoma cell lines expressing full-length PS, recombinant PS1 NTF, or chimeric PS1/PS2 polypeptides. 

Phrase: "In this report,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "examine"

Phrase: "the assembly of PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1706853:Assembly [Activity]
   770   C1879748:Assembly [Manufactured Object]

Phrase: "and"

Phrase: "PS2 derivatives in stable mouse N2a neuroblastoma cell lines"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0243072:derivatives [Chemical Viewed Structurally]
   708 E C1527240:Derivative [Functional Concept]

Phrase: "expressing"

Phrase: "full-length PS,"

Phrase: "recombinant PS1 NTF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "or"

Phrase: "chimeric PS1/PS2 polypeptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.32: We demonstrate that transgene-derived COOH-terminally truncated human PS polypeptides that correspond to PS1 NTF (residues 1-298) fail to co-assemble with endogenous PS1 CTF and are rapidly degraded. 

Phrase: "We"

Phrase: "demonstrate"

Phrase: "that transgene-derived COOH-terminally truncated human PS polypeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "that"

Phrase: "correspond to PS1 NTF (residues 1-298"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   748   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1418985:PS1 [Gene or Genome]
   748   C2986918:PS1 [Gene or Genome]
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: ")"

Phrase: "fail to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0231175:fail [Functional Concept]

Phrase: "co-assemble with endogenous PS1 CTF"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   744   C0205088:Terminal [Temporal Concept]
   744   C0205227:Endogenous [Functional Concept]
   744   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0332255:fragments [Functional Concept]
   744   C0486805:Fragments [Body Substance]
   744   C1418985:PS1 [Gene or Genome]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]
   744   C1706853:Assemble [Activity]
   744   C2986918:PS1 [Gene or Genome]
   711 E C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "are"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "degraded."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]
Processing 00000000.tx.33: In cells co-expressing PS1 and PS2, processed fragments derived from full-length PS polypeptides form assemblies consisting entirely of either PS1 NTFCTF or PS2 NTFCTF. 

Phrase: "In cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "co-expressing"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2,"

Phrase: "processed fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "derived from full-length PS polypeptides"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0443225:Full [Qualitative Concept]
   753   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]
   753   C1441547:Derived [Qualitative Concept]
   753   C1444754:Length [Quantitative Concept]
   753   C1706316:LENGTH [Research Activity]
   753   C3245521:derived [Idea or Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "assemblies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1706853:Assembly [Activity]
   966   C1879748:Assembly [Manufactured Object]

Phrase: "consisting"

Phrase: "entirely of either PS1 NTFCTF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1418985:PS1 [Gene or Genome]
   760   C2986918:PS1 [Gene or Genome]

Phrase: "or"

Phrase: "PS2 NTFCTF."
Processing 00000000.tx.34: Based on these results, we conclude that the association of NH2 and COOH domains of the precursor PS polypeptide precedes endoproteolytic cleavage and that PS1 and PS2 do not form heteromultimeric assemblies. 

Phrase: "Based on these results,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737 E C1880279:Base [Biomedical or Dental Material]
   737   C2825142:Result [Finding]

Phrase: "we"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the association of NH2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "COOH domains of the precursor PS polypeptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1880389:Domain [Functional Concept]
   714   C1883221:Domain [Conceptual Entity]
   714   C3541951:Domain [Intellectual Product]

Phrase: "precedes"

Phrase: "endoproteolytic cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "that PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "heteromultimeric assemblies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]
Processing 00000000.tx.35: Interestingly, fragments derived from proteolytic processing of a chimeric PS1/PS2 precursor polypeptide are capable of forming stable heteromeric PS1 NTFPS2 CTF assemblies. 

Phrase: "Interestingly,"

Phrase: "fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "derived from proteolytic processing of a chimeric PS1/PS2 precursor polypeptide"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   756   C1514570:Proteolytic Processing [Molecular Function]
   738   C0008109:chimeric [Organism]
   738   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0597304:Proteolytic [Molecular Function]
   738   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]
   738   C1418985:PS1 [Gene or Genome]
   738   C1441547:Derived [Qualitative Concept]
   738   C1709634:Precursor [Idea or Concept]
   738   C1709694:Processing [Activity]
   738   C1947941:proteolytic [Enzyme]
   738   C2986918:PS1 [Gene or Genome]
   738   C3245521:derived [Idea or Concept]

Phrase: "are"

Phrase: "capable of forming stable heteromeric PS1 NTFPS2 CTF assemblies."
Processing 00000000.tx.36: Furthermore, expression of a FAD-linked M146L mutant PS1/PS2 chimera elevated the production of A42 peptides, indicating that the gain of function properties associated with the FAD-linked mutation is preserved in a PS1/PS2 chimera. 

Phrase: "Furthermore,"

Phrase: "expression of a FAD-linked M146L mutant PS1/PS2 chimera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "the production of A42 peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "indicating"

Phrase: "that"

Phrase: "the gain of function properties"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517378:Gain [Quantitative Concept]

Phrase: "associated with the FAD-linked mutation"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]
   753   C3247466:FAD [Pharmacologic Substance]
   719 E C0750490:Associate [Idea or Concept]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "is"

Phrase: "preserved in a PS1/PS2 chimera."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0008109:Chimera [Organism]
   753   C0033085:Preserved [Laboratory Procedure]
   753   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1262946:Chimaera [Fish]
   753   C1318484:Chimera [Disease or Syndrome]
   753   C1418985:PS1 [Gene or Genome]
   753   C2986918:PS1 [Gene or Genome]
Processing 00000000.tx.37: Our results are consistent with a model where stabilization of intramolecular interaction(s) between domains within the NH2- and COOH-terminal regions of PS1 is a prerequisite for endoproteolytic processing.  

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "consistent with a model where stabilization of intramolecular interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "("

Phrase: "s) between domains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C2603362:S' [Clinical Attribute]
   756   C1880389:Domain [Functional Concept]
   756   C1883221:Domain [Conceptual Entity]
   756   C3541951:Domain [Intellectual Product]

Phrase: "within the NH2-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002508:NH2 [Organic Chemical]
  1000   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "COOH-terminal regions of PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]

Phrase: "is"

Phrase: "a prerequisite for endoproteolytic processing."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0679209:prerequisite [Idea or Concept]
Processing 00000000.tx.38: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Generation of Expression Plasmids-- Expression plasmids encoding human PS1 (pCB6PS1), PS2 (pCB6PS2), FAD-linked PS variants, and PS2 CTF have been described (10, 12, 18). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Generation of Expression Plasmids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079411:Generation [Temporal Concept]
   770   C3146294:Generation [Activity]

Phrase: "--"

Phrase: "Expression plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "human PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "(pCB6PS1"

Phrase: ")"

Phrase: ","

Phrase: "PS2"

Phrase: "(pCB6PS2"

Phrase: ")"

Phrase: ","

Phrase: "FAD-linked PS variants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205419:variants [Qualitative Concept]

Phrase: "and"

Phrase: "PS2 CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(10,"

Phrase: "12,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.39: A plasmid encoding a polypeptide that corresponds to human PS1 NTF was generated as follows. 

Phrase: "A plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "that"

Phrase: "corresponds to human PS1 NTF"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0086418:Human [Human]
   760   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1418985:PS1 [Gene or Genome]
   760   C2986918:PS1 [Gene or Genome]

Phrase: "was"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "as"

Phrase: "follows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.40: A 252-base pair DNA fragment, which encodes PS1 amino acids 214-298 followed by a stop codon, was generated by polymerase chain reaction using primers 5'-GCCTACATTACTGTTGCACTCC (195S) and 5' CCGGATCCTACATATTCACCAACC and subsequent digestion with PflMI and BamHI. 

Phrase: "A 252-base pair DNA fragment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332255:fragment [Functional Concept]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: "which"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "PS1 amino acids 214-298"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   840   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806 E C2917660:Amino Acid [Pharmacologic Substance]
   804   C0001128:Acids [Chemical]
   804   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1418985:PS1 [Gene or Genome]
   804   C2986918:PS1 [Gene or Genome]
   771 E C0202406:Acid [Laboratory Procedure]

Phrase: "followed by a stop codon,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0242611:Stop Codon [Nucleotide Sequence]
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0009221:Codon [Nucleotide Sequence]
   760   C1095825:Codon [Plant]
   760   C1947925:Stop [Activity]
   760   C2746065:Stop [Temporal Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "was"

Phrase: "generated by polymerase chain reaction"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0337112:Chain [Manufactured Object]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1524075:Chain [Idea or Concept]
   760   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers 5'-GCCTACATTACTGTTGCACTCC"

Phrase: "(195S"

Phrase: ")"

Phrase: "and"

Phrase: "5' CCGGATCCTACATATTCACCAACC"

Phrase: "and"

Phrase: "subsequent digestion with PflMI"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0012238:Digestion [Organism Function]
   770   C2349986:Digestion [Research Activity]
   715 E C0443277:Peptic [Functional Concept]

Phrase: "and"

Phrase: "BamHI."
Processing 00000000.tx.41: After gel purification, this product was ligated to PflM1-BamHI pCB6PS1 "vector" fragment, to generate pBSPS1NTF. 

Phrase: "After gel purification,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243114:purification [Functional Concept]
   861   C1998793:Purification [Functional Concept]

Phrase: "this product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514468:product [Entity]
  1000   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "ligated to PflM1-BamHI pCB6PS1 ""vector"" fragment,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0332255:fragment [Functional Concept]
   748   C0442335:Vector [Spatial Concept]
   748   C1705099:Vector [Idea or Concept]
   748   C1708096:Fragment [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "pBSPS1NTF."
Processing 00000000.tx.42: A plasmid encoding a chimeric PS1 NTF-PS2 CTF polypeptide was generated as follows. 

Phrase: "A plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a chimeric PS1 NTF-PS2 CTF polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "as"

Phrase: "follows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.43: A 235-base pair DNA fragment, which encodes PS1 amino acids 214-269, was generated using primers 195S (see above) and 5'-GGCAACCAGCATTCGAAGTGGACCTTTCGG and subsequent digestion with PflMI and BsmI. 

Phrase: "A 235-base pair DNA fragment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332255:fragment [Functional Concept]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: "which"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "PS1 amino acids 214-269,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   840   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806 E C2917660:Amino Acid [Pharmacologic Substance]
   804   C0001128:Acids [Chemical]
   804   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1418985:PS1 [Gene or Genome]
   804   C2986918:PS1 [Gene or Genome]
   771 E C0202406:Acid [Laboratory Procedure]

Phrase: "was"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers 195S"

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "5'-GGCAACCAGCATTCGAAGTGGACCTTTCGG"

Phrase: "and"

Phrase: "subsequent digestion with PflMI"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0012238:Digestion [Organism Function]
   770   C2349986:Digestion [Research Activity]
   715 E C0443277:Peptic [Functional Concept]

Phrase: "and"

Phrase: "BsmI."
Processing 00000000.tx.44: This product was incubated in a ligation mixture with an Asp718I-PflMI fragment isolated from pBSPS1 (28) and Asp718I-BsmI pBSPS2 "vector" fragment (18), to generate pBSPS1/PS2. 

Phrase: "This product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514468:product [Entity]
  1000   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "incubated in a ligation mixture"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0023690:Ligation [Therapeutic or Preventive Procedure]
   760   C0439962:Mixture [Substance]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "with an Asp718I-PflMI fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "isolated from pBSPS1"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(28"

Phrase: ")"

Phrase: "and"

Phrase: "Asp718I-BsmI pBSPS2 ""vector"" fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332255:fragment [Functional Concept]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: "(18"

Phrase: ")"

Phrase: ","

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "pBSPS1/PS2."
Processing 00000000.tx.45: Polymerase chain reaction-amplified sequences in pBSPS1NTF and pBSPS1/PS2 were confirmed by sequencing using Sequenase (U.S. Biochemical Corp.), and the inserts were subcloned into cytomegalovirus expression vectors to generate pCB6PS1NTF and pCDNAPS1/PS2, respectively. 

Phrase: "Polymerase chain reaction-amplified sequences in pBSPS1NTF"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0162326:Sequences [Nucleotide Sequence]
   714 E C0004793:Sequence [Nucleotide Sequence]
   714 E C0162327:Sequence [Nucleotide Sequence]
   714 E C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "pBSPS1/PS2"

Phrase: "were"

Phrase: "confirmed by sequencing"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0750484:Confirmed [Idea or Concept]
   790   C1553778:Sequencing [Intellectual Product]
   790   C1561491:Sequencing [Functional Concept]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Sequenase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0142005:sequenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2257064:sequenase [Genetic Function]

Phrase: "(U.S. Biochemical Corp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0683758:Corp. [Organization]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the inserts"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0813036:Inserts [Medical Device]
   966 E C0441587:Insert [Health Care Activity]
   966 E C1743766:Insert [Medical Device]
   966 E C1883719:Insert [Functional Concept]

Phrase: "were"

Phrase: "subcloned into cytomegalovirus expression vectors to"

Phrase: "generate"

Phrase: "pCB6PS1NTF"

Phrase: "and"

Phrase: "pCDNAPS1/PS2,"

Phrase: "respectively."
Processing 00000000.tx.46: M146L mutation was introduced into pCDNAPS1/PS2 by exchanging Asp718I-XmnI fragment from a PS1M146L plasmid. 

Phrase: "M146L mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "introduced into pCDNAPS1/PS2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1292748:introduce [Functional Concept]

Phrase: "by exchanging Asp718I-XmnI fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "from a PS1M146L plasmid."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.47: Cell Culture and Generation of Stable Cell Lines-- Mouse N2a neuroblastoma cells were cultured in 1:1 Dulbecco's minimal essential medium/OptiMEM (Life Technologies, Inc.) supplemented with 10% fetal calf serum. 

Phrase: "Cell Culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "Generation of Stable Cell Lines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]

Phrase: "--"

Phrase: "Mouse N2a neuroblastoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   844   C0815000:neuroblastoma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   708   C1524043:Mouse Neuroblastoma [Neoplastic Process]

Phrase: "were"

Phrase: "cultured in 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: ":"

Phrase: "1 Dulbecco's minimal essential medium/OptiMEM"

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc.)"

Phrase: "supplemented with 10% fetal calf serum."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0230445:Calf [Body Location or Region]
   753   C0521457:Fetal [Functional Concept]
   753   C1305418:Calf [Body Part, Organ, or Organ Component]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.48: Monkey COS-1 cells were cultured in Dulbecco's minimal essential medium supplemented with 10% fetal calf serum. 

Phrase: "Monkey COS-1 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   923   C1257857:COS-1 Cells [Cell]
   875   C0376702:COS Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured in Dulbecco's minimal essential medium"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   767   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   753   C0009458:Medium [Intellectual Product]
   753   C0205224:Essential [Qualitative Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C0547040:Minimal [Qualitative Concept]
   753   C1524031:MINIMAL [Qualitative Concept]
   753   C1705217:Medium [Substance]
   753   C2945599:Minimal [Qualitative Concept]
   753   C3244283:medium [Intellectual Product]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "supplemented with 10% fetal calf serum."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0230445:Calf [Body Location or Region]
   753   C0521457:Fetal [Functional Concept]
   753   C1305418:Calf [Body Part, Organ, or Organ Component]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.49: Stable N2a cell lines expressing human PS1 and PS2 were described (18, 21). 

Phrase: "Stable N2a cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   906   C0598091:stable cell line [Cell]
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "human PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2"

Phrase: "were"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(18,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.50: Stable N2a lines expressing PS1 NTF or PS1/PS2 were generated by transfecting 0.5g of the respective expression plasmids (see above). 

Phrase: "Stable N2a lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "or"

Phrase: "PS1/PS2"

Phrase: "were"

Phrase: "generated by transfecting 0.5g of the respective expression plasmids"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C3146294:Generated [Activity]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.51: Expression of transgene-derived PS polypeptides in G418-resistant lines was determined by Western blot analysis with PS1NT and PS2Loop antisera (26). 

Phrase: "Expression of transgene-derived PS polypeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in G418-resistant lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "was"

Phrase: "determined by Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]

Phrase: "with PS1NT"

Phrase: "and"

Phrase: "PS2Loop antisera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.52: Cycloheximide was added to the culture medium at a final concentration of 30g/ml to block protein synthesis in some experiments. 

Phrase: "Cycloheximide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "was"

Phrase: "added to the culture medium"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C0439536:Medium [Quantitative Concept]
   760   C1524062:Added [Functional Concept]
   760   C1705217:Medium [Substance]
   760   C2242979:Culture [Laboratory Procedure]
   760   C3244283:medium [Intellectual Product]
   726 E C1883712:Add [Functional Concept]

Phrase: "at a final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 30g/ml to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "protein synthesis in some experiments."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0597295:Protein Synthesis [Molecular Function]
   762 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0220781:synthesis [Biologic Function]
   760   C1883254:Synthesis [Activity]
Processing 00000000.tx.53: Co-immunoprecipitation and Western Blot Analyses-- Detergent lysates were prepared by lysing cells in cold PBS containing 0.25% n-dodecyl -D-maltoside (Sigma) as described previously (26). 

Phrase: "Co-immunoprecipitation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   861   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "Western Blot Analyses"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   966   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C1705493:Western [Spatial Concept]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "--"

Phrase: "Detergent lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "prepared by lysing cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0024348:lysing [Pathologic Function]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1521827:Prepare [Functional Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "in cold PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720830:PBS [Disease or Syndrome]
   861   C1823521:PBS [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.25% n-dodecyl -"

Phrase: "D-"

Phrase: "maltoside"

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.54: We obtained similar results when lysates were prepared using buffers containing 1% digitonin (29). 

Phrase: "We"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "when"

Phrase: "lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "buffers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffers [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% digitonin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012256:Digitonin [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.55: Aliquots of lysates were incubated with 3l of antisera at 4C for 2h. 

Phrase: "Aliquots of lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "incubated with 3l of antisera"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "for 2h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]
Processing 00000000.tx.56: PS1 NTF and CTF were immunoprecipitated using antisera PS1NT and PS1Loop, respectively (18, 26). 

Phrase: "PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antisera PS1NT"

Phrase: "and"

Phrase: "PS1Loop,"

Phrase: "respectively"

Phrase: "(18,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.57: PS2 CTF was immunoprecipitated using PS2Loop antiserum (21). 

Phrase: "PS2 CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PS2Loop antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.58: A rat monoclonal antibody (mAb) specific for human PS1 (30) (provided by Dr. Allan I.Levey, Emory University School of Medicine, Atlanta) was used to immunoprecipitate transgene-derived human PS1 NTF. 

Phrase: "A rat monoclonal antibody (mAb)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0746619:monoclonal [Finding]

Phrase: "specific for human PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]

Phrase: "(30"

Phrase: ")"

Phrase: "("

Phrase: "provided by Dr. Allan I.Levey,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0021966:I- [Inorganic Chemical]
   753   C0031831:DR [Professional or Occupational Group]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C1707664:DR [Biomedical or Dental Material]
   753   C1999230:Provided [Activity]
   753   C2348314:Dr. [Conceptual Entity]
   753   C3540849:DR [Idea or Concept]

Phrase: "Emory University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "Atlanta"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2993063:Atlanta [Eukaryote]

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "immunoprecipitate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "transgene-derived human PS1 NTF."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.59: To generate antibodies against the PS2 NH2-terminal region, New Zealand White rabbits were immunized with a glutathione S-transferase fusion protein containing residues 1-75 of human PS2. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "antibodies against the PS2 NH2-terminal region,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "New Zealand White rabbits"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0324547:New Zealand White Rabbits [Mammal]
           New Zealand Rabbits
           New Zealand White
   861   C0027978:New Zealand [Geographic Area]
   812   C0007457:White [Population Group]
   812   C0034493:Rabbit [Mammal]
   812   C0043157:White [Population Group]
   812   C0205314:New [Temporal Concept]
   812   C0220938:White [Qualitative Concept]

Phrase: "were"

Phrase: "immunized with a glutathione S-transferase fusion protein containing residues 1-75"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   770   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   766   C1333582:Fusion 1 Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   751   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   751   C0072393:Protein S [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751   C1418948:PROTEIN S [Gene or Genome]
   736   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   736   C0332256:Containing [Functional Concept]
   736   C0332466:Fusion [Functional Concept]
   736   C1293131:Fusion [Therapeutic or Preventive Procedure]
   736   C2700400:Containing [Activity]
   703   C1709915:Residue [Conceptual Entity]
   703   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "of human PS2."
Processing 00000000.tx.60: The specificity of the resultant antiserum, termed PS2NT, for PS2 was established by Western blot analysis of lysates prepared from stable N2a cell lines expressing PS1 or PS2 (data not shown). 

Phrase: "The specificity of the resultant antiserum,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037791:Specificity [Quantitative Concept]
   753   C1511884:Specificity [Quantitative Concept]

Phrase: "termed PS2NT,"

Phrase: "for PS2"

Phrase: "was"

Phrase: "established by Western blot analysis of lysates"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   778   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0443211:Established [Qualitative Concept]
   748   C0936012:Analysis [Research Activity]
   748   C1272684:Established [Qualitative Concept]
   748   C1524024:analysis [Functional Concept]
   748   C1705493:Western [Spatial Concept]
   714   C1881488:Lysate [Physical Object]

Phrase: "prepared from stable N2a cell lines"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   804   C0598091:stable cell line [Cell]
   790   C0007600:Cell lines [Cell]
   753   C0007634:Cell [Cell]
   753   C0205132:lines [Spatial Concept]
   753   C0205360:Stable [Qualitative Concept]
   753   C0445079:N2a [Finding]
   753   C1269647:Cell [Cell]
   753   C1547311:Stable [Intellectual Product]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719   C1521827:Prepare [Functional Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "or"

Phrase: "PS2"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.61: As negative controls, we used SOD1, an antiserum raised against human erythrocyte Cu/Zn superoxide dismutase 1(31), and normal rabbit serum (Sigma). 

Phrase: "As negative controls,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   966   C1639518:% negative control [Quantitative Concept]
   966   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SOD1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1151619:SOD-1 [Molecular Function]
  1000   C1420306:SOD1 [Gene or Genome]

Phrase: "an antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "raised against human erythrocyte Cu/Zn superoxide dismutase 1"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   818   C0010461:Cu-Zn Superoxide Dismutase [Amino Acid, Peptide, or Protein,Enzyme]
           Superoxide Dismutase 1
   790   C0669516:superoxide dismutase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1420306:SUPEROXIDE DISMUTASE 1 [Gene or Genome]
   784   C0010434:Cu-Superoxide Dismutase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0038838:Superoxide Dismutase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   742   C0014792:Erythrocyte [Cell]
   742   C0038836:Superoxide [Element, Ion, or Isotope]
   742   C0086418:Human [Human]
   742   C0442818:Raised [Quantitative Concept]
   742   C1177210:Cu++ [Inorganic Chemical,Pharmacologic Substance]
   742   C2347872:Cu+ [Element, Ion, or Isotope]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "normal rabbit serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0034493:Rabbit [Mammal]
   827   C0205307:Normal [Qualitative Concept]
   827   C0229671:Serum [Body Substance]
   827   C0439166:% normal [Quantitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C2347086:% Normal [Quantitative Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.62: Immunoprecipitates were collected using protein A-agarose, washed twice in lysis buffer, and resuspended in Laemmli buffer. 

Phrase: "Immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "protein A-agarose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0036681:Agarose [Carbohydrate]
   734   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice in lysis buffer,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:Lysis [Pathologic Function]
   770   C1536403:lysis [Cell Function]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]

Phrase: "and"

Phrase: "resuspended in Laemmli buffer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0258024:Laemmli buffer [Organic Chemical]
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.63: Proteins were eluted by incubation at 37C for 15min and analyzed by immunoblotting. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "eluted by incubation"

Phrase: "at 37C"

Phrase: "for 15min"

Phrase: "and"

Phrase: "analyzed by immunoblotting."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.64: For Western blot analyses, cells were lysed in a buffer containing 50mM Tris-HCl (pH 7.4), 150mM NaCl, 5mM EDTA, 0.5% Nonidet P-40, 0.5% deoxycholate, 0.5% SDS, and a protease inhibitor mixture (50g/ml pepstatin, 50g/ml leupeptin, 10g/ml aprotinin, and 0.25mM phenylmethylsulfonyl fluoride). 

Phrase: "For Western blot analyses,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   966   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C1705493:Western [Spatial Concept]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed in a buffer containing 50mM Tris-HCl (pH 7.4"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   756   C1882074:pH 7 [Qualitative Concept]
   754   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   754   C0492253:PH BUFFER [Medical Device]
   754   C2678549:PH-4 [Gene or Genome]
   738   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   738   C0020283:[pH] [Quantitative Concept]
   738   C0024348:lysed [Pathologic Function]
   738   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   738   C0332256:Containing [Functional Concept]
   738   C0450400:50mm [Quantitative Concept]
   738   C0450407:ph+ [Finding]
   738   C0450408:ph++ [Finding]
   738   C0450409:ph+++ [Finding]
   738   C0814229:TRI [Intellectual Product]
   738   C2700400:Containing [Activity]

Phrase: ")"

Phrase: ","

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "5mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "0.5% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   804   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   804   C0439509:/40 [Temporal Concept]

Phrase: "0.5% deoxycholate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0086123:Deoxycholate [Hormone,Pharmacologic Substance,Steroid]
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "0.5% SDS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "and"

Phrase: "a protease inhibitor mixture"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439962:Mixture [Substance]
   734   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   734   C3536890:Protease Inhibitor [Pharmacologic Substance]

Phrase: "(50g/ml pepstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "50g/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "10g/ml aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.25mM phenylmethylsulfonyl fluoride"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.65: Lysates were briefly sonicated to reduce viscosity and fractionated on SDS gels without heating. 

Phrase: "Lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "briefly"

Phrase: "sonicated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reduce"

Phrase: "viscosity"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0042784:Viscosity [Natural Phenomenon or Process]
  1000   C0391802:viscosity [Laboratory Procedure]
  1000   C1547055:*Viscosity [Quantitative Concept]
   928 E C0311419:Viscous [Functional Concept]

Phrase: "and"

Phrase: "fractionated on SDS gels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0017243:Gels [Biomedical or Dental Material]
   770   C1979893:Fractionated [Qualitative Concept]
   737 E C1382104:Gel [Substance]

Phrase: "without heating."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018851:Heating [Environmental Effect of Humans]
Processing 00000000.tx.66: Membranes were incubated with PS1- or PS2-specific antisera (see above), and bound antibodies were detected using protein A-horseradish peroxidase (Sigma) followed by chemiluminescence detection (NEN Life Science Products). 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "incubated with PS1-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PS1 [Gene or Genome]
   790   C1439852:Incubated [Laboratory Procedure]
   790   C2986918:PS1 [Gene or Genome]

Phrase: "or"

Phrase: "PS2-specific antisera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "bound antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "protein A-horseradish peroxidase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   812   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0330510:Horseradish [Food]
   812   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   812   C1110641:Horseradish [Plant]
   812   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "followed by chemiluminescence detection"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   770   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   770   C1511790:Detection [Therapeutic or Preventive Procedure]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "(NEN Life Science Products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   923   C0332070:Life Science Products [Health Care Related Organization]
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.67: Quantification of A by Two-site ELISAs-- Monkey COS-1 cells were transfected by the DEAE-dextran method with cDNAs encoding PS1, PS2, or PS1/PS2 polypeptides and cDNAs encoding either full-length APP or the COOH-terminal 100amino acids of APP as described (12, 32). 

Phrase: "Quantification of A by Two-site ELISAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1709793:Quantification [Quantitative Concept]

Phrase: "--"

Phrase: "Monkey COS-1 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   923   C1257857:COS-1 Cells [Cell]
   875   C0376702:COS Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected by the DEAE-dextran method"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0011051:DEAE-Dextran [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]
   753   C0025663:Method [Intellectual Product]
   753   C0046079:DEAE [Organic Chemical,Pharmacologic Substance]
   753   C0086140:Dextran [Carbohydrate,Pharmacologic Substance]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]

Phrase: "with cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "PS1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "PS2,"

Phrase: "or"

Phrase: "PS1/PS2 polypeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "either full-length APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   861   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   839   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1709634:Precursor [Idea or Concept]

Phrase: "or"

Phrase: "the COOH-terminal 100amino acids of APP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0001128:Acids [Chemical]
   708 E C0202406:Acid [Laboratory Procedure]

Phrase: "as described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(12,"

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.68: Conditioned media were collected 48h after transfection, and secreted A species ending at 40or 42/43 were quantified using BNT77/BA27 or BC05 two-site ELISAs (33-35) as described previously (12, 32). 

Phrase: "Conditioned media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "48h after transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1442464:48H [Temporal Concept]

Phrase: "and"

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]

Phrase: "ending at 40or 42/43"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0444930:ending [Spatial Concept]
   760   C2746065:Ending [Temporal Concept]

Phrase: "were"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "BNT77/BA27"

Phrase: "or"

Phrase: "BC05 two-site ELISAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0014441:ELISA [Laboratory Procedure]

Phrase: "(33-35"

Phrase: ")"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(12,"

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.69: Data obtained from full-length APP or APP C100 cDNA transfections were combined for analysis. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "obtained from full-length APP"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443225:Full [Qualitative Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1301820:Obtained [Functional Concept]
   748   C1444754:Length [Quantitative Concept]
   748   C1706316:LENGTH [Research Activity]
   748   C1709634:Precursor [Idea or Concept]
   714 E C1706701:Obtain [Activity]

Phrase: "or"

Phrase: "APP C100 cDNA transfections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "were"

Phrase: "combined for analysis."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0205195:Combined [Qualitative Concept]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]
   756 E C0336789:Combine [Manufactured Object]
Processing 00000000.tx.70: To facilitate comparison between media from cells transfected with different cDNA, the ratio of A42/total A was calculated for each sample and statistically examined using analysis of variance followed by Fisher LSD test and expressed as meanS.E.  

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "facilitate"

Phrase: "comparison between media"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "from cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with different cDNA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1705242:Different [Qualitative Concept]

Phrase: "the ratio of A42/total A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "calculated for each sample"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0370003:Sample [Substance]
   770   C0444686:Calculated [Functional Concept]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]
   770   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "statistically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038215:Statistically [Occupation or Discipline]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "analysis of variance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "followed by Fisher LSD test"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C0332283:Followed by [Temporal Concept]
           followed
   797   C1708064:Fisher's Test [Intellectual Product]
   760   C0022885:Test [Laboratory Procedure]
   760   C0024334:LSD [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   760   C0039593:Test [Functional Concept]
   760   C0202406:LSD [Laboratory Procedure]
   760   C0325045:Fisher [Mammal]
   760   C0392366:test [Intellectual Product]
   760   C1414110:LSD [Gene or Genome]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "expressed as meanS.E."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.71: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Transgene-derived Human PS1 NTF Fails to Assemble with Endogenous PS1 CTF-- In previous studies, we and others reported that the NTF and CTF derived from endoproteolysis of PS1 (or PS2) are noncovalently associated to each other in vivo (26, 36, 37). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Transgene-derived Human PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "Fails to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0231175:fail [Functional Concept]

Phrase: "Assemble with Endogenous PS1 CTF"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   748   C0205088:Terminal [Temporal Concept]
   748   C0205227:Endogenous [Functional Concept]
   748   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332255:fragments [Functional Concept]
   748   C0486805:Fragments [Body Substance]
   748   C1418985:PS1 [Gene or Genome]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]
   748   C1706853:Assemble [Activity]
   748   C2986918:PS1 [Gene or Genome]
   714 E C1708096:Fragment [Qualitative Concept]

Phrase: "-"

Phrase: "-"

Phrase: "In previous studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "derived from endoproteolysis of PS1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1418985:PS1 [Gene or Genome]
   760   C1441547:Derived [Qualitative Concept]
   760   C2986918:PS1 [Gene or Genome]
   760   C3245521:derived [Idea or Concept]

Phrase: "("

Phrase: "or"

Phrase: "PS2"

Phrase: ")"

Phrase: "are"

Phrase: "noncovalently"

Phrase: "associated to each other in vivo"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C1515655:In Vivo [Spatial Concept]
           vivo
   753   C0332281:Associated [Qualitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(26,"

Phrase: "36,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.72: To further characterize the NTF and CTF assemblies, we generated stable mouse N2a neuroblastoma cell lines transfected with a plasmid that encodes human PS1 residues 1-298 (analogous to NTF). 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "characterize"

Phrase: "the NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "CTF assemblies,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C1707720:Terminal Assembly [Manufactured Object]
   779   C1706853:Assembly [Activity]
   779   C1879748:Assembly [Manufactured Object]

Phrase: "we"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "stable mouse N2a neuroblastoma cell lines"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   887   C0598091:stable cell line [Cell]
   869   C1513528:Mouse Cell Line [Cell]
   839   C1524043:Mouse Neuroblastoma [Neoplastic Process]
   827   C0007600:Cell lines [Cell]
   827   C0815000:neuroblastoma cell [Cell]
   799   C0007634:Cell [Cell]
   799   C0027819:Neuroblastoma [Neoplastic Process]
   799   C0205132:lines [Spatial Concept]
   799   C0700095:neuroblastoma [Neoplastic Process]
   799   C1269647:Cell [Cell]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
   799   C3540583:Neuroblastoma [Intellectual Product]
   766 E C1550648:Line [Substance]
   766 E C1552960:Line [Quantitative Concept]

Phrase: "transfected with a plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "that"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "human PS1 residues 1-298"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   804   C0086418:Human [Human]
   804   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1418985:PS1 [Gene or Genome]
   804   C2986918:PS1 [Gene or Genome]
   771   C1709915:Residue [Conceptual Entity]
   771   C1882936:RESIDUE [Phenomenon or Process]
   721 E C1609982:Residual [Qualitative Concept]

Phrase: "(analogous to NTF"

Phrase: ")."
Processing 00000000.tx.73: Expression of transgene-derived human PS1 NTF was assessed by Western blotting using PS1NT, a polyclonal PS1 antiserum that recognizes epitopes in the NH2 terminus of PS1 (26). 

Phrase: "Expression of transgene-derived human PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "assessed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1516048:Assessed [Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PS1NT,"

Phrase: "a polyclonal PS1 antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "that"

Phrase: "recognizes"

Phrase: "epitopes in the NH2 terminus of PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0003316:Epitopes [Immunologic Factor]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.74: Transgene-derived human PS1 NTF was readily detected in several independent stable N2a cell lines (Fig. 1A, top, lanes 3-5). 

Phrase: "Transgene-derived human PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "was"

Phrase: "readily"

Phrase: "detected in several independent stable N2a cell lines"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   776   C0598091:stable cell line [Cell]
   770   C0007600:Cell lines [Cell]
   744   C0007634:Cell [Cell]
   744   C0085862:Independent [Idea or Concept]
   744   C0205132:lines [Spatial Concept]
   744   C0205360:Stable [Qualitative Concept]
   744   C0442726:Detected [Finding]
   744   C0445079:N2a [Finding]
   744   C1269647:Cell [Cell]
   744   C1299583:Independent [Finding]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]
   744   C1547311:Stable [Intellectual Product]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   711 E C1550648:Line [Substance]
   711 E C1552960:Line [Quantitative Concept]

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "top,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "lanes 3-5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.75: Consistent with previous reports (10, 11, 18, 21), the recombinant human PS1 NTF exhibited accelerated migration relative to the mouse PS1 NTF on SDS-polyacrylamide gel electrophoresis (lane 1) and co-migrated with the human NTF derived from full-length human PS1 (lane 2). 

Phrase: "Consistent with previous reports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(10,"

Phrase: "11,"

Phrase: "18,"

Phrase: "21"

Phrase: ")"

Phrase: ","

Phrase: "the recombinant human PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "accelerated migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "relative to the mouse PS1 NTF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "on SDS-polyacrylamide gel electrophoresis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   923   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   861   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   861   C0596607:Gel Electrophoresis [Laboratory Procedure]
   812   C0013855:Electrophoresis [Laboratory Procedure]
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   812   C1382104:Gel [Substance]

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "co-migrated with the human NTF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0086418:Human [Human]
   753   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   753   C0232902:Migrated [Functional Concept]

Phrase: "derived from full-length human PS1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0086418:Human [Human]
   753   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0443225:Full [Qualitative Concept]
   753   C1418985:PS1 [Gene or Genome]
   753   C1441547:Derived [Qualitative Concept]
   753   C1444754:Length [Quantitative Concept]
   753   C1706316:LENGTH [Research Activity]
   753   C2986918:PS1 [Gene or Genome]
   753   C3245521:derived [Idea or Concept]

Phrase: "(lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.76: Previously, we reported that the expression of human full-length PS1 in mouse N2a cells resulted in a decrease in the levels of murine PS1-derived NTF and CTF (21). 

Phrase: "Previously,"

Phrase: "we"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the expression of human full-length PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in mouse N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "resulted in a decrease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "in the levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "of murine PS1-derived NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.77: To examine whether the expression of recombinant human NTF abrogated accumulation of endogenous murine PS1 derivatives, we performed Western blots using PS1Loop, an antiserum that reacts with epitopes in the hydrophilic loop domain of PS1 (18). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "the expression of recombinant human NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "abrogated"

Phrase: "accumulation of endogenous murine PS1 derivatives,"

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "Western blots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PS1Loop,"

Phrase: "an antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "that"

Phrase: "reacts with epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0003316:Epitopes [Immunologic Factor]

Phrase: "in the hydrophilic loop domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "of PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.78: The steady-state levels of mouse PS1 CTF in three independent N2a lines examined were essentially identical to N2a cells transfected with empty vector (21) (Fig. 1A, bottom), indicating that human NTF did not interfere with the accumulation of mouse CTF. 

Phrase: "The steady-state levels of mouse PS1 CTF"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0678587:steady state [Natural Phenomenon or Process]
   743   C0683927:state level [Spatial Concept]
   739   C0205361:Steady [Qualitative Concept]
   739   C0441889:Levels [Qualitative Concept]
   739   C1301808:State [Geographic Area]
   739   C1442792:State [Functional Concept]
   739   C3148680:State [Geographic Area]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "in three independent N2a lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "were"

Phrase: "essentially identical to N2a cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205280:Identical [Qualitative Concept]

Phrase: "transfected with empty vector"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vector [Spatial Concept]
   770   C1705099:Vector [Idea or Concept]
   770   C1880497:Empty [Qualitative Concept]
   715 E C0333668:Depleted [Functional Concept]

Phrase: "(21"

Phrase: ")"

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that human NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interfere with the accumulation of mouse CTF."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0205088:Terminal [Temporal Concept]
   742   C0332255:fragments [Functional Concept]
   742   C0486805:Fragments [Body Substance]
   742   C0521102:Interfere [Qualitative Concept]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
   708 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.79: View larger version (33K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(33K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.80: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.81: Characterization of transgene-derived human NTF expressed in stably transfected mouse N2a cells. 

Phrase: "Characterization of transgene-derived human NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "expressed in stably transfected mouse N2a cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0007634:Cells [Cell]
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0445079:N2a [Finding]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.82: A, detergent lysates prepared from stable N2a cell lines transfected with empty vector (lane 1), full-length PS1 cDNA (lane 2), or human PS1 NTF cDNA (lanes 3-5) were fractionated by SDS-polyacrylamide gel electrophoresis and analyzed by immunoblotting with PS1NT (top) or PS1Loop (bottom). 

Phrase: "A,"

Phrase: "detergent lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "prepared from stable N2a cell lines"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   804   C0598091:stable cell line [Cell]
   790   C0007600:Cell lines [Cell]
   753   C0007634:Cell [Cell]
   753   C0205132:lines [Spatial Concept]
   753   C0205360:Stable [Qualitative Concept]
   753   C0445079:N2a [Finding]
   753   C1269647:Cell [Cell]
   753   C1547311:Stable [Intellectual Product]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719   C1521827:Prepare [Functional Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]

Phrase: "transfected with empty vector"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vector [Spatial Concept]
   770   C1705099:Vector [Idea or Concept]
   770   C1880497:Empty [Qualitative Concept]
   715 E C0333668:Depleted [Functional Concept]

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "full-length PS1 cDNA (lane 2"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   876   C0806636:Length 2 [Quantitative Concept]
   799   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0443225:Full [Qualitative Concept]
   799   C1418985:PS1 [Gene or Genome]
   799   C1444754:Length [Quantitative Concept]
   799   C1706316:LENGTH [Research Activity]
   799   C1708639:Lane [Spatial Concept]
   799   C2986918:PS1 [Gene or Genome]
   727 E C0205166:Long [Qualitative Concept]
   727 E C1522425:Longest [Qualitative Concept]
   727 E C1706317:Long [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "human PS1 NTF cDNA (lanes 3-5"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   795   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0086418:Human [Human]
   795   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   795   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C1418985:PS1 [Gene or Genome]
   795   C2986918:PS1 [Gene or Genome]
   762   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "fractionated by SDS-polyacrylamide gel electrophoresis"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   882   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   833   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   790   C0596607:Gel Electrophoresis [Laboratory Procedure]
   783 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C1382104:Gel [Substance]
   753   C1979893:Fractionated [Qualitative Concept]

Phrase: "and"

Phrase: "analyzed by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "with PS1NT"

Phrase: "(top)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "or"

Phrase: "PS1Loop"

Phrase: "(bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.83: Full-length human PS1 (FL), human (Hu), and murine (Mo) PS1 NTF and CTF are indicated. 

Phrase: "Full-length human PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1418985:PS1 [Gene or Genome]
   812   C2986918:PS1 [Gene or Genome]

Phrase: "(FL), human (Hu),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086418:Human [Human]

Phrase: "and"

Phrase: "murine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026809:Murine [Mammal]
  1000   C0591833:Murine [Organic Chemical,Pharmacologic Substance]

Phrase: "(Mo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: ")"

Phrase: "PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.84: B, stable N2a cells expressing human PS1 NTF were incubated in culture medium containing cycloheximide (30g/ml) for the intervals indicated. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "stable N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "human PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "were"

Phrase: "incubated in culture medium containing cycloheximide"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   753   C0009458:Medium [Intellectual Product]
   753   C0010453:Culture [Idea or Concept]
   753   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   753   C0220814:culture [Functional Concept]
   753   C0332256:Containing [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0439536:Medium [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1705217:Medium [Substance]
   753   C2242979:Culture [Laboratory Procedure]
   753   C2700400:Containing [Activity]
   753   C3244283:medium [Intellectual Product]

Phrase: "(30g/ml) for the intervals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439526:/mL [Quantitative Concept]

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.85: Detergent lysates prepared after the incubation period were analyzed by immunoblotting with PS1NT (top) or PS1Loop (bottom). 

Phrase: "Detergent lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "prepared after the incubation period"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1320226:Incubation period [Finding]
   760   C0439531:/period [Temporal Concept]
   760   C1948053:Period [Temporal Concept]
   726   C1521827:Prepare [Functional Concept]

Phrase: "were"

Phrase: "analyzed by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "with PS1NT"

Phrase: "(top)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "or"

Phrase: "PS1Loop"

Phrase: "(bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.86: C, stable N2a cells expressing human PS1 NTF were lysed under nondenaturing conditions, and lysates were used to co-immunoprecipitate PS1 NTF using polyclonal PS1NT antiserum, a PS1 mAb (which reacts specifically with human PS1 NH2-terminal epitopes), or control Myc and SOD1 antibodies. 

Phrase: "C,"

Phrase: "stable N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "human PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "were"

Phrase: "lysed under nondenaturing conditions,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0024348:lysed [Pathologic Function]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "and"

Phrase: "lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "used to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   833   C1273517:used [Finding]
   799 E C0042153:use [Functional Concept]
   799 E C0457083:Use [Functional Concept]
   799 E C1947944:Use [Intellectual Product]

Phrase: "co-immunoprecipitate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "polyclonal PS1NT antiserum,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "a PS1 mAb"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0746619:monoclonal [Finding]

Phrase: "("

Phrase: "which"

Phrase: "reacts"

Phrase: "specifically with human PS1 NH2-terminal epitopes"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0002508:NH2 [Organic Chemical]
   748   C0003316:Epitopes [Immunologic Factor]
   748   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   748   C0086418:Human [Human]
   748   C0205088:Terminal [Temporal Concept]
   748   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1418985:PS1 [Gene or Genome]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]
   748   C2986918:PS1 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "control Myc"

Phrase: "and"

Phrase: "SOD1 antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.87: The resulting immunoprecipitates and total lysates (corresponding to of the volume used for immunoprecipitations) were probed with PS1NT (top panels) or PS1Loop (bottom panels). 

Phrase: "The resulting immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "total lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "("

Phrase: "corresponding to of the volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0449468:*Volume [Quantitative Concept]
   760   C1690016:% volume [Qualitative Concept]
   760   C1705102:Volume [Intellectual Product]
   760   C2700258:Volume [Laboratory Procedure]

Phrase: "used for immunoprecipitations"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1273517:used [Finding]
   756   C0021069:Immunoprecipitation [Laboratory Procedure]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "probed with PS1NT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0182400:Probe [Medical Device]
   756   C1704681:Probe [Gene or Genome]
   756   C2347609:Probe [Chemical Viewed Functionally]
   756   C3536729:Probe [Manufactured Object]

Phrase: "(top panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "PS1Loop"

Phrase: "(bottom panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.88: PS1 NTF and CTF are indicated by arrowheads. 

Phrase: "PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "indicated by arrowheads."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1080898:Arrowheads [Plant]
   790   C1444656:Indicated [Finding]
   756 E C0453107:Arrowhead [Food]
Processing 00000000.tx.89: The slower migrating PS1Loop-reactive band probably represents the phosphorylated form of PS1 CTF (36, 43). 

Phrase: "The slower migrating PS1Loop-reactive band probably"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0175723:Band [Medical Device]
   799   C0439645:Band [Spatial Concept]
   799   C1521913:band [Cell Component]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the phosphorylated form of PS1 CTF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1522492:Form [Functional Concept]

Phrase: "(36,"

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.90: The high molecular weight PS1NT-reactive species (lane 5) represent nonspecific aggregation of overexpressed human NTF. 

Phrase: "The high molecular weight PS1NT-reactive species"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0205332:Reactive [Qualitative Concept]
   799   C1705920:Species [Conceptual Entity]

Phrase: "(lane 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "nonspecific aggregation of overexpressed human NTF."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]
Processing 00000000.tx.91: The small decrease in the CTF signal in lane 5is not reproducible and is seen only in samples with aggregated human NTF. 

Phrase: "The small decrease in the CTF signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0392756:Decrease [Qualitative Concept]
   742   C0547047:Decrease [Quantitative Concept]

Phrase: "in lane 5is"

Phrase: "not reproducible"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C1514863:Reproducibility [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "only in samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205171:Only [Quantitative Concept]
   790   C1720467:Only [Intellectual Product]
   756   C0370003:Sample [Substance]
   756   C2347026:Sample [Conceptual Entity]

Phrase: "with aggregated human NTF."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.92: Recently, Steiner and colleagues (25) reported that recombinant human PS1 NTF expressed in stably transfected human 293cells undergoes rapid degradation mediated by the proteasome. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "Steiner"

Phrase: "and"

Phrase: "colleagues"

Phrase: "(25"

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that recombinant human PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "expressed in stably transfected human 293cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0086418:Human [Human]

Phrase: "undergoes"

Phrase: "rapid degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "mediated by the proteasome."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.93: While endogenous NTF and CTF were detected in a stable human 293cell line expressing recombinant human NTF, it could not be determined whether high level expression of recombinant human NTF affected endogenous NTF because of the comigration of endogenous and exogenous NTFs (25, 27). 

Phrase: "While"

Phrase: "endogenous NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "detected in a stable human 293cell line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0086418:Human [Human]
   748   C0205132:Line [Spatial Concept]
   748   C0205360:Stable [Qualitative Concept]
   748   C0442726:Detected [Finding]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1547311:Stable [Intellectual Product]
   748   C1550648:Line [Substance]
   748   C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "recombinant human NTF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "it"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "determined"

Phrase: "whether"

Phrase: "high level expression of recombinant human NTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C3244092:expression level [Idea or Concept]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "endogenous NTF because of the comigration of endogenous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "exogenous NTFs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "(25,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.94: We addressed this issue in our stable N2a cell lines expressing human PS1 NTF. 

Phrase: "We"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "this issue in our stable N2a cell lines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0033213:Issue [Finding]
   744   C1706387:Issue [Intellectual Product]

Phrase: "expressing"

Phrase: "human PS1 NTF."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.95: A PS1NT-reactive species co-migrating with the mouse NTF was visible in lysates of stable N2a cells expressing low levels of recombinant human NTF (Fig. 1A, top, compare lanes 1and 3). 

Phrase: "A PS1NT-reactive species"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "co-migrating with the mouse NTF"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   753   C0232902:migrating [Functional Concept]

Phrase: "was"

Phrase: "visible in lysates of stable N2a cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205379:Visible [Qualitative Concept]

Phrase: "expressing"

Phrase: "low levels of recombinant human NTF (Fig. 1A,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "top,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "lanes 1and 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.96: However, the mouse NTF and the recombinant human NTF were not sufficiently resolved on SDS-polyacrylamide gel electrophoresis to convincingly demonstrate whether or not the expression of human NTF influenced the accumulation of mouse NTF. 

Phrase: "However,"

Phrase: "the mouse NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "the recombinant human NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "were"

Phrase: "not sufficiently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "resolved on SDS-polyacrylamide gel electrophoresis"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   882   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   833   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   790   C0596607:Gel Electrophoresis [Laboratory Procedure]
   783 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C1382104:Gel [Substance]
   753   C1514893:Resolved [Idea or Concept]
   753   C2699488:Resolved [Conceptual Entity]

Phrase: "to convincingly"

Phrase: "demonstrate"

Phrase: "whether"

Phrase: "or"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the expression of human NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "influenced"

Phrase: "the accumulation of mouse NTF."
Processing 00000000.tx.97: Therefore, we used an alternate strategy that takes advantage of the findings that while the recombinant human NTF is short lived (25), endogenous PS-derived NTF has a half-life of several hours (22, 23). 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an alternate strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679199:strategy [Mental Process]

Phrase: "that"

Phrase: "takes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "advantage of the findings"

Phrase: "that"

Phrase: "while"

Phrase: "the recombinant human NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "is"

Phrase: "short lived"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1282927:short [Qualitative Concept]
   861   C1806781:Short [Quantitative Concept]
   861   C2350002:Short [Quantitative Concept]
   827   C1548795:Live [Qualitative Concept]
   827   C1634625:% live [Qualitative Concept]
   827   C2982691:Live [Activity]

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "endogenous PS-derived NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "has"

Phrase: "a half-life of several hours"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0018517:Half-Life [Temporal Concept]
   767   C1442458:Half Hour [Temporal Concept]
   753   C0376558:Life [Idea or Concept]
   753   C2825407:Half [Quantitative Concept]

Phrase: "(22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.98: We incubated stable N2a cell line PS1298.6, which expresses high levels of human NTF (Fig. 1B, lane 1), with cycloheximide to arrest protein synthesis and examined the decay of human NTF over a 6-h interval. 

Phrase: "We"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "stable N2a cell line PS1298.6,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   867   C0598091:stable cell line [Cell]
   827   C0007600:Cell Line [Cell]
   799   C0007634:Cell [Cell]
   799   C0205132:Line [Spatial Concept]
   799   C0205360:Stable [Qualitative Concept]
   799   C0445079:N2a [Finding]
   799   C1269647:Cell [Cell]
   799   C1547311:Stable [Intellectual Product]
   799   C1550648:Line [Substance]
   799   C1552960:Line [Quantitative Concept]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "expresses"

Phrase: "high levels of human NTF (Fig. 1B,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "with cycloheximide to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   805 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "arrest"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0237477:Arrest [Temporal Concept]
  1000   C0392351:arrest [Governmental or Regulatory Activity]
   944 E C0311403:Inhibited [Qualitative Concept]
   944 E C3463820:Inhibiting [Activity]
   916 E C0018790:arrested [Disease or Syndrome]
   916 E C0521111:Retarded [Qualitative Concept]

Phrase: "protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the decay of human NTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1265875:Decay [Acquired Abnormality]
   760   C2700592:Decay [Phenomenon or Process]

Phrase: "over a 6-h interval."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
Processing 00000000.tx.99: Immunoblot of cell lysates collected at various time points revealed that the faster migrating PS1NT-reactive species, which corresponds to recombinant human NTF, degraded rapidly (t1/2~1.5h) after the addition of cycloheximide. 

Phrase: "Immunoblot of cell lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "collected at various time points"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   773   C2348792:Time Point [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]
   760   C3541383:Time [Temporal Concept]
   726   C1552961:Point [Quantitative Concept]
   726   C2347617:point [Quantitative Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the faster migrating PS1NT-reactive species,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0205332:Reactive [Qualitative Concept]
   804   C1705920:Species [Conceptual Entity]

Phrase: "which"

Phrase: "corresponds to recombinant human NTF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0086418:Human [Human]
   760   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C1514798:recombinant [Organism]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "(t1/2~1.5h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1442467:5H [Temporal Concept]

Phrase: ")"

Phrase: "after the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of cycloheximide."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]
Processing 00000000.tx.100: The slower migrating PS1NT-reactive species, which corresponds to mouse PS1 NTF was readily visible after 1h of cycloheximide treatment and was the only remaining PS1 NTF after 4h of cycloheximide treatment (Fig. 1B, top). 

Phrase: "The slower migrating PS1NT-reactive species,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0205332:Reactive [Qualitative Concept]
   804   C1705920:Species [Conceptual Entity]

Phrase: "which"

Phrase: "corresponds to mouse PS1 NTF"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1418985:PS1 [Gene or Genome]
   760   C2986918:PS1 [Gene or Genome]

Phrase: "was"

Phrase: "readily visible after 1h of cycloheximide treatment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205379:Visible [Qualitative Concept]

Phrase: "and"

Phrase: "was"

Phrase: "the only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "remaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1527428:Remaining [Qualitative Concept]

Phrase: "PS1 NTF after 4h of cycloheximide treatment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "(Fig. 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "top)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]
Processing 00000000.tx.101: Reprobing of the blots using PS1Loop antiserum revealed that the levels of mouse CTF remained unchanged during the 6-h cycloheximide treatment (Fig. 1B, bottom). 

Phrase: "Reprobing of the blots"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PS1Loop antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the levels of mouse CTF"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "remained"

Phrase: "unchanged during the 6-h cycloheximide treatment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0442739:Unchanged [Finding]
   748   C2346711:Unchanged [Qualitative Concept]

Phrase: "(Fig. 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.102: Similar results were obtained in cell lines expressing low or high levels of human PS1 NTF (data not shown). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "in cell lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0007600:Cell lines [Cell]
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "or"

Phrase: "high levels of human PS1 NTF (data"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.103: These results provide evidence for the presence of stable pools of endogenous NTF in N2a cell lines expressing high levels of recombinant human NTF. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence for the presence of stable pools of endogenous NTF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in N2a cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "high levels of recombinant human NTF."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.104: Furthermore, the short half-life of transgene-derived human NTF in our stable N2a cell lines is entirely consistent with previous studies (25). 

Phrase: "Furthermore,"

Phrase: "the short half-life of transgene-derived human NTF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0018517:Half-Life [Temporal Concept]
   742   C0376558:Life [Idea or Concept]
   742   C2825407:Half [Quantitative Concept]

Phrase: "in our stable N2a cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   906   C0598091:stable cell line [Cell]
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "is"

Phrase: "entirely consistent with previous studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.105: From these results, we conclude that the expression of transgene-derived human NTF failed to interfere with the endoproteolysis of endogenous murine PS1, or the accumulation of mouse PS1 derivatives. 

Phrase: "From these results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "we"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the expression of transgene-derived human NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interfere with the endoproteolysis of endogenous murine PS1,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0026809:Murine [Mammal]
   744   C0205227:Endogenous [Functional Concept]
   744   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0521102:Interfere [Qualitative Concept]
   744   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   744   C1418985:PS1 [Gene or Genome]
   744   C2986918:PS1 [Gene or Genome]

Phrase: "or"

Phrase: "the accumulation of mouse PS1 derivatives."
Processing 00000000.tx.106: We then examined whether the transgene-derived human NTF associated with endogenous mouse PS1 CTF. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "the transgene-derived human NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "associated with endogenous mouse PS1 CTF."
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0205088:Terminal [Temporal Concept]
   744   C0205227:Endogenous [Functional Concept]
   744   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0332255:fragments [Functional Concept]
   744   C0486805:Fragments [Body Substance]
   744   C1418985:PS1 [Gene or Genome]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]
   744   C2986918:PS1 [Gene or Genome]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]
   711 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.107: Previous studies demonstrated that after repeated immunodepletion of PS1 NTFCTF complexes, only recombinant human NTF remained in the lysates of human 293cells expressing human PS1 NTF (25). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "after"

Phrase: "repeated immunodepletion of PS1 NTFCTF complexes,"

Phrase: "only recombinant human NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "remained in the lysates of human 293cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0086418:Human [Human]
   714   C1881488:Lysate [Physical Object]

Phrase: "expressing"

Phrase: "human PS1 NTF (25"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0086418:Human [Human]
   812   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1418985:PS1 [Gene or Genome]
   812   C2986918:PS1 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.108: We were interested in directly testing whether we could isolate complexes containing human PS1 NTF and mouse PS1 CTF using a human PS1-specific antibody. 

Phrase: "We"

Phrase: "were"

Phrase: "interested in directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0543488:Interested [Mental Process]
   790   C1947931:Directly [Qualitative Concept]

Phrase: "testing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0039593:Testing [Functional Concept]
  1000   C0392366:testing [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]

Phrase: "whether"

Phrase: "we"

Phrase: "could"

Phrase: "isolate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370215:Isolate [Substance]
  1000   C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704241:Complexes [Chemical Viewed Structurally]
   966 E C0439855:Complex [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "human PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "mouse PS1 CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0332255:fragments [Functional Concept]
   804   C0486805:Fragments [Body Substance]
   771 E C1708096:Fragment [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a human PS1-specific antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.109: To distinguish between the transgene-derived human NTF and endogenous mouse NTF, we used a rat mAb that reacts specifically with the human PS1 NH2 terminus (21, 30). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "distinguish between the transgene-derived human NTF"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0086418:Human [Human]
   748   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   748   C0282641:Transgene [Gene or Genome]
   748   C1441547:Derived [Qualitative Concept]
   748   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "endogenous mouse NTF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a rat mAb"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0746619:monoclonal [Finding]

Phrase: "that"

Phrase: "reacts"

Phrase: "specifically with the human PS1 NH2 terminus"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0002508:NH2 [Organic Chemical]
   748   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   748   C0086418:Human [Human]
   748   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1418985:PS1 [Gene or Genome]
   748   C2986918:PS1 [Gene or Genome]

Phrase: "(21,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.110: Stable N2a cells expressing human PS1 NTF were lysed under nondenaturing conditions, and aliquots of the lysates were incubated with either the anti-human PS1 mAb or polyclonal PS1NT antiserum (which reacts with both human and murine PS1). 

Phrase: "Stable N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "human PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "were"

Phrase: "lysed under nondenaturing conditions,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0024348:lysed [Pathologic Function]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "and"

Phrase: "aliquots of the lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "incubated with either"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "the anti-human PS1 mAb"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0746619:monoclonal [Finding]

Phrase: "or"

Phrase: "polyclonal PS1NT antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "which"

Phrase: "reacts with both human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0086418:Human [Human]

Phrase: "and"

Phrase: "murine PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.111: The immunoprecipitates were first probed using PS1NT to confirm successful immunoprecipitation of PS1 NTF by both antibodies (Fig. 1C, top panels, lanes 1and 3). 

Phrase: "The immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "probed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0182400:Probe [Medical Device]
   966   C1704681:Probe [Gene or Genome]
   966   C2347609:Probe [Chemical Viewed Functionally]
   966   C3536729:Probe [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PS1NT to"

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "successful immunoprecipitation of PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "by both antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 1C,"

Phrase: "top panels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "lanes 1and 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.112: As expected, control immunoprecipitations performed using monoclonal anti-Myc antibody, 9E10, and polyclonal anti-superoxide dismutase antibody, SOD1, failed to isolate PS1 NTF (lanes 2and 4). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "control immunoprecipitations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "monoclonal anti-Myc antibody,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "9E10,"

Phrase: "and"

Phrase: "polyclonal anti-superoxide dismutase antibody,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "SOD1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1151619:SOD-1 [Molecular Function]
  1000   C1420306:SOD1 [Gene or Genome]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "isolate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370215:Isolate [Substance]
  1000   C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "PS1 NTF (lanes 2and 4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   804   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1418985:PS1 [Gene or Genome]
   804   C2986918:PS1 [Gene or Genome]
   771   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.113: Reprobing of the blots using PS1Loop antiserum revealed the presence of co-purified mouse PS1 CTF in immunoprecipitates prepared using PS1NT antiserum (Fig. 1C, bottom panels, lane 3), but not by using anti-human PS1 mAb (lane 1). 

Phrase: "Reprobing of the blots"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PS1Loop antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the presence of"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "co-purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1998793:Purified [Functional Concept]
   768 E C1947930:Cleanse [Activity]

Phrase: "mouse PS1 CTF in immunoprecipitates"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0332255:fragments [Functional Concept]
   748   C0486805:Fragments [Body Substance]
   714 E C1708096:Fragment [Qualitative Concept]

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PS1NT antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 1C,"

Phrase: "bottom panels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1518422:Not [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-human PS1 mAb"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0746619:monoclonal [Finding]

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.114: These results demonstrate that transgene-derived recombinant human NTF could not assemble into complexes containing the endogenous murine PS1 CTF. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that transgene-derived recombinant human NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "assemble into complexes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1704241:Complexes [Chemical Viewed Structurally]
   790   C1706853:Assemble [Activity]
   756 E C0439855:Complex [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the endogenous murine PS1 CTF."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0332255:fragments [Functional Concept]
   799   C0486805:Fragments [Body Substance]
   766 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.115: Cells Co-expressing PS1 and PS2 Do Not Form heteromeric PS1PS2 Assemblies-- Both PS1 and PS2 have been reported to form heteromeric assemblies and migrate as high molecular weight complexes on size exclusion columns and velocity density gradients (29, 36, 37). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Co-expressing"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2"

Phrase: "Do"

Phrase: "Not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "Form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "heteromeric PS1PS2 Assemblies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1706853:Assembly [Activity]
   793   C1879748:Assembly [Manufactured Object]

Phrase: "-"

Phrase: "-"

Phrase: "Both PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2"

Phrase: "have"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "heteromeric assemblies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]

Phrase: "and"

Phrase: "migrate as high molecular weight complexes"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   833   C1979900:High molecular weight [Qualitative Concept]
   790   C0026385:Molecular Weight [Quantitative Concept]
   783   C0948775:high weight [Sign or Symptom]
   753   C0005910:weight [Organism Attribute]
   753   C0043100:Weight [Quantitative Concept]
   753   C0205250:High [Qualitative Concept]
   753   C0232902:migrate [Functional Concept]
   753   C1299351:High [Qualitative Concept]
   753   C1305866:weight [Diagnostic Procedure]
   753   C1521991:Molecular [Qualitative Concept]
   753   C1704241:Complexes [Chemical Viewed Structurally]
   753   C1705104:Weight [Idea or Concept]
   753   C2700149:HIGH [Intellectual Product]
   719 E C0439855:Complex [Qualitative Concept]

Phrase: "on size exclusion columns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1185738:Column [Body Part, Organ, or Organ Component]
   793   C1706132:Column [Idea or Concept]

Phrase: "and"

Phrase: "velocity density gradients"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0178587:density [Quantitative Concept]
   827   C0812409:gradients [Quantitative Concept]
   793 E C0439182:% gradient [Quantitative Concept]
   755 E C0439794:Dense [Qualitative Concept]

Phrase: "(29,"

Phrase: "36,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.116: However, it is not clear whether PS1 derivatives form heteromeric complexes with PS2 derivatives. 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "whether"

Phrase: "PS1 derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "heteromeric complexes with PS2 derivatives."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1704241:Complexes [Chemical Viewed Structurally]
   726 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.117: To address this issue, we used a stable N2a cell line transfected with human full-length PS2 cDNA. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this issue,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a stable N2a cell line"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0598091:stable cell line [Cell]
   861   C0007600:Cell Line [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "transfected with human full-length PS2 cDNA."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0086418:Human [Human]
   748   C0443225:Full [Qualitative Concept]
   748   C1444754:Length [Quantitative Concept]
   748   C1706316:LENGTH [Research Activity]
Processing 00000000.tx.118: As we reported previously (21), high level expression of human PS2 in mouse N2a cells results in the diminution of mouse PS1 derivatives (Fig. 2A, lane 6). 

Phrase: "As"

Phrase: "we"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "high level expression of human PS2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C3244092:expression level [Idea or Concept]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in mouse N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "results in the diminution of mouse PS1 derivatives"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0243072:derivatives [Chemical Viewed Structurally]
   744   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0332511:Diminution [Qualitative Concept]
   744   C1274040:Result [Functional Concept]
   744   C1418985:PS1 [Gene or Genome]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]
   744   C2986918:PS1 [Gene or Genome]
   711 E C1527240:Derivative [Functional Concept]

Phrase: "(Fig. 2A,"

Phrase: "lane 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.119: Therefore, we chose a cell line that expresses low levels of human PS2 (lane 2) for the present studies; 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "chose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Choose [Activity]

Phrase: "a cell line"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007600:Cell Line [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: "that"

Phrase: "expresses"

Phrase: "low levels of human PS2"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "(lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "for the present studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: ";"
Processing 00000000.tx.120: PS1 derivatives are only partially replaced in this cell line (compare lanes 4and 5). 

Phrase: "PS1 derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "are"

Phrase: "only partially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "replaced in this cell line"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C0007600:Cell Line [Cell]
   760   C0007634:Cell [Cell]
   760   C0205132:Line [Spatial Concept]
   760   C0559956:Replaced [Functional Concept]
   760   C1269647:Cell [Cell]
   760   C1299987:replaced [Functional Concept]
   760   C1550648:Line [Substance]
   760   C1552960:Line [Quantitative Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1554078:Replace [Idea or Concept]

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "lanes 4and 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.121: We performed co-immunoprecipitation analyses using PS1 and PS2 antibodies: PS1 derivatives were immunoprecipitated using antibodies PS1NT and PS1Loop; 

Phrase: "We"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "co-immunoprecipitation analyses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]
   734   C1449705:Co-Immunoprecipitation [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2 antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ":"

Phrase: "PS1 derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "were"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibodies PS1NT"

Phrase: "and"

Phrase: "PS1Loop"

Phrase: ";"
Processing 00000000.tx.122: PS2 NTF and CTF were immunoprecipitated using PS2NT and PS2Loop, respectively. 

Phrase: "PS2 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PS2NT"

Phrase: "and"

Phrase: "PS2Loop,"

Phrase: "respectively."
Processing 00000000.tx.123: In parallel, polyclonal SOD1 antiserum and normal rabbit serum were used in control immunoprecipitations. 

Phrase: "In parallel, polyclonal SOD1 antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "normal rabbit serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0034493:Rabbit [Mammal]
   827   C0205307:Normal [Qualitative Concept]
   827   C0229671:Serum [Body Substance]
   827   C0439166:% normal [Quantitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C2347086:% Normal [Quantitative Concept]

Phrase: "were"

Phrase: "used in control immunoprecipitations."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0243148:control [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C0021069:Immunoprecipitation [Laboratory Procedure]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.124: The immunoprecipitates were analyzed by sequential immunoblotting using PS1 and PS2 antisera. 

Phrase: "The immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "analyzed by sequential immunoblotting"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0020985:Immunoblotting [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1548958:Sequential [Idea or Concept]
   770   C1705294:Sequential [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2 antisera."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.125: As expected, PS1NT and PS1Loop antisera co-immunoprecipitated PS1 CTF and NTF, respectively (Fig. 2B, top panels, lanes 1and 5), but failed to co-purify PS2 derivatives (Fig. 2B, bottom panels, lanes 1and 4). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "PS1NT"

Phrase: "and"

Phrase: "PS1Loop antisera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "co-immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "PS1 CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "NTF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "respectively"

Phrase: "(Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "top panels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "lanes 1and 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "failed to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0231175:Failed [Functional Concept]

Phrase: "co-purify"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   777   C1947930:Cleanse [Activity]
   777   C1998793:Purified [Functional Concept]

Phrase: "PS2 derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "(Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "bottom panels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "lanes 1and 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.126: Furthermore, PS2NT and PS2Loop antisera co-immunoprecipitated PS2 CTF and NTF, respectively (Fig. 2B, bottom panels, lanes 2and 6), but failed to co-purify PS1 derivatives (Fig. 2B, top panels, lanes 2and 6). 

Phrase: "Furthermore,"

Phrase: "PS2NT"

Phrase: "and"

Phrase: "PS2Loop antisera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "co-immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "PS2 CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "NTF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "respectively"

Phrase: "(Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "bottom panels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "lanes 2and 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "failed to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0231175:Failed [Functional Concept]

Phrase: "co-purify"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   777   C1947930:Cleanse [Activity]
   777   C1998793:Purified [Functional Concept]

Phrase: "PS1 derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "(Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "top panels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "lanes 2and 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.127: These results demonstrate that the derivatives resulting from endoproteolysis of PS1 and PS2 form either PS1 NTFPS1 CTF or PS2 NTFPS2 CTF assemblies but do not form mixed complexes containing the derivatives from both of the precursor polypeptides. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243072:derivatives [Chemical Viewed Structurally]
   966 E C1527240:Derivative [Functional Concept]

Phrase: "resulting from endoproteolysis of PS1"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0678226:resulting [Functional Concept]
   760   C1418985:PS1 [Gene or Genome]
   760   C2986918:PS1 [Gene or Genome]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "PS2 form either PS1 NTFPS1 CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C0332255:fragments [Functional Concept]
   793   C0486805:Fragments [Body Substance]
   760 E C1708096:Fragment [Qualitative Concept]

Phrase: "or"

Phrase: "PS2 NTFPS2 CTF assemblies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   822   C1707720:Terminal Assembly [Manufactured Object]
   766   C1706853:Assembly [Activity]
   766   C1879748:Assembly [Manufactured Object]

Phrase: "but"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "mixed complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the derivatives from both of the precursor polypeptides."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0243072:derivatives [Chemical Viewed Structurally]
   711 E C1527240:Derivative [Functional Concept]
Processing 00000000.tx.128: View larger version (39K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(39K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.129: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.130: PS1 and PS2 derivatives do not form mixed complexes. 

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2 derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "mixed complexes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.131: A, detergent lysates prepared from cells transfected with empty vector or PS2 cDNA were analyzed by immunoblotting with PS2Loop (lanes 1-3) or a mixture of PS1NT and PS1Loop (lanes 4-6). 

Phrase: "A,"

Phrase: "detergent lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "prepared from cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756   C1521827:Prepare [Functional Concept]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with empty vector"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vector [Spatial Concept]
   770   C1705099:Vector [Idea or Concept]
   770   C1880497:Empty [Qualitative Concept]
   715 E C0333668:Depleted [Functional Concept]

Phrase: "or"

Phrase: "PS2 cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "analyzed by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "with PS2Loop"

Phrase: "(lanes 1-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "a mixture of PS1NT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439962:Mixture [Substance]

Phrase: "and"

Phrase: "PS1Loop"

Phrase: "(lanes 4-6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.132: Full-length human PS2 (FL) and endoproteolytic PS1 and PS2 derivatives (arrowheads) are indicated. 

Phrase: "Full-length human PS2"

Phrase: "(FL)"

Phrase: "and"

Phrase: "endoproteolytic PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2 derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "(arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1080898:Arrowheads [Plant]
   966 E C0453107:Arrowhead [Food]

Phrase: ")"

Phrase: "are"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.133: B, stable N2a cells expressing low levels of human PS2 were lysed under nondenaturing conditions, and lysates were used for co-immunoprecipitation analyses using PS1NT, PS1Loop (PS1L), PS2 NT, or PS2Loop (PS2L) antibodies as indicated. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "stable N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "low levels of human PS2"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "lysed under nondenaturing conditions,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0024348:lysed [Pathologic Function]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "and"

Phrase: "lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "used for co-immunoprecipitation analyses"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   760   C0021069:Immunoprecipitation [Laboratory Procedure]
   760   C1273517:used [Finding]
   726   C0002778:Analysis [Laboratory Procedure]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PS1NT,"

Phrase: "PS1Loop (PS1L),"

Phrase: "PS2 NT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332126:NT [Qualitative Concept]
   861   C1449832:NT [Diagnostic Procedure]

Phrase: "or"

Phrase: "PS2Loop (PS2L) antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.134: SOD1 and normal rabbit serum (NRS) were used as negative controls. 

Phrase: "SOD1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1151619:SOD-1 [Molecular Function]
  1000   C1420306:SOD1 [Gene or Genome]

Phrase: "and"

Phrase: "normal rabbit serum (NRS)"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0034493:Rabbit [Mammal]
   827   C0205307:Normal [Qualitative Concept]
   827   C0229671:Serum [Body Substance]
   827   C0439166:% normal [Quantitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C2347086:% Normal [Quantitative Concept]

Phrase: "were"

Phrase: "used as negative controls."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   799   C1639518:% negative control [Quantitative Concept]
   799   C1947986:Negative Control [Conceptual Entity]
   770   C0205160:Negative [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1513916:Negative [Finding]
   770   C2825415:Negative [Conceptual Entity]
   770   C2825491:Negative [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737   C0243148:control [Qualitative Concept]
   737 E C0457083:Use [Functional Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737 E C1947944:Use [Intellectual Product]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.135: After fractionation by SDS-polyacrylamide gel electrophoresis and transfer to membranes, blots containing NTF immunoprecipitates were sequentially probed with PS1Loop (top panels, lanes 1-4) and PS2Loop antibodies (bottom panels, lanes 1-4). 

Phrase: "After fractionation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016640:fractionation [Laboratory Procedure]
  1000   C0524811:fractionation [Therapeutic or Preventive Procedure]
  1000   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "by SDS-polyacrylamide gel electrophoresis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   923   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   861   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   861   C0596607:Gel Electrophoresis [Laboratory Procedure]
   812   C0013855:Electrophoresis [Laboratory Procedure]
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   812   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "transfer to membranes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0040671:Transfer [Mental Process]
   790   C1705822:Transfer [Activity]

Phrase: "blots"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "NTF immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "sequentially"

Phrase: "probed with PS1Loop"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0182400:Probe [Medical Device]
   756   C1704681:Probe [Gene or Genome]
   756   C2347609:Probe [Chemical Viewed Functionally]
   756   C3536729:Probe [Manufactured Object]

Phrase: "(top panels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "lanes 1-4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "PS2Loop antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(bottom panels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "lanes 1-4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.136: Blots containing CTF immunoprecipitates were sequentially probed with PS1NT (top panels, lanes 5-8) and PS1NT antibodies (bottom panels, lanes 5-8). 

Phrase: "Blots"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "sequentially"

Phrase: "probed with PS1NT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0182400:Probe [Medical Device]
   756   C1704681:Probe [Gene or Genome]
   756   C2347609:Probe [Chemical Viewed Functionally]
   756   C3536729:Probe [Manufactured Object]

Phrase: "(top panels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "lanes 5-8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "PS1NT antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(bottom panels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "lanes 5-8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.137: The Endoproteolytic Derivatives from a PS1/PS2 Chimeric Polypeptide Can Form Functional PS1/PS2 Assemblies-- PS1 and PS2 have similar protein structures, share a high degree of amino acid sequence identity, and undergo endoproteolytic cleavage, and the resulting fragments derived from each precursor associate with each other. 

Phrase: "The Endoproteolytic Derivatives from a PS1/PS2 Chimeric Polypeptide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0243072:derivatives [Chemical Viewed Structurally]
   708 E C1527240:Derivative [Functional Concept]

Phrase: "Can"

Phrase: "Form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "Functional PS1/PS2 Assemblies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1706853:Assembly [Activity]
   779   C1879748:Assembly [Manufactured Object]

Phrase: "--"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2"

Phrase: "have"

Phrase: "similar protein structures,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0175168:protein structure [Amino Acid, Peptide, or Protein]
   884   C1510464:Protein Structure [Amino Acid, Peptide, or Protein]
   827   C0678594:structures [Spatial Concept]

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "a high degree of amino acid sequence identity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0441889:Degree [Qualitative Concept]
   744   C0449286:Degree [Quantitative Concept]
   744   C0542560:Degree [Intellectual Product]
   744   C1561545:degree [Quantitative Concept]
   744   C2348088:Degree [Quantitative Concept]

Phrase: "and"

Phrase: "undergo"

Phrase: "endoproteolytic cleavage,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "the resulting fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "derived from each precursor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1441547:Derived [Qualitative Concept]
   770   C1709634:Precursor [Idea or Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "associate with each other."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0750490:Associate [Idea or Concept]
   770   C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.138: Despite these similarities, our results indicate that fragments derived from endoproteolytic cleavage of PS1 and PS2 fail to form mixed complexes. 

Phrase: "Despite these similarities,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2348205:Similarity [Qualitative Concept]

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "derived from endoproteolytic cleavage of PS1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0010813:cleavage [Cell Function]
   753   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]
   753   C1418985:PS1 [Gene or Genome]
   753   C1441547:Derived [Qualitative Concept]
   753   C2986918:PS1 [Gene or Genome]
   753   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "PS2"

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "mixed complexes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.139: The absence of complexes containing PS1 NTF and PS2 CTF or PS2 NTF and PS1 NTF strongly suggests that the noncovalent association between the NH2- and COOH-terminal structural domains of the precursor polypeptide may precede endoproteolytic cleavage. 

Phrase: "The absence of complexes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "PS2 CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "or"

Phrase: "PS2 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "PS1 NTF strongly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the noncovalent association between the NH2-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "COOH-terminal structural domains of the precursor polypeptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C1880389:Domain [Functional Concept]
   711   C1883221:Domain [Conceptual Entity]
   711   C3541951:Domain [Intellectual Product]

Phrase: "may"

Phrase: "precede"

Phrase: "endoproteolytic cleavage."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]
Processing 00000000.tx.140: If this prediction were correct, one would expect that endoproteolysis of a chimeric polypeptide containing PS1 NTF and PS2 CTF should result in the generation of processed PS1 NTF and PS2 CTF derivatives that can be co-immunoprecipitated. 

Phrase: "If"

Phrase: "this prediction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681842:Prediction [Idea or Concept]

Phrase: "were"

Phrase: "correct, one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "would"

Phrase: "expect"

Phrase: "that endoproteolysis of a chimeric polypeptide containing PS1 NTF"

Phrase: "and"

Phrase: "PS2 CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "should"

Phrase: "result in the generation of processed PS1 NTF"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   744   C0079411:Generation [Temporal Concept]
   744   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   744   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1274040:Result [Functional Concept]
   744   C1418985:PS1 [Gene or Genome]
   744   C1522240:Processed [Phenomenon or Process]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]
   744   C2986918:PS1 [Gene or Genome]
   744   C3146294:Generation [Activity]
   711 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "PS2 CTF derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0243072:derivatives [Chemical Viewed Structurally]
   771 E C1527240:Derivative [Functional Concept]

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "co-immunoprecipitated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.141: To test this hypothesis, we generated stable N2a cell lines transfected with an expression plasmid encoding a chimeric polypeptide corresponding to amino acids 1-280 of human PS1 fused to amino acids 287-448 of human PS2. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "we"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "stable N2a cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   906   C0598091:stable cell line [Cell]
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "transfected with an expression plasmid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a chimeric polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "corresponding to amino acids 1-280 of human PS1"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   764   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0001128:Acids [Chemical]
   742   C0086418:Human [Human]
   742   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1418985:PS1 [Gene or Genome]
   742   C2986918:PS1 [Gene or Genome]
   731 E C2917660:Amino Acid [Pharmacologic Substance]
   708 E C0202406:Acid [Laboratory Procedure]

Phrase: "fused to amino acids 287-448 of human PS2."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   764   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0001128:Acids [Chemical]
   742   C0086418:Human [Human]
   742   C0699952:Fused [Functional Concept]
   731 E C2917660:Amino Acid [Pharmacologic Substance]
   708 E C0202406:Acid [Laboratory Procedure]
   708 E C1414861:FUSE [Gene or Genome]
   708 E C1708111:Fuse [Manufactured Object]
Processing 00000000.tx.142: Expression of the PS1/PS2 chimera was assessed in several cell lines by Western blotting using PS1NT and PS2Loop antisera (data not shown). 

Phrase: "Expression of the PS1/PS2 chimera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "assessed in several cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0007600:Cell lines [Cell]
   760   C0007634:Cell [Cell]
   760   C0205132:lines [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1516048:Assessed [Activity]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "by Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PS1NT"

Phrase: "and"

Phrase: "PS2Loop antisera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.143: The chimeric polypeptide was endoproteolytically processed to generate fragments corresponding to PS1 NTF and PS2 CTF, and in cell lines expressing high levels of the PS1/PS2 chimera, endogenous PS1 derivatives were replaced (Fig. 3A). 

Phrase: "The chimeric polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "endoproteolytically"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "corresponding to PS1 NTF"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   770   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418985:PS1 [Gene or Genome]
   770   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2 CTF,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "in cell lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0007600:Cell lines [Cell]
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "high levels of the PS1/PS2 chimera,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "endogenous PS1 derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0243072:derivatives [Chemical Viewed Structurally]
   793 E C1527240:Derivative [Functional Concept]

Phrase: "were"

Phrase: "replaced"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0559956:Replaced [Functional Concept]
  1000   C1299987:replaced [Functional Concept]
   966 E C1554078:Replace [Idea or Concept]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.144: Thus, the metabolism of the PS1/PS2 chimera was similar to that of PS1 or PS2, and the accumulation of the resulting derivatives (PS1 NTF and PS2 CTF) was similar to that of the fragments derived from full-length PS1 or PS2. 

Phrase: "Thus,"

Phrase: "the metabolism of the PS1/PS2 chimera"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0025519:Metabolism [Organism Function]
   748   C0025520:metabolism [Functional Concept]

Phrase: "was"

Phrase: "similar to that of PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "or"

Phrase: "PS2,"

Phrase: "and"

Phrase: "the accumulation of the resulting derivatives"

Phrase: "(PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "PS2 CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "similar to that of the fragments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "derived from full-length PS1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0443225:Full [Qualitative Concept]
   760   C1418985:PS1 [Gene or Genome]
   760   C1441547:Derived [Qualitative Concept]
   760   C1444754:Length [Quantitative Concept]
   760   C1706316:LENGTH [Research Activity]
   760   C2986918:PS1 [Gene or Genome]
   760   C3245521:derived [Idea or Concept]

Phrase: "or"

Phrase: "PS2."
Processing 00000000.tx.145: Next, we performed co-immunoprecipitation studies to assess whether the fragments derived from endoproteolytic processing of the PS1/PS2 chimera could be co-immunoprecipitated. 

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "co-immunoprecipitation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   861   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "whether"

Phrase: "the fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "derived from endoproteolytic processing of the PS1/PS2 chimera"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0008109:Chimera [Organism]
   742   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1262946:Chimaera [Fish]
   742   C1318484:Chimera [Disease or Syndrome]
   742   C1418985:PS1 [Gene or Genome]
   742   C1441547:Derived [Qualitative Concept]
   742   C1709694:Processing [Activity]
   742   C2986918:PS1 [Gene or Genome]
   742   C3245521:derived [Idea or Concept]

Phrase: "could"

Phrase: "be"

Phrase: "co-immunoprecipitated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.146: For these studies, we chose a stable cell line in which the endogenous mouse PS1 derivatives are incompletely replaced. 

Phrase: "For these studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "chose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Choose [Activity]

Phrase: "a stable cell line in which"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0598091:stable cell line [Cell]
   790   C0007600:Cell Line [Cell]
   753   C0007634:Cell [Cell]
   753   C0205132:Line [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "the endogenous mouse PS1 derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0243072:derivatives [Chemical Viewed Structurally]
   779 E C1527240:Derivative [Functional Concept]

Phrase: "are"

Phrase: "incompletely"

Phrase: "replaced."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0559956:Replaced [Functional Concept]
  1000   C1299987:replaced [Functional Concept]
   966 E C1554078:Replace [Idea or Concept]
Processing 00000000.tx.147: Nondenaturing lysates were subject to immunoprecipitation with PS1 and PS2 antibodies. 

Phrase: "Nondenaturing lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were subject to immunoprecipitation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0021069:Immunoprecipitation [Laboratory Procedure]
   770   C0681850:Subject [Group]
   770   C1550501:{Subject} [Idea or Concept]
   770   C1706203:Subject [Idea or Concept]
   770   C2349001:Subject [Human]
   770   C2697811:Subject [Functional Concept]

Phrase: "with PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2 antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.148: As expected, PS1NT antiserum co-immunoprecipitated endogenous murine PS1-derived CTF (Fig. 3B, top panels, lane 1). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "PS1NT antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "co-immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "endogenous murine PS1-derived CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   795   C0332255:fragments [Functional Concept]
   795   C0486805:Fragments [Body Substance]
   762 E C1708096:Fragment [Qualitative Concept]

Phrase: "(Fig. 3B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: "top panels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.149: Interestingly, reprobing of the blot using PS2Loop antiserum revealed that PS1NT antiserum also co-purified PS2 CTF (bottom panels, lane 1). 

Phrase: "Interestingly,"

Phrase: "reprobing of the blot"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PS2Loop antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that PS1NT antiserum also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "co-purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1998793:Purified [Functional Concept]
   768 E C1947930:Cleanse [Activity]

Phrase: "PS2 CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "(bottom panels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.150: Furthermore, PS1Loop antiserum co-precipitated the slower migrating mouse PS1 NTF, whereas PS2Loop antiserum co-precipitated the faster migrating human PS1 NTF (top panels, lanes 7and 8, respectively). 

Phrase: "Furthermore,"

Phrase: "PS1Loop antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "co-precipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "the slower migrating mouse PS1 NTF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "whereas"

Phrase: "PS2Loop antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "co-precipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "the faster migrating human PS1 NTF (top panels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0441833:Panel [Idea or Concept]
   795   C1999270:Panel [Intellectual Product]
   795   C3537156:Panel [Manufactured Object]

Phrase: "lanes 7and 8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.151: Because endogenous murine PS2 NTF is not detectable in total lysates prepared from the PS1/PS2 cell line used for this experiment (bottom panel, lane 12), we failed to detect any signal for PS2 CTF or NTF in co-precipitations (bottom panels, lanes 2and 8, respectively). 

Phrase: "Because"

Phrase: "endogenous murine PS2 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "is"

Phrase: "not detectable in total lysates"

Phrase: "prepared from the PS1/PS2 cell line"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0007600:Cell Line [Cell]
   748   C0007634:Cell [Cell]
   748   C0205132:Line [Spatial Concept]
   748   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1269647:Cell [Cell]
   748   C1418985:PS1 [Gene or Genome]
   748   C1550648:Line [Substance]
   748   C1552960:Line [Quantitative Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C2986918:PS1 [Gene or Genome]
   714   C1521827:Prepare [Functional Concept]

Phrase: "used for this experiment"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0681814:Experiment [Research Activity]
   770   C1273517:used [Finding]
   770   C1706386:Experiment [Conceptual Entity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "(bottom panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "lane 12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "any signal for PS2 CTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710082:Signal [Phenomenon or Process]

Phrase: "or"

Phrase: "NTF in co-precipitations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "(bottom panels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "lanes 2and 8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.152: These results demonstrate that the PS1 NTF and PS2 CTF are capable of forming mixed complexes when derived from cleavage of a chimeric polypeptide and strongly support our view that interaction between NH2- and COOH-terminal regions of a precursor PS polypeptide precedes endoproteolysis. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "PS2 CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "capable of forming mixed complexes"

Phrase: "when"

Phrase: "derived from cleavage of a chimeric polypeptide"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0008109:chimeric [Organism]
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]
   748   C1330957:cleavage [Cell Function]
   748   C1441547:Derived [Qualitative Concept]
   748   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "strongly"

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "our"

Phrase: "view"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "that interaction between NH2-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "COOH-terminal regions of a precursor PS polypeptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0017446:Region [Geographic Area]
   711   C0205147:Region [Spatial Concept]

Phrase: "precedes"

Phrase: "endoproteolysis."
Processing 00000000.tx.153: View larger version (34K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.154: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.155: PS1 NTF and PS2 CTF derived from a chimeric precursor can be co-precipitated. 

Phrase: "PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "PS2 CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "derived from a chimeric precursor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008109:chimeric [Organism]
   760   C1441547:Derived [Qualitative Concept]
   760   C1709634:Precursor [Idea or Concept]
   760   C3245521:derived [Idea or Concept]

Phrase: "can"

Phrase: "be"

Phrase: "co-precipitated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1882443:PRECIPITATE [Phenomenon or Process]
Processing 00000000.tx.156: A, detergent lysates prepared from stable N2a cells transfected with an empty vector or cDNA encoding a chimeric PS1/PS2 polypeptide (PS1/2) were analyzed by immunoblotting using PS1NT (lanes 1and 2) and PS2Loop antibodies (lanes 3and 4). 

Phrase: "A,"

Phrase: "detergent lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "prepared from stable N2a cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0007634:Cells [Cell]
   760   C0205360:Stable [Qualitative Concept]
   760   C0445079:N2a [Finding]
   760   C1547311:Stable [Intellectual Product]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726   C1521827:Prepare [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with an empty vector"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   760   C1880497:Empty [Qualitative Concept]
   704 E C0333668:Depleted [Functional Concept]

Phrase: "or"

Phrase: "cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a chimeric PS1/PS2 polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "(PS1/2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: ")"

Phrase: "were"

Phrase: "analyzed by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PS1NT"

Phrase: "(lanes 1and 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "PS2Loop antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(lanes 3and 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.157: The positions of mouse (Mo) and human (Hu) PS1 NTF and PS2 CTF are indicated. 

Phrase: "The positions of mouse (Mo)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0733755:positions [Spatial Concept]

Phrase: "and"

Phrase: "human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "(Hu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: ")"

Phrase: "PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "PS2 CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.158: B, stable N2a cells expressing PS1/PS2 chimera were lysed under nondenaturing conditions, and lysates were used for co-immunoprecipitation analyses as described in the legend to Fig. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "stable N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "PS1/PS2 chimera"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0008109:Chimera [Organism]
   827   C1262946:Chimaera [Fish]
   827   C1318484:Chimera [Disease or Syndrome]

Phrase: "were"

Phrase: "lysed under nondenaturing conditions,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0024348:lysed [Pathologic Function]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "and"

Phrase: "lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "used for co-immunoprecipitation analyses"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   760   C0021069:Immunoprecipitation [Laboratory Procedure]
   760   C1273517:used [Finding]
   726   C0002778:Analysis [Laboratory Procedure]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "as"

Phrase: "described in the legend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   770   C2729544:Legend [Pharmacologic Substance]

Phrase: "to Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.159: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.160: Total lysate corresponding to of the volume of lysate used for immunoprecipitation and an aliquot of stable PS2 cell line were also fractionated on SDS gels as markers for PS2 NTF and CTF. 

Phrase: "Total lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881488:Lysate [Physical Object]

Phrase: "corresponding to of the volume of lysate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0449468:*Volume [Quantitative Concept]
   748   C1690016:% volume [Qualitative Concept]
   748   C1705102:Volume [Intellectual Product]
   748   C1881488:Lysate [Physical Object]
   748   C2700258:Volume [Laboratory Procedure]

Phrase: "used for immunoprecipitation"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "an aliquot of stable PS2 cell line"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "also"

Phrase: "fractionated on SDS gels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0017243:Gels [Biomedical or Dental Material]
   770   C1979893:Fractionated [Qualitative Concept]
   737 E C1382104:Gel [Substance]

Phrase: "as markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0005516:Marker [Clinical Attribute]

Phrase: "for PS2 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "CTF."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.161: Note that the ~30-kDa band in the PS2NT blot indicated by an asterisk (bottom panel, lane 8) is the PS1 NTF signal that remained due to the incomplete stripping of PS1NT antibody. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the ~30-kDa band in the PS2NT blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0175723:Band [Medical Device]
   744   C0439645:Band [Spatial Concept]
   744   C1521913:band [Cell Component]

Phrase: "indicated by an asterisk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1444656:Indicated [Finding]
   770   C2945706:asterisk [Conceptual Entity]

Phrase: "(bottom panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "lane 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "is"

Phrase: "the PS1 NTF signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "that"

Phrase: "remained due to the incomplete stripping of PS1NT antibody."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0678226:Due to [Functional Concept]
           due
   762   C0301846:Incomplete antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0185047:Stripping [Therapeutic or Preventive Procedure]
   742   C0205257:Incomplete [Quantitative Concept]
   742   C0728938:incomplete [Quantitative Concept]
   742   C1548386:incomplete [Idea or Concept]
   742   C3146286:Due [Idea or Concept]
Processing 00000000.tx.162: Next we examined whether the chimeric PS1 NTFPS2 CTF assembly is stable. 

Phrase: "Next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "the chimeric PS1 NTFPS2 CTF assembly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   829   C1707720:Terminal Assembly [Manufactured Object]
   795   C1706853:Assembly [Activity]
   795   C1879748:Assembly [Manufactured Object]

Phrase: "is"

Phrase: "stable."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205360:Stable [Qualitative Concept]
  1000   C1547311:Stable [Intellectual Product]
Processing 00000000.tx.163: To address this issue, we incubated cells expressing PS1/PS2 chimera with cycloheximide to block protein synthesis. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this issue,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]

Phrase: "we"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "PS1/PS2 chimera with cycloheximide to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0008109:Chimera [Organism]
   753   C1262946:Chimaera [Fish]
   753   C1318484:Chimera [Disease or Syndrome]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "protein synthesis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]
Processing 00000000.tx.164: In parallel, we incubated cells expressing full-length PS1 or PS2 with cycloheximide. 

Phrase: "In parallel,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C2348042:Parallel [Qualitative Concept]
   861   C2826345:PARALLEL [Research Activity]

Phrase: "we"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "full-length PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]

Phrase: "or"

Phrase: "PS2 with cycloheximide."
Processing 00000000.tx.165: Detergent lysates prepared at the end of the incubation period were analyzed by immunoblotting using PS1 and PS2 antisera. 

Phrase: "Detergent lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "prepared at the end of the incubation period"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1320226:Incubation period [Finding]
   744   C0439531:/period [Temporal Concept]
   744   C0444930:End [Spatial Concept]
   744   C1948053:Period [Temporal Concept]
   744   C2746065:End [Temporal Concept]
   711   C1521827:Prepare [Functional Concept]

Phrase: "were"

Phrase: "analyzed by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2 antisera."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.166: As expected from previous studies (21-24), in stable N2a cells expressing PS1 the full-length PS1 molecules were rapidly degraded, while the NTF and CTF were stable (Fig. 4A). 

Phrase: "As"

Phrase: "expected from previous studies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0205156:Previous [Temporal Concept]
   770   C0947630:studies [Laboratory Procedure]
   770   C1517001:Expected [Idea or Concept]
   770   C1552607:previous [Temporal Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "(21-24"

Phrase: ")"

Phrase: ","

Phrase: "in stable N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "the full-length PS1 molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0567416:molecules [Substance]
   729 E C1521991:Molecular [Qualitative Concept]

Phrase: "were"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: ","

Phrase: "while"

Phrase: "the NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "stable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205360:Stable [Qualitative Concept]
  1000   C1547311:Stable [Intellectual Product]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.167: Similar results were obtained in stable cell lines expressing PS2 (data not shown). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained in stable cell lines"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   845   C0598091:stable cell line [Cell]
   806   C0007600:Cell lines [Cell]
   760   C0007634:Cell [Cell]
   760   C0205132:lines [Spatial Concept]
   760   C0205360:Stable [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1301820:Obtained [Functional Concept]
   760   C1547311:Stable [Intellectual Product]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "expressing"

Phrase: "PS2"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.168: Analysis of lysates from stable N2a cells expressing the PS1/PS2 chimera revealed that full-length PS1/PS2 polypeptides were also rapidly degraded, while the endoproteolytic fragments derived from the chimera remained stable over a 6-h incubation period in the presence of cycloheximide (Fig. 4A). 

Phrase: "Analysis of lysates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "from stable N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "the PS1/PS2 chimera"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0008109:Chimera [Organism]
   827   C1262946:Chimaera [Fish]
   827   C1318484:Chimera [Disease or Syndrome]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that full-length PS1/PS2 polypeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "also rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1637379:Rapidly [Qualitative Concept]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: ","

Phrase: "while"

Phrase: "the endoproteolytic fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "derived from the chimera"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0008109:Chimera [Organism]
   770   C1262946:Chimaera [Fish]
   770   C1318484:Chimera [Disease or Syndrome]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "remained"

Phrase: "stable over a 6-h incubation period"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205360:Stable [Qualitative Concept]
   748   C1547311:Stable [Intellectual Product]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of cycloheximide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.169: From these results, we conclude that endoproteolytic fragments derived from the processing of PS1/PS2 chimera are long lived. 

Phrase: "From these results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "we"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that endoproteolytic fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "derived from the processing of PS1/PS2 chimera"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0008109:Chimera [Organism]
   744   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1262946:Chimaera [Fish]
   744   C1318484:Chimera [Disease or Syndrome]
   744   C1418985:PS1 [Gene or Genome]
   744   C1441547:Derived [Qualitative Concept]
   744   C1709694:Processing [Activity]
   744   C2986918:PS1 [Gene or Genome]
   744   C3245521:derived [Idea or Concept]

Phrase: "are"

Phrase: "long lived."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205166:Long [Qualitative Concept]
   861   C1706317:Long [Qualitative Concept]
   827   C1548795:Live [Qualitative Concept]
   827   C1634625:% live [Qualitative Concept]
   827   C2982691:Live [Activity]
Processing 00000000.tx.170: View larger version (32K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(32K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.171: 4.  

Phrase: "4."
Processing 00000000.tx.172: Analysis of PS1/PS2 stability and the influence of mutant PS1/PS2 on A42 production. 

Phrase: "Analysis of PS1/PS2 stability"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "the influence of mutant PS1/PS2"

Phrase: "on A42 production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]
Processing 00000000.tx.173: A, stable N2a cells expressing human PS1 or PS1/PS2 chimera were incubated in culture medium containing cycloheximide (30g/ml) for the intervals indicated. 

Phrase: "A,"

Phrase: "stable N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "human PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "or"

Phrase: "PS1/PS2 chimera"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0008109:Chimera [Organism]
   827   C1262946:Chimaera [Fish]
   827   C1318484:Chimera [Disease or Syndrome]

Phrase: "were"

Phrase: "incubated in culture medium containing cycloheximide"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   753   C0009458:Medium [Intellectual Product]
   753   C0010453:Culture [Idea or Concept]
   753   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   753   C0220814:culture [Functional Concept]
   753   C0332256:Containing [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0439536:Medium [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1705217:Medium [Substance]
   753   C2242979:Culture [Laboratory Procedure]
   753   C2700400:Containing [Activity]
   753   C3244283:medium [Intellectual Product]

Phrase: "(30g/ml) for the intervals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439526:/mL [Quantitative Concept]

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.174: Detergent lysates prepared from stable PS1 cells were analyzed by immunoblotting with PS1NT and PS1Loop (top three panels); 

Phrase: "Detergent lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "prepared from stable PS1 cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   760   C0007634:Cells [Cell]
   760   C0205360:Stable [Qualitative Concept]
   760   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1418985:PS1 [Gene or Genome]
   760   C1547311:Stable [Intellectual Product]
   760   C2986918:PS1 [Gene or Genome]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726   C1521827:Prepare [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "analyzed by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "with PS1NT"

Phrase: "and"

Phrase: "PS1Loop"

Phrase: "(top three panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.175: lysates from PS1/PS2 cells were blotted with PS1NT and PS2Loop (bottom three panels). 

Phrase: "lysates from PS1/PS2 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "blotted with PS1NT"

Phrase: "and"

Phrase: "PS2Loop"

Phrase: "(bottom three panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.176: Only the regions of gels corresponding to the full-length polypeptide (FL) and endoproteolytic derivatives (NTF and CTF) are shown. 

Phrase: "Only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the regions of gels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0017446:Region [Geographic Area]
   737   C0205147:Region [Spatial Concept]

Phrase: "corresponding to the full-length polypeptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0443225:Full [Qualitative Concept]
   753   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]
   753   C1444754:Length [Quantitative Concept]
   753   C1706316:LENGTH [Research Activity]

Phrase: "(FL)"

Phrase: "and"

Phrase: "endoproteolytic derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "(NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: ")"

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.177: B, COS cells transfected with PS1, PS2, or PS1/PS2 cDNA along with cDNA encoding full-length APP or APP C100 cDNA (see "Materials and Methods"). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "COS cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0376702:COS Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with PS1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PS1 [Gene or Genome]
   790   C2986918:PS1 [Gene or Genome]

Phrase: "PS2,"

Phrase: "or"

Phrase: "PS1/PS2 cDNA along with cDNA"

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "full-length APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "or"

Phrase: "APP C100 cDNA (see ""Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.178: The levels of A x-40 and A x-42 secreted from doubly transfected cells were quantified by two-site ELISAs. 

Phrase: "The levels of A x-40"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "A x-42"

Phrase: "secreted from doubly transfected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C1327616:Secreted [Cell Function]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "quantified by two-site ELISAs."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205145:Site [Spatial Concept]
   760   C0205448:Two [Quantitative Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]
   726   C0014441:ELISA [Laboratory Procedure]
   726   C1709793:Quantify [Quantitative Concept]
Processing 00000000.tx.179: Mean valuesS.E. from two independent experiments are shown. 

Phrase: "Mean valuesS.E."

Phrase: "from two independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.180: *, p=0.0012; 

Phrase: "*,"

Phrase: "p=0.0012"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.181: **, p<0.001,relative to values from cells transfected with the corresponding wild-type cDNA. 

Phrase: "*"

Phrase: "*,"

Phrase: "p<0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "relative to values"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   841   C0205345:Relative Value [Qualitative Concept]
           Relative
   790   C0080103:Relative [Family Group]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "from cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with the corresponding wild-type cDNA."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.182: Finally, we examined whether the PS1/PS2 chimera could influence APP processing and elevate the production of A42 peptides. 

Phrase: "Finally,"

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "the PS1/PS2 chimera"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0008109:Chimera [Organism]
   827   C1262946:Chimaera [Fish]
   827   C1318484:Chimera [Disease or Syndrome]

Phrase: "could"

Phrase: "influence"

Phrase: "APP processing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033666:protein processing [Molecular Function]
   812   C1709694:Processing [Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "elevate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:elevate [Qualitative Concept]

Phrase: "the production of A42 peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]
Processing 00000000.tx.183: For these studies, we constructed expression plasmids encoding PS1/PS2 chimeric polypeptide that harbors the FAD-linked M146L substitution. 

Phrase: "For these studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "expression plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "PS1/PS2 chimeric polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "that"

Phrase: "harbors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475311:Harbor [Manufactured Object]

Phrase: "the FAD-linked M146L substitution."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1555721:Substitution [Idea or Concept]
   812   C1706204:Substitution [Activity]
Processing 00000000.tx.184: COS cells were co-transfected with plasmids encoding wild-type or mutant PS1/PS2, and APP (or C100; 

Phrase: "COS cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0376702:COS Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "mutant PS1/PS2,"

Phrase: "and"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "("

Phrase: "or"

Phrase: "C100"

Phrase: ";"
Processing 00000000.tx.185: see "Materials and Methods"). 

Phrase: "see ""Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.186: In parallel, we also transfected cells with plasmids encoding wild-type or mutant full-length PS1 or PS2. 

Phrase: "In parallel,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C2348042:Parallel [Qualitative Concept]
   861   C2826345:PARALLEL [Research Activity]

Phrase: "we also transfected cells with plasmids"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "mutant full-length PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1418985:PS1 [Gene or Genome]
   812   C2986918:PS1 [Gene or Genome]

Phrase: "or"

Phrase: "PS2."
Processing 00000000.tx.187: The levels of secreted A x-40 and x-42 peptides in conditioned media of transfected cells were quantified using a two-site ELISA assay as described (33-35). 

Phrase: "The levels of secreted"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "A x-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "and"

Phrase: "x-42 peptides in conditioned media of transfected cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a two-site ELISA assay as described"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0014441:ELISA assay [Laboratory Procedure]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C1510438:Assay [Laboratory Procedure]

Phrase: "(33-35"

Phrase: ")."
Processing 00000000.tx.188: To account for variations in the levels of A40 and A42 due to differences in transfection efficiencies of different expression plasmids, we calculated the ratio A x-42/total A for each expression construct and compared the relative ratios (32, 27). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "account for variations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205419:variations [Qualitative Concept]
   790   C1551359:account [Idea or Concept]
   790   C2741673:Account # [Clinical Attribute]
   790   C2981730:Account [Classification]

Phrase: "in the levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "of A40"

Phrase: "and"

Phrase: "A42 due to differences"

Phrase: "in transfection efficiencies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0013682:efficiencies [Quantitative Concept]
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   777 E C0442799:Efficient [Qualitative Concept]

Phrase: "of different expression plasmids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "we"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "the ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456603:Ratio [Quantitative Concept]
  1000   C1547037:Ratio [Intellectual Product]

Phrase: "A x-42/total A for each expression construct"

Phrase: "and"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the relative ratios"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   983   C1264683:Relative ratio [Quantitative Concept]
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "(32,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.189: Results of these analyses are presented in Fig. 

Phrase: "Results of these analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "are"

Phrase: "presented in Fig."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C0449450:Presented [Idea or Concept]
   790   C1337208:FIG [Food]
   756 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.190: 4B. 

Phrase: "4B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450375:4b [Intellectual Product]
Processing 00000000.tx.191: As reported previously (10, 12, 13), expression of mutant PS1 (A x-42/total A ratio PS1 wild-type was 10.300.7versus PS1 M146L, 18.161.2) or PS2 (wild-type was 14.510.8versus N141I, 26.721.8) elevated the secretion of A 42peptides. 

Phrase: "As"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(10,"

Phrase: "12,"

Phrase: "13"

Phrase: ")"

Phrase: ","

Phrase: "expression of mutant PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "A x-42/total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439175:% total [Quantitative Concept]
   827   C0439810:Total [Qualitative Concept]

Phrase: "A ratio PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "was"

Phrase: "10.300.7versus PS1 M146L,"

Phrase: "18.161.2"

Phrase: ")"

Phrase: "or"

Phrase: "PS2"

Phrase: "(wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "was"

Phrase: "14.510.8versus N141I,"

Phrase: "26.721.8"

Phrase: ")"

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "the secretion of A 42peptides."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
Processing 00000000.tx.192: The levels of A 42in cells transfected with PS1/PS2 chimera lacking FAD-linked mutation were comparable with that of wild-type PS2. 

Phrase: "The levels of A 42in cells"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "transfected with PS1/PS2 chimera"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0008109:Chimera [Organism]
   760   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1262946:Chimaera [Fish]
   760   C1318484:Chimera [Disease or Syndrome]
   760   C1418985:PS1 [Gene or Genome]
   760   C2986918:PS1 [Gene or Genome]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "FAD-linked mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "comparable with that of wild-type PS2."
Processing 00000000.tx.193: In contrast, expression of the PS1/PS2 chimera harboring the FAD-linked M146L mutation markedly elevated the levels of A 42in the conditioned medium (wild-type PS1/PS2 was 14.371.8versus M146L PS1/PS2, 23.161.9). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "expression of the PS1/PS2 chimera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "the FAD-linked M146L mutation markedly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0026882:Mutation [Genetic Function]
   804   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "the levels of A 42in"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "the conditioned medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "(wild-type PS1/PS2"

Phrase: "was"

Phrase: "14.371.8versus M146L PS1/PS2,"

Phrase: "23.161.9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.194: Thus, we argue that chimeric PS1/PS2 polypeptides harboring FAD-linked PS1 M146L are effective in influencing A42 production. 

Phrase: "Thus,"

Phrase: "we"

Phrase: "argue"

Phrase: "that chimeric PS1/PS2 polypeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "FAD-linked PS1 M146L"

Phrase: "are"

Phrase: "effective in influencing A42 production."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280519:effective [Qualitative Concept]
   760   C1704419:Effective [Qualitative Concept]
Processing 00000000.tx.195: Collectively, these results document that the endoproteolytic fragments derived from PS1/PS2 chimera can co-assemble into stable heteromeric assemblies, and PS1/PS2 polypeptides harboring FAD-linked mutation were capable of elevating the production of A42 peptides.  

Phrase: "Collectively,"

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "document"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1301746:document [Intellectual Product]
  1000   C1547673:Document [Intellectual Product]

Phrase: "that"

Phrase: "the endoproteolytic fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "derived from PS1/PS2 chimera"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0008109:Chimera [Organism]
   760   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1262946:Chimaera [Fish]
   760   C1318484:Chimera [Disease or Syndrome]
   760   C1418985:PS1 [Gene or Genome]
   760   C1441547:Derived [Qualitative Concept]
   760   C2986918:PS1 [Gene or Genome]
   760   C3245521:derived [Idea or Concept]

Phrase: "can"

Phrase: "co-assemble into stable heteromeric assemblies,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205360:Stable [Qualitative Concept]
   753   C1547311:Stable [Intellectual Product]
   753   C1706853:Assemble [Activity]
           Assembly
   719   C1879748:Assembly [Manufactured Object]

Phrase: "and"

Phrase: "PS1/PS2 polypeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "FAD-linked mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "capable of elevating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C2698977:Capability [Qualitative Concept]

Phrase: "the production of A42 peptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]
Processing 00000000.tx.196: DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Our understanding of the nature of the functional PS "unit" is still very incomplete. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Our understanding of the nature of the functional PS ""unit"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0162340:Understanding [Mental Process]

Phrase: "is"

Phrase: "still very incomplete."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205257:Incomplete [Quantitative Concept]
   827   C0728938:incomplete [Quantitative Concept]
   827   C1548386:incomplete [Idea or Concept]
Processing 00000000.tx.197: Knowledge about the subunit stoichiometry is essential for further studies on the structure and function of the PS complex. 

Phrase: "Knowledge about the subunit stoichiometry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0376554:Knowledge [Intellectual Product]

Phrase: "is"

Phrase: "essential for further studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]

Phrase: "on the structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "function of the PS complex."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]
Processing 00000000.tx.198: In the present study, we exclusively focused on the composition and stoichiometry of PS NTF and CTF complexes immunoprecipitated from stable mouse neuroblastoma cells that express recombinant human PS1 NTF, full-length PS2, or a chimeric PS1/PS2 polypeptide. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we exclusively"

Phrase: "focused on the composition"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205234:Focused [Spatial Concept]
   770   C0486616:Composition [Clinical Attribute]
   770   C1285542:focused [Functional Concept]
   770   C1555710:composition [Idea or Concept]

Phrase: "and"

Phrase: "stoichiometry of PS NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597526:Stoichiometry [Quantitative Concept]

Phrase: "and"

Phrase: "CTF complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]

Phrase: "immunoprecipitated from stable mouse neuroblastoma cells"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   790   C1524043:Mouse Neuroblastoma [Neoplastic Process]
   773   C0815000:neuroblastoma cell [Cell]
   753   C0007634:Cells [Cell]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0027819:Neuroblastoma [Neoplastic Process]
   753   C0205360:Stable [Qualitative Concept]
   753   C0700095:neuroblastoma [Neoplastic Process]
   753   C1547311:Stable [Intellectual Product]
   753   C3282337:Cells [Cell]
   753   C3540583:Neuroblastoma [Intellectual Product]
   719   C0301871:Immunoprecipitate [Immunologic Factor]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "express"

Phrase: "recombinant human PS1 NTF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "full-length PS2,"

Phrase: "or"

Phrase: "a chimeric PS1/PS2 polypeptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.199: These studies demonstrate that transgene-derived recombinant PS1 NTF neither influenced the metabolism of endogenous PS1 polypeptides nor associated with endogenous PS1-derived CTF. 

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "demonstrate"

Phrase: "that transgene-derived recombinant PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "neither"

Phrase: "influenced"

Phrase: "the metabolism of endogenous PS1 polypeptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]

Phrase: "nor"

Phrase: "associated with endogenous PS1-derived CTF."
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0205088:Terminal [Temporal Concept]
   744   C0205227:Endogenous [Functional Concept]
   744   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0332255:fragments [Functional Concept]
   744   C0486805:Fragments [Body Substance]
   744   C1418985:PS1 [Gene or Genome]
   744   C1441547:Derived [Qualitative Concept]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]
   744   C2986918:PS1 [Gene or Genome]
   744   C3245521:derived [Idea or Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]
   711 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.200: PS1 and PS2 fragments derived from the cleavage of co-expressed full-length PS1 and PS2 do not form mixed heteromeric assemblies. 

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2 fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "derived from the cleavage of"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]
   760   C1441547:Derived [Qualitative Concept]
   760   C3245521:derived [Idea or Concept]

Phrase: "co-expressed"

Phrase: "full-length PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "mixed heteromeric assemblies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1706853:Assembly [Activity]
   793   C1879748:Assembly [Manufactured Object]
Processing 00000000.tx.201: In contrast, endoproteolysis of a PS1/PS2 chimera generates stable PS1 NTFPS2 CTF assemblies. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "endoproteolysis of a PS1/PS2 chimera"

Phrase: "generates"

Phrase: "stable PS1 NTFPS2 CTF assemblies."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   813   C1707720:Terminal Assembly [Manufactured Object]
   762   C1706853:Assembly [Activity]
   762   C1879748:Assembly [Manufactured Object]
Processing 00000000.tx.202: The results of our studies provide an important insight: an intramolecular association(s) between domains of the PS NTF and CTF is established prior to endoproteolytic cleavage. 

Phrase: "The results of our studies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683954:results studies [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "an important insight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0233820:Insight [Mental Process]

Phrase: ":"

Phrase: "an intramolecular association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "("

Phrase: "s) between domains of the PS NTF"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   748   C2603362:S' [Clinical Attribute]
   714   C1880389:Domain [Functional Concept]
   714   C1883221:Domain [Conceptual Entity]
   714   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "is"

Phrase: "established prior to endoproteolytic cleavage."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0332152:Prior to [Temporal Concept]
           Prior
   760   C0010813:cleavage [Cell Function]
   760   C0443211:Established [Qualitative Concept]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1272684:Established [Qualitative Concept]
   760   C1330957:cleavage [Cell Function]
   760   C2826257:PRIOR [Event]
Processing 00000000.tx.203: In the present study, by examining the metabolism of a PS1/PS2 chimera we provide evidence that intramolecular association(s) between structural domains located within NH2- and COOH-terminal halves of PS precedes endoproteolytic cleavage. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "by examining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332128:examining [Finding]
  1000   C2004054:Examining [Activity]

Phrase: "the metabolism of a PS1/PS2 chimera"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0025519:Metabolism [Organism Function]
   748   C0025520:metabolism [Functional Concept]

Phrase: "we"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that intramolecular association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "("

Phrase: "s) between structural domains"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0678594:Structural [Spatial Concept]
   770   C2603362:S' [Clinical Attribute]
   737   C1880389:Domain [Functional Concept]
   737   C1883221:Domain [Conceptual Entity]
   737   C3541951:Domain [Intellectual Product]

Phrase: "located within NH2-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0002508:NH2 [Organic Chemical]
   790   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "COOH-terminal halves of PS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C2825407:Half [Quantitative Concept]

Phrase: "precedes"

Phrase: "endoproteolytic cleavage."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]
Processing 00000000.tx.204: Our conclusion is consistent with previous gel filtration chromatography and velocity gradient analyses, which revealed that full-length PS and the PS-derived NTF and CTF are components of high molecular weight complexes (29, 36, 37). 

Phrase: "Our conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "is"

Phrase: "consistent with previous gel filtration chromatography"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "and"

Phrase: "velocity gradient analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "which"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that full-length PS"

Phrase: "and"

Phrase: "the PS-derived NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "components of high molecular weight complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0449432:Components [Manufactured Object]
   719 E C1705248:Component [Conceptual Entity]

Phrase: "(29,"

Phrase: "36,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.205: Independently, two studies demonstrated that complexes containing PS1 NTF and CTF were larger than the complexes containing full-length PS1 (29, 37). 

Phrase: "Independently,"

Phrase: "two studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "demonstrated"

Phrase: "that complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704241:Complexes [Chemical Viewed Structurally]
   966 E C0439855:Complex [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "larger than the complexes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0443228:larger [Quantitative Concept]
   770   C0549177:Larger [Quantitative Concept]
   770   C1704243:Larger [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "full-length PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]

Phrase: "(29,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.206: Interestingly, a FAD-linked PS1 deletion mutant that fails to undergo endoproteolytic cleavage (18, 38) was found to be in a high molecular weight complex, similar in size to that of the cleaved fragments, suggesting that cleavage was not necessary for the assembly of stable PS complexes (37). 

Phrase: "Interestingly,"

Phrase: "a FAD-linked PS1 deletion mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "undergo"

Phrase: "endoproteolytic cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "(18,"

Phrase: "38"

Phrase: ")"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be in a high molecular weight complex,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   814   C1979900:High molecular weight [Qualitative Concept]
   778   C0026385:Molecular Weight [Quantitative Concept]
   774   C0948775:high weight [Sign or Symptom]
   748   C0005910:weight [Organism Attribute]
   748   C0043100:Weight [Quantitative Concept]
   748   C0205250:High [Qualitative Concept]
   748   C0439855:Complex [Qualitative Concept]
   748   C1299351:High [Qualitative Concept]
   748   C1305866:weight [Diagnostic Procedure]
   748   C1521991:Molecular [Qualitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]
   748   C1705104:Weight [Idea or Concept]
   748   C2700149:HIGH [Intellectual Product]
   748   C2987476:Be [Conceptual Entity]

Phrase: "similar in size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "to that"

Phrase: "of the cleaved fragments,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "was"

Phrase: "not necessary for the assembly of stable PS complexes"

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.207: Nevertheless, attempts to bypass the requirement for endoproteolysis by co-expressing truncated PS2 polypeptides, which correspond to FAD-linked mutant NTF and CTF, did not lead to elevated A42 production (32). 

Phrase: "Nevertheless,"

Phrase: "attempts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bypass"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0741847:Bypass [Therapeutic or Preventive Procedure]

Phrase: "the requirement for endoproteolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514873:Requirement [Functional Concept]

Phrase: "by"

Phrase: "co-expressing"

Phrase: "truncated PS2 polypeptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "which"

Phrase: "correspond to FAD-linked mutant NTF"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   753   C0596988:Mutant [Cell or Molecular Dysfunction]
   753   C3247466:FAD [Pharmacologic Substance]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "CTF,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "lead to elevated A42 production"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0033268:production [Occupational Activity]
   760   C0205250:Elevated [Qualitative Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3163633:Elevated [Qualitative Concept]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.208: Together with our present results, these studies indicate that the formation of a functional PS complex may be an ordered and stepwise process in which newly synthesized PS polypeptides establish intramolecular association(s) during the process of folding and subsequently bind to other proteins expressed at limiting levels that "stabilize" the PS complex; 

Phrase: "Together with our present results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "these studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "indicate"

Phrase: "that"

Phrase: "the formation of a functional PS complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "an ordered"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C1705176:Ordered [Qualitative Concept]
  1000   C1705178:Ordered [Activity]
   928 E C1705175:Order [Intellectual Product]
   928 E C1705177:Order [Classification]
   928 E C1882348:Order [Qualitative Concept]
   928 E C3244315:orders [Intellectual Product]

Phrase: "and"

Phrase: "stepwise process in which newly synthesized PS polypeptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1184743:Process [Body Part, Organ, or Organ Component]
   744   C1522240:Process [Phenomenon or Process]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "intramolecular association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "("

Phrase: "s) during the process of folding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0185026:Folding [Therapeutic or Preventive Procedure]
   753   C1184743:Process [Body Part, Organ, or Organ Component]
   753   C1522240:Process [Phenomenon or Process]
   753   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "subsequently"

Phrase: "bind to other proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]

Phrase: "expressed at limiting levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0439801:limiting [Functional Concept]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "that """

Phrase: "stabilize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:stabilize [Qualitative Concept]

Phrase: """"

Phrase: "the PS complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: ";"
Processing 00000000.tx.209: properly folded and "mature" PS molecules that have associated with limiting accessory molecules are then cleaved (or not in the case of PS1 lacking exon 9-encoded residues). 

Phrase: "properly"

Phrase: "folded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332462:Folded [Spatial Concept]
  1000   C1880834:FOLDED [Phenomenon or Process]

Phrase: "and """

Phrase: "mature"" PS molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "that"

Phrase: "have"

Phrase: "associated with limiting accessory molecules"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0439801:limiting [Functional Concept]
   760   C0567416:molecules [Substance]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1549649:Limit [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   726 E C2349209:Limit [Conceptual Entity]

Phrase: "are"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "("

Phrase: "or"

Phrase: "not in the case of PS1 lacking exon 9-encoded residues"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   738   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0332268:Lacking [Qualitative Concept]
   738   C0679058:encoded [Mental Process]
   738   C0868928:Case [Functional Concept]
   738   C1418985:PS1 [Gene or Genome]
   738   C1518422:Not [Functional Concept]
   738   C1706255:CASE [Medical Device]
   738   C1706256:Case [Conceptual Entity]
   738   C2700640:Encoded [Activity]
   738   C2986918:PS1 [Gene or Genome]
   704   C1709915:Residue [Conceptual Entity]
   704   C1882936:RESIDUE [Phenomenon or Process]

Phrase: ")."
Processing 00000000.tx.210: The mechanisms involved in facilitating PS endoproteolysis are not known. 

Phrase: "The mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "involved in facilitating PS endoproteolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involved [Functional Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]
Processing 00000000.tx.211: It is likely that both protein stabilization and endoproteolytic cleavage may rely on proper folding of the synthetic PS polypeptides. 

Phrase: "It"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "both protein stabilization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1327386:protein stabilization [Molecular Function]
   861   C1293130:Stabilisation [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "endoproteolytic cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "may"

Phrase: "rely on proper folding of the synthetic PS polypeptides."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0185026:Folding [Therapeutic or Preventive Procedure]
   742   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]
   742   C1883254:synthetic [Activity]
Processing 00000000.tx.212: The lack of an intact COOH terminus, for example, might prevent proper folding and/or association with PS binding proteins and thereby lead to rapid degradation. 

Phrase: "The lack of an intact COOH terminus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332268:lack [Qualitative Concept]

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "might"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "proper folding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185026:Folding [Therapeutic or Preventive Procedure]

Phrase: "and/or"

Phrase: "association with PS binding proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "thereby"

Phrase: "lead to rapid degradation."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0243125:degradation [Functional Concept]
   770   C0439831:Rapid [Qualitative Concept]
   770   C0699900:Degradation [Organism Function]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.213: In this regard, previously we showed that COOH-terminally truncated PS polypeptides, which lack the last two transmembrane domains and the cytoplasmic tail, failed to undergo endoproteolysis and were rapidly degraded (21). 

Phrase: "In this regard,"

Phrase: "previously"

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that COOH-terminally truncated PS polypeptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "which"

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "the last two transmembrane domains"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C1519623:Transmembrane Domain [Amino Acid Sequence]
   812   C1167322:transmembrane [Cell Component]
   812   C2752508:transmembrane [Cell Component]
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "the cytoplasmic tail,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1511625:Cytoplasmic Tail [Cell Component]
   861   C0010834:Cytoplasmic [Cell Component]
   861   C0039259:Tail [Body Part, Organ, or Organ Component]
   861   C0521449:Cytoplasmic [Body Location or Region]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "undergo"

Phrase: "endoproteolysis"

Phrase: "and"

Phrase: "were"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.214: Our present results confirm studies by Steiner et al. 

Phrase: "Our present results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "studies by Steiner et al."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]
Processing 00000000.tx.215: (25) that recombinant transgene-derived PS1 NTF is not incorporated into complexes containing endogenous PS1 CTF and is rapidly degraded. 

Phrase: "(25"

Phrase: ")"

Phrase: "that recombinant transgene-derived PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "incorporated into complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1704241:Complexes [Chemical Viewed Structurally]
   756 E C0439855:Complex [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "endogenous PS1 CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0332255:fragments [Functional Concept]
   804   C0486805:Fragments [Body Substance]
   771 E C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "degraded."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]
Processing 00000000.tx.216: In recent studies, it was reported that recombinant PS1 NTF with a FAD mutation failed to increase A42 production, even after stabilization of recombinant NTF by incubation with proteasome inhibitors (25, 27). 

Phrase: "In recent studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "it"

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that recombinant PS1 NTF with a FAD mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "A42 production,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "even"

Phrase: "after"

Phrase: "stabilization of recombinant NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1293130:Stabilisation [Therapeutic or Preventive Procedure]

Phrase: "by incubation"

Phrase: "with proteasome inhibitors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
  1000   C2266856:Proteasome Inhibitors [Molecular Function]
   966 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(25,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.217: Based on the recombinant NTF studies, it was suggested that full-length PS molecules, and not the endoproteolytic derivatives, were the functional PS units in vivo (27). 

Phrase: "Based on the recombinant NTF studies,"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   753   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   753   C0947630:studies [Laboratory Procedure]
   753   C1514798:recombinant [Organism]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C0557651:Study [Manufactured Object]
   719 E C1880279:Base [Biomedical or Dental Material]
   719 E C2603343:Study [Research Activity]

Phrase: "it"

Phrase: "was"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that full-length PS molecules,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0567416:molecules [Substance]
   729 E C1521991:Molecular [Qualitative Concept]

Phrase: "and"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the endoproteolytic derivatives,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "were"

Phrase: "the functional PS units"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0439148:Units [Quantitative Concept]
   827   C1519795:Units [Quantitative Concept]
   793 E C1704753:Unit [Manufactured Object]
   793 E C1880519:Unit [Quantitative Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.218: It is known that proper assembly contributes to the structural maturation as well as the function of oligomeric membrane proteins. 

Phrase: "It"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that proper assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1706853:Assembly [Activity]
   861   C1879748:Assembly [Manufactured Object]

Phrase: "contributes to the structural maturation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0678594:Structural [Spatial Concept]
   760   C0678723:Maturation [Organism Function]
   760   C0870861:maturation [Phenomenon or Process]
   760   C1254042:Maturation [Physiologic Function]
   760   C1880177:Contribute [Activity]

Phrase: "as well as"

Phrase: "the function of oligomeric membrane proteins."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   783   C0682568:membrane function [Body Part, Organ, or Organ Component]
   783   C0815043:function proteins [Amino Acid, Peptide, or Protein]
   767 E C1527118:Protein Function [Molecular Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]
Processing 00000000.tx.219: Thus, our demonstration that exogenously expressed human NTF failed to assemble with endogenous CTF provides direct evidence that the recombinant NTFs were not incorporated into PS complexes. 

Phrase: "Thus,"

Phrase: "our demonstration"

Phrase: "that exogenously expressed human NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "failed to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0231175:Failed [Functional Concept]

Phrase: "assemble with endogenous CTF"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0205088:Terminal [Temporal Concept]
   753   C0205227:Endogenous [Functional Concept]
   753   C0332255:fragments [Functional Concept]
   753   C0486805:Fragments [Body Substance]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   753   C1706853:Assemble [Activity]
   719 E C1708096:Fragment [Qualitative Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "direct evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the recombinant NTFs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "incorporated into PS complexes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1704241:Complexes [Chemical Viewed Structurally]
   737 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.220: We argue that the transgene-derived NTF molecules are structurally quite different from NTFCTF assemblies derived from full-length PS polypeptides; 

Phrase: "We"

Phrase: "argue"

Phrase: "that"

Phrase: "the transgene-derived NTF molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0567416:molecules [Substance]
   729 E C1521991:Molecular [Qualitative Concept]

Phrase: "are"

Phrase: "structurally quite different from NTFCTF assemblies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "derived from full-length PS polypeptides"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0443225:Full [Qualitative Concept]
   753   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]
   753   C1441547:Derived [Qualitative Concept]
   753   C1444754:Length [Quantitative Concept]
   753   C1706316:LENGTH [Research Activity]
   753   C3245521:derived [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.221: hence, their inability to increase A42 production cannot be interpreted in a way that provides any meaningful information regarding the functional form of PS. 

Phrase: "hence,"

Phrase: "their inability to"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "A42 production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "cannot"

Phrase: "be"

Phrase: "interpreted in a way"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1285553:interpreted [Functional Concept]

Phrase: "that"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "any meaningful information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1533716:Information [Idea or Concept]
   789 E C3242430:informational [Idea or Concept]

Phrase: "regarding"

Phrase: "the functional form of PS."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]
Processing 00000000.tx.222: The outcome of co-expression of full-length and truncated membrane receptors has been investigated for several membrane proteins. 

Phrase: "The outcome of co-expression of full-length"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1274040:Outcome [Functional Concept]

Phrase: "and"

Phrase: "truncated membrane receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0230664:membrane receptors [Receptor]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "has"

Phrase: "been"

Phrase: "investigated for several membrane proteins."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0025255:Membrane [Tissue]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0596901:Membrane [Cell Component]
   760   C1292732:investigated [Functional Concept]
   760   C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.223: In several instances, expression of truncated polypeptides disrupted the functional assembly and activity of endogenous proteins by a dominant negative mechanism (39). 

Phrase: "In several instances,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550608:Instance [Idea or Concept]

Phrase: "expression of truncated polypeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "disrupted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:Disrupted [Qualitative Concept]

Phrase: "the functional assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1706853:Assembly [Activity]
   861   C1879748:Assembly [Manufactured Object]

Phrase: "and"

Phrase: "activity of endogenous proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   802   C1537044:protein activity [Molecular Function]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "by a dominant negative mechanism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]
   734   C1512032:Dominant Negative [Cell or Molecular Dysfunction]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.224: For example, expression of fragments derived from the extracellular NH2-terminal domains of -, -, and -subunits of the acetylcholine receptor blocked the assembly and cell surface expression of functional acetylcholine receptors (40). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "expression of fragments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "derived from the extracellular NH2-terminal domains of -, -"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   750   C1517050:Extracellular Domain [Spatial Concept]
   744   C0002508:NH2 [Organic Chemical]
   744   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   744   C0205088:Terminal [Temporal Concept]
   744   C0521119:Extracellular [Cell Component]
   744   C1441547:Derived [Qualitative Concept]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]
   744   C3245521:derived [Idea or Concept]
   711   C1880389:Domain [Functional Concept]
   711   C1883221:Domain [Conceptual Entity]
   711   C3541951:Domain [Intellectual Product]

Phrase: ","

Phrase: "and -"

Phrase: "subunits of the acetylcholine receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1711351:Subunit [Quantitative Concept]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706853:Assembly [Activity]
  1000   C1879748:Assembly [Manufactured Object]

Phrase: "and"

Phrase: "cell surface expression of functional acetylcholine receptors"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   804   C0034800:Receptors, Cell Surface [Amino Acid, Peptide, or Protein,Receptor]
   800   C0699040:Surface of cell [Cell Component]
           Cell surface
   757   C0597360:receptor expression [Genetic Function]
   757   C1514760:Receptor Cell [Cell]
   748   C0007634:Cell [Cell]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0205148:Surface [Spatial Concept]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.225: In analogous studies, co-expression of truncated and full-length gonadotropin-releasing hormone receptors resulted in the inhibition of gonadotropin-releasing hormone signaling via the full-length receptor, probably because of specific interactions between the two receptor proteins resulting in impaired maturation of the full-length receptor (41). 

Phrase: "In analogous studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "co-expression of truncated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "full-length gonadotropin-releasing hormone receptors"
Meta Candidates (Total=18; Excluded=9; Pruned=0; Remaining=9)
   901   C0034811:Gonadotropin Releasing-Hormone Receptors [Amino Acid, Peptide, or Protein,Receptor]
   884 E C1415171:GONADOTROPIN-RELEASING HORMONE RECEPTOR [Gene or Genome]
   861   C0023610:Gonadotrophin releasing hormone [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   858   C0034812:Receptors, Gonadotropin [Amino Acid, Peptide, or Protein,Receptor]
   841 E C1416843:GONADOTROPIN RECEPTOR [Gene or Genome]
   827   C0019929:hormone receptors [Amino Acid, Peptide, or Protein,Receptor]
   799   C0018061:Gonadotrophin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0019932:Hormone [Hormone]
   799   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   799   C1283071:Releasing [Functional Concept]
   799   C3536870:Gonadotropin [Pharmacologic Substance]
   793 E C1367453:HORMONE RECEPTOR [Gene or Genome]
   766 E C0030685:Release [Health Care Activity]
   766 E C0391871:Release [Functional Concept]
   766 E C0439180:% release [Quantitative Concept]
   766 E C0680255:release [Health Care Activity]
   766 E C1963578:Release [Therapeutic or Preventive Procedure]
   727 E C0458083:Hormonal [Qualitative Concept]

Phrase: "resulted in the inhibition of gonadotropin-releasing hormone signaling"
Meta Candidates (Total=20; Excluded=5; Pruned=0; Remaining=15)
   790   C0023610:Gonadotrophin releasing hormone [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   762   C0815016:hormone releasing [Hormone]
   742   C0018061:Gonadotrophin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0019932:Hormone [Hormone]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C0037083:Signaling [Cell Function]
   742   C1283071:Releasing [Functional Concept]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]
   742   C3536870:Gonadotropin [Pharmacologic Substance]
   742   C3537152:signaling [Biologic Function]
   708 E C0030685:Release [Health Care Activity]
   708 E C0391871:Release [Functional Concept]
   708 E C0439180:% release [Quantitative Concept]
   708 E C0680255:release [Health Care Activity]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708 E C1963578:Release [Therapeutic or Preventive Procedure]
   708   C2825142:Result [Finding]

Phrase: "via the full-length receptor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "probably because of specific interactions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205369:Specific [Qualitative Concept]
   760   C0750492:Probably [Idea or Concept]
   760   C1552740:specific [Intellectual Product]
   726   C1704675:Interaction [Functional Concept]

Phrase: "between the two receptor proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0597357:receptor proteins [Amino Acid, Peptide, or Protein,Receptor]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "resulting in impaired maturation of the full-length receptor"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   764   C0332294:Resulting in [Functional Concept]
   742   C0221099:Impaired [Functional Concept]
   742   C0443225:Full [Qualitative Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0678226:resulting [Functional Concept]
   742   C0678723:Maturation [Organism Function]
   742   C0684336:Impaired [Pathologic Function]
   742   C0870861:maturation [Phenomenon or Process]
   742   C1254042:Maturation [Physiologic Function]
   742   C1444754:Length [Quantitative Concept]
   742   C1706316:LENGTH [Research Activity]
   708 E C1274040:Result [Functional Concept]
   708 E C1546471:Result [Idea or Concept]
   708 E C2825142:Result [Finding]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.226: In contrast to these studies, our analysis of stable cell lines expressing transgene-derived human PS1 NTF shows that the expression of PS1 NTF did not have any dominant negative inhibitory effect on the cleavage of endogenous full-length PS1 or on the stable accumulation of endogenous PS1-derived fragments. 

Phrase: "In contrast to these studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "our analysis of stable cell lines"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "expressing"

Phrase: "transgene-derived human PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the expression of PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "any dominant negative inhibitory effect on the cleavage of endogenous full-length PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C1280500:Effect [Qualitative Concept]
   735   C2348382:Effect [Qualitative Concept]

Phrase: "or on the stable accumulation of endogenous PS1-derived fragments."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   739   C0205227:Endogenous [Functional Concept]
   739   C0205360:Stable [Qualitative Concept]
   739   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0332255:fragments [Functional Concept]
   739   C0486805:Fragments [Body Substance]
   739   C1418985:PS1 [Gene or Genome]
   739   C1441547:Derived [Qualitative Concept]
   739   C1547311:Stable [Intellectual Product]
   739   C2986918:PS1 [Gene or Genome]
   739   C3245521:derived [Idea or Concept]
   706 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.227: Moreover, we and others showed that transgene-derived PS1 NTF cannot be co-isolated with endogenous PS1-derived CTF, excluding any direct physical interaction between truncated PS molecules and endogenous PS1. 

Phrase: "Moreover,"

Phrase: "we"

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that transgene-derived PS1 NTF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "cannot"

Phrase: "be"

Phrase: "co-isolated with endogenous PS1-derived CTF,"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   742   C0205088:Terminal [Temporal Concept]
   742   C0205227:Endogenous [Functional Concept]
   742   C0205409:Isolated [Functional Concept]
   742   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0332255:fragments [Functional Concept]
   742   C0486805:Fragments [Body Substance]
   742   C1418985:PS1 [Gene or Genome]
   742   C1441547:Derived [Qualitative Concept]
   742   C1548221:Isolated [Idea or Concept]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
   742   C2986918:PS1 [Gene or Genome]
   742   C3245521:derived [Idea or Concept]
   708 E C0370215:Isolate [Substance]
   708 E C1708096:Fragment [Qualitative Concept]
   708 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "excluding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0332196:Exclude [Functional Concept]
   966   C2828389:Exclude [Activity]

Phrase: "any direct physical interaction between truncated PS molecules"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1167622:Physical Interaction [Molecular Function]
           Molecular Interaction
   744   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "endogenous PS1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]
Processing 00000000.tx.228: Together, these results strongly suggest that the COOH terminus of PS might provide information essential for protein folding and/or interaction with proteins that interact with PS. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results strongly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the COOH terminus of PS"

Phrase: "might"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1533716:Information [Idea or Concept]
   928 E C3242430:informational [Idea or Concept]

Phrase: "essential for protein folding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]

Phrase: "and/or"

Phrase: "interaction with proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C0872079:interaction protein [Molecular Function]
   790   C1704675:Interaction [Functional Concept]

Phrase: "that"

Phrase: "interact with PS."
Processing 00000000.tx.229: In this regard, a calcium-binding protein, termed calsenilin, has been shown to bind to the COOH-terminal 40residues of PS (42). 

Phrase: "In this regard,"

Phrase: "a calcium-binding protein,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0006732:Calcium-binding protein [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1822659:calcium binding protein [Gene or Genome]
   913   C0805431:Calcium/Protein [Quantitative Concept]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1516144:Calcium Binding [Molecular Function]
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C2936886:Calcium [Pharmacologic Substance]

Phrase: "termed calsenilin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0758551:Calsenilin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1825644:CALSENILIN [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind to the COOH-terminal 40residues of PS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0205088:Terminal [Temporal Concept]
   744   C1145667:Bind [Activity]
   744   C1167622:bind [Molecular Function]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.230: As described above, PS1 and PS2 fragments derived from cleavage of co-expressed full-length PS1 and PS2 neither form mixed heteromeric assemblies nor exchange subunits to result in complexes containing PS1-NTFPS2 CTF or PS2 NTFPS1 CTF. 

Phrase: "As"

Phrase: "described above, PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2 fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "derived from cleavage of"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "co-expressed"

Phrase: "full-length PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2"

Phrase: "neither form mixed heteromeric assemblies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1706853:Assembly [Activity]
   779   C1879748:Assembly [Manufactured Object]

Phrase: "nor"

Phrase: "exchange subunits to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1711351:Subunit [Quantitative Concept]

Phrase: "result in complexes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C1704241:Complexes [Chemical Viewed Structurally]
   790   C2825142:Result [Finding]
   756 E C0439855:Complex [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "PS1-NTFPS2 CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0332255:fragments [Functional Concept]
   804   C0486805:Fragments [Body Substance]
   771 E C1708096:Fragment [Qualitative Concept]

Phrase: "or"

Phrase: "PS2 NTFPS1 CTF."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0332255:fragments [Functional Concept]
   804   C0486805:Fragments [Body Substance]
   771 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.231: Yet, overexpression of human PS1 resulted in diminution of endogenous PS2 derivatives (21). 

Phrase: "Yet,"

Phrase: "overexpression of human PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "resulted in diminution of endogenous PS2 derivatives"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0205227:Endogenous [Functional Concept]
   748   C0243072:derivatives [Chemical Viewed Structurally]
   748   C0332511:Diminution [Qualitative Concept]
   714   C1274040:Result [Functional Concept]
   714 E C1527240:Derivative [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.232: In studies presented here, we demonstrate that a chimeric polypeptide consisting of PS1 NTF and PS2 CTF undergoes endoproteolysis, and the resulting derivatives accumulate to saturable levels. 

Phrase: "In studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here,"

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that"

Phrase: "a chimeric polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "consisting of PS1 NTF"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   770   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418985:PS1 [Gene or Genome]
   770   C2986918:PS1 [Gene or Genome]
   737   C0332529:CONSIST [Qualitative Concept]

Phrase: "and"

Phrase: "PS2 CTF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "undergoes"

Phrase: "endoproteolysis,"

Phrase: "and"

Phrase: "the resulting derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "accumulate to saturable levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.233: Furthermore, expression of chimeric PS1/PS2 polypeptides harboring the FAD-linked M146L mutation resulted in the elevated production of A42. 

Phrase: "Furthermore,"

Phrase: "expression of chimeric PS1/PS2 polypeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "the FAD-linked M146L mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "resulted in the elevated production of A42."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0033268:production [Occupational Activity]
   748   C0205250:Elevated [Qualitative Concept]
   748   C3163633:Elevated [Qualitative Concept]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]
Processing 00000000.tx.234: Together, these findings indicate that PS1 and PS2 share common pathways of processing and likely interact with similar factors that modulate 42 processing of APP. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "indicate"

Phrase: "that PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "common pathways of processing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1704259:Pathways [Molecular Function]
   770   C1705987:Pathways [Conceptual Entity]

Phrase: "and"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "interact with similar factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C2348205:Similar [Qualitative Concept]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "42 processing of APP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0033666:protein processing [Molecular Function]
   753   C1709694:Processing [Activity]
Processing 00000000.tx.235: Future efforts to identity of individual polypeptide components of the oligomeric PS complex will be required to define the multiple steps involved in the regulation of assembly of the functional PS "unit".  

Phrase: "Future efforts to identity of individual polypeptide components of the oligomeric PS complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   702   C0015264:Effort [Organism Function]

Phrase: "will"

Phrase: "be"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "the multiple steps"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261552:steps [Conceptual Entity]
   827 E C1704379:Step [Functional Concept]
   827 E C1705117:Step [Quantitative Concept]
   827 E C2825408:Step [Manufactured Object]

Phrase: "involved in the regulation of assembly of the functional PS ""unit""."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   738   C0205245:Functional [Functional Concept]
   738   C0439148:Unit [Quantitative Concept]
   738   C0542341:Functional [Functional Concept]
   738   C0851285:Regulation [Governmental or Regulatory Activity]
   738   C1314939:Involved [Functional Concept]
   738   C1327622:Regulation [Biologic Function]
   738   C1519795:Unit [Quantitative Concept]
   738   C1704753:Unit [Manufactured Object]
   738   C1706853:Assembly [Activity]
   738   C1879748:Assembly [Manufactured Object]
   738   C1880519:Unit [Quantitative Concept]
   738   C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.236: ACKNOWLEDGEMENTS We thank Drs. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Drs."
Processing 00000000.tx.237: Sangram S.

Phrase: "Sangram S."
Processing 00000000.tx.238: Sisodia and David R.

Phrase: "Sisodia"

Phrase: "and"

Phrase: "David R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.239: Borchelt for helpful discussions and Dr. 

Phrase: "Borchelt for helpful discussions"

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.240: Sangram S.

Phrase: "Sangram S."
Processing 00000000.tx.241: Sisodia for comments on the manuscript. 

Phrase: "Sisodia for comments"

Phrase: "on the manuscript."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]
Processing 00000000.tx.242: We thank Dr. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.243: Allan I.Levey for providing the rat mAb specific for human PS1.  

Phrase: "Allan I.Levey for providing"

Phrase: "the rat mAb"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0746619:monoclonal [Finding]

Phrase: "specific for human PS1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]
Processing 00000000.tx.244: FOOTNOTES * This work was supported by the U.S. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by the U.S."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0041703:U S [Geographic Area]
   760   C1521721:Supported [Conceptual Entity]
   726 E C0183683:Support [Medical Device]
Processing 00000000.tx.245: Public Health Service, National Institutes of Health Grant 1PO1 AG14248 and grants-in-aid from the Ministry of Health and Welfare, the Ministry of Education, Science, Culture and Sports, Japan, CREST of Japan Science and Technology Corporation, and the Adler Foundation (to G.T. and C.A.S.).

Phrase: "Public Health Service,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0041734:Public Health Service [Health Care Related Organization]
  1000   C0699943:Public health service [Health Care Activity]
           public health
   901   C0018747:Service, Health [Health Care Activity]
   901   C0034019:Public Health [Biomedical Occupation or Discipline]
   901   C3244304:public health [Intellectual Product]
   827   C0018684:Health [Idea or Concept]
   827   C0557854:Service [Occupational Activity]
   827   C2825316:Service [Manufactured Object]
   827   C3245478:service [Idea or Concept]
   727 E C0031206:healthiness [Finding]

Phrase: "National Institutes of Health Grant 1PO1 AG14248"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   710   C0027468:National Institutes of Health [Health Care Related Organization]

Phrase: "and"

Phrase: "grants-in-aid from the Ministry of Health"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   744   C0018173:Grants [Quantitative Concept]
   744   C0018896:Aid [Social Behavior]
   744   C0449435:Aid [Manufactured Object]
   744   C3540469:AID [Gene or Genome]
   711 E C1548284:Grant [Idea or Concept]

Phrase: "and"

Phrase: "Welfare,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037440:welfare [Self-help or Relief Organization]

Phrase: "the Ministry of Education,"

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "Culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "Sports,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038039:Sports [Daily or Recreational Activity]
  1000   C1552306:Sports [Professional or Occupational Group]

Phrase: "Japan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "CREST of Japan Science"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332243:crest [Functional Concept]
   770   C1947915:Crest [Spatial Concept]
   770   C2948667:Crest [Pharmacologic Substance]

Phrase: "and"

Phrase: "Technology Corporation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corporation [Organization]

Phrase: "and"

Phrase: "the Adler Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundation [Organization]
   777 E C0002055:base [Inorganic Chemical]
   777 E C0178499:Base [Chemical Viewed Functionally]
   777 E C1626935:Bases [Quantitative Concept]
   777 E C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]

Phrase: "("

Phrase: "to G.T."

Phrase: "and"

Phrase: "C.A.S."

Phrase: ")."
Processing 00000000.tx.246: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.247: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.248: Section 1734solely to indicate this fact. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.249: To whom correspondence should be addressed: Dept. of Neurobiology, Pharmacology and Physiology, University of Chicago, Knapp Research Center, 924E.57th St., Chicago, IL 60637.Tel.: 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Neurobiology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027817:Neurobiology [Biomedical Occupation or Discipline]

Phrase: "Pharmacology"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031330:Pharmacology [Biomedical Occupation or Discipline]
  1000   C1524059:pharmacology [Functional Concept]
   928 E C0205464:Pharmacologic [Functional Concept]

Phrase: "and"

Phrase: "Physiology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "University of Chicago,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0008044:Chicago [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Knapp Research Center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0683939:research center [Manufactured Object,Organization]
   827   C0205099:Center [Spatial Concept]

Phrase: "924E.57th St., Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0008044:Chicago [Geographic Area]

Phrase: "IL 60637.Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0796520:TEL [Gene or Genome]
   827   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.250: 773-834-3752; 

Phrase: "773-834-3752"

Phrase: ";"
Processing 00000000.tx.251: Fax: 773-834-3808; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "773-834-3808"

Phrase: ";"
Processing 00000000.tx.252: E-mail: gopal{at}uchicago.edu .  ABBREVIATIONS The abbreviations used are: AD, Alzheimer's disease; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "gopal{at}uchicago.edu .  ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.253: APP, amyloid precursor protein; 

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.254: A, -amyloid peptide(s); 

Phrase: "A, -"

Phrase: "amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "s)"

Phrase: ";"
Processing 00000000.tx.255: CTF, COOH-terminal fragment(s); 

Phrase: "CTF,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "COOH-terminal fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "("

Phrase: "s)"

Phrase: ";"
Processing 00000000.tx.256: ELISA, enzyme-linked immunosorbent assay; 

Phrase: "ELISA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]

Phrase: "enzyme-linked immunosorbent assay"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]

Phrase: ";"
Processing 00000000.tx.257: FAD, familial early onset AD; 

Phrase: "FAD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3247466:FAD [Pharmacologic Substance]

Phrase: "familial early onset AD"

Phrase: ";"
Processing 00000000.tx.258: N2a, mouse neuro2a neuroblastoma; 

Phrase: "N2a,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445079:N2a [Finding]

Phrase: "mouse neuro2a neuroblastoma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1524043:Mouse Neuroblastoma [Neoplastic Process]
   827   C0027819:Neuroblastoma [Neoplastic Process]
   827   C0700095:neuroblastoma [Neoplastic Process]
   827   C3540583:Neuroblastoma [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.259: NTF, NH2-terminal fragment(s); 

Phrase: "NTF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0132298:NTF [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "NH2-terminal fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "("

Phrase: "s)"

Phrase: ";"
Processing 00000000.tx.260: PS, presenilin; 

Phrase: "PS,"

Phrase: "presenilin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ";"
Processing 00000000.tx.261: PS1, presenilin 1; 

Phrase: "PS1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "presenilin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ";"
Processing 00000000.tx.262: PS2, presenilin 2; 

Phrase: "PS2,"

Phrase: "presenilin 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ";"
Processing 00000000.tx.263: mAb, monoclonal antibody.  

Phrase: "mAb,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]

Phrase: "monoclonal antibody."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]
Processing 00000000.tx.264: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Wisniewski, H., and Terry, R. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Wisniewski,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Terry,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.265: (1973) in Progress in Neuropathology (Zimmerman, H., ed), Vol. 

Phrase: "(1973"

Phrase: ")"

Phrase: "in Progress in Neuropathology"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1272688:In progress [Functional Concept]
           progress
   833   C1548387:in progress [Idea or Concept]
   770   C0150312:In [Quantitative Concept]
   770   C0332285:In [Spatial Concept]
   770   C1280477:Progress [Functional Concept]

Phrase: "(Zimmerman,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "ed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "Vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449468:VOL [Quantitative Concept]
  1000   C0560268:vol% [Quantitative Concept]
  1000   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.266: II, pp. 

Phrase: "II,"

Phrase: "pp."
Processing 00000000.tx.267: 1-26, Grune and Stratton, New York Glenner, G. 

Phrase: "1-26,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "Grune"

Phrase: "and"

Phrase: "Stratton,"

Phrase: "New York Glenner,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027976:New York [Geographic Area]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.268: G., and Wong, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Wong,"

Phrase: "C."
Processing 00000000.tx.269: W. 

Phrase: "W."
Processing 00000000.tx.270: (1984) Biochem. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.271: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.272: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.273: Commun. 

Phrase: "Commun."
Processing 00000000.tx.274: 120, 885-890[Medline] [OrderarticleviaInfotrieve] Selkoe, D. 

Phrase: "120,"

Phrase: "885-890"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Selkoe,"

Phrase: "D."
Processing 00000000.tx.275: J. 

Phrase: "J."
Processing 00000000.tx.276: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.277: Biol. 

Phrase: "Biol."
Processing 00000000.tx.278: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.279: 271, 18295-18298[Free FullText] Busfield, F., and Goate, A. 

Phrase: "271,"

Phrase: "18295-18298"

Phrase: "[Free FullText"

Phrase: "] Busfield,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Goate,"

Phrase: "A."
Processing 00000000.tx.280: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.281: (1995) Pathology of Alzheimer's Disease, pp. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Pathology of Alzheimer's Disease,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030664:Pathology [Biomedical Occupation or Discipline]
   770   C0205469:pathology [Functional Concept]
   770   C0677042:pathology [Pathologic Function]

Phrase: "pp."
Processing 00000000.tx.282: 59-75, Academic Press, Inc., San Diego Sherrington, R., Rogaev, E. 

Phrase: "59-75,"

Phrase: "Academic Press,"

Phrase: "Inc.,"

Phrase: "San Diego Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaev,"

Phrase: "E."
Processing 00000000.tx.283: I., Liang, Y., Rogaeva, E. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Rogaeva,"

Phrase: "E."
Processing 00000000.tx.284: A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J.-F., Bruni, A. 

Phrase: "A.,"

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Chi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Holman,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tsuda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mar"

Phrase: ","

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Foncin,"

Phrase: "J.-F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Bruni,"

Phrase: "A."
Processing 00000000.tx.285: C., Montesi, M. 

Phrase: "C., Montesi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.286: P., Sorbi, S., Rainero, I., Pinessi, L., Nee, L., Chumakov, I., Pollen, D., Brookes, A., Sansequ, P., Polinsky, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sorbi,"

Phrase: "S."

Phrase: ","

Phrase: "Rainero,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Pinessi,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Nee,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Chumakov,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Pollen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032385:Pollen [Plant]
  1000   C0795585:POLLEN [Organic Chemical,Pharmacologic Substance]
  1000   C1320238:Pollen [Immunologic Factor]

Phrase: "D."

Phrase: ","

Phrase: "Brookes,"

Phrase: "A.,"

Phrase: "Sansequ,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Polinsky,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.287: J., Wasco, W., Da Silva, H. 

Phrase: "J.,"

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Da Silva,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   789   C0144237:Silvan [Organic Chemical]
   768 E C0043217:Wood [Substance]
   768 E C0442548:Woods [Geographic Area]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.288: A.R., Haines, J. 

Phrase: "A.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Haines,"

Phrase: "J."
Processing 00000000.tx.289: L., Pericak-Vance, M. 

Phrase: "L., Pericak-Vance,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.290: A., Tanzi, R. 

Phrase: "A.,"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.291: E., Roses, A. 

Phrase: "E.,"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.292: D., Fraser, P. 

Phrase: "D."

Phrase: ","

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.293: E., Rommens, J. 

Phrase: "E.,"

Phrase: "Rommens,"

Phrase: "J."
Processing 00000000.tx.294: M., and St. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.295: George-Hyslop, P. 

Phrase: "George-Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.296: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.297: (1995) Nature 375, 754-760[CrossRef][Medline] [OrderarticleviaInfotrieve] Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nature 375,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "754-760"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Levy-Lahad,"

Phrase: "E.,"

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Romano,"

Phrase: "D."
Processing 00000000.tx.298: M., Oshima, J., Pettingell, W. 

Phrase: "M."

Phrase: ","

Phrase: "Oshima,"

Phrase: "J.,"

Phrase: "Pettingell,"

Phrase: "W."
Processing 00000000.tx.299: H., Yu, C.E., Jondro, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "C.E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Jondro,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.300: D., Schmidt, S. 

Phrase: "D."

Phrase: ","

Phrase: "Schmidt,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.301: D., Wang, K., Crowley, A. 

Phrase: "D."

Phrase: ","

Phrase: "Wang,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Crowley,"

Phrase: "A."
Processing 00000000.tx.302: C., Fu, Y.-H., Guenette, S. 

Phrase: "C., Fu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016360:FU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C1424823:FU [Gene or Genome]

Phrase: "Y.-H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Guenette,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.303: Y., Galas, D., Nemens, E., Wijsman, E. 

Phrase: "Y.,"

Phrase: "Galas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0082651:gala [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966   C1439334:GALA [Gene or Genome]

Phrase: "D."

Phrase: ","

Phrase: "Nemens,"

Phrase: "E.,"

Phrase: "Wijsman,"

Phrase: "E."
Processing 00000000.tx.304: M., Bird, T. 

Phrase: "M."

Phrase: ","

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.305: D., Schellenberg, G. 

Phrase: "D."

Phrase: ","

Phrase: "Schellenberg,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.306: D., and Tanzi, R. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.307: E. 

Phrase: "E."
Processing 00000000.tx.308: (1995) Science 269, 973-977[Medline] [OrderarticleviaInfotrieve] Rogaev, E. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Science 269,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "973-977"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Rogaev,"

Phrase: "E."
Processing 00000000.tx.309: I., Sherrington, R., Rogaeva, E. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaeva,"

Phrase: "E."
Processing 00000000.tx.310: A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., Mar, L., Sorbi, S., Nacmias, B., Piacentini, S., Amaducci, L., Chumakov, I., Cohen, D., Lannfelt, L., Fraser, P. 

Phrase: "A.,"

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Chi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Holman,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tsuda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mar"

Phrase: ","

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Sorbi,"

Phrase: "S."

Phrase: ","

Phrase: "Nacmias,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Piacentini,"

Phrase: "S."

Phrase: ","

Phrase: "Amaducci,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Chumakov,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Cohen,"

Phrase: "D."

Phrase: ","

Phrase: "Lannfelt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.311: E., Rommens, J. 

Phrase: "E.,"

Phrase: "Rommens,"

Phrase: "J."
Processing 00000000.tx.312: M., and St. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.313: George-Hyslop, P. 

Phrase: "George-Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.314: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.315: (1995) Nature 376, 775-778[CrossRef][Medline] [OrderarticleviaInfotrieve] Hardy, J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nature 376,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "775-778"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hardy,"

Phrase: "J."
Processing 00000000.tx.316: (1997) Trends Neurosci. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci."
Processing 00000000.tx.317: 20, 154-159[CrossRef][Medline] [OrderarticleviaInfotrieve] Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. 

Phrase: "20,"

Phrase: "154-159"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Scheuner,"

Phrase: "D."

Phrase: ","

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Jensen,"

Phrase: "M."

Phrase: ","

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "X.,"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.318: D., Hardy, J., Hutton, M., Kukull, W., Larson, E., Levy-Lahad, E., Viitanen, M., Peskind, E., Poorkaj, P., Schellenberg, G., Tanzi, R., Wasco, W., Lannfelt, L., Selkoe, D., and Younkin, S. 

Phrase: "D."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Kukull,"

Phrase: "W.,"

Phrase: "Larson,"

Phrase: "E.,"

Phrase: "Levy-Lahad,"

Phrase: "E.,"

Phrase: "Viitanen,"

Phrase: "M."

Phrase: ","

Phrase: "Peskind,"

Phrase: "E.,"

Phrase: "Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Schellenberg,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Tanzi,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Lannfelt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Selkoe,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.319: (1996) Nat. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.320: Med. 

Phrase: "Med."
Processing 00000000.tx.321: 2, 864-870[Medline] [OrderarticleviaInfotrieve] Borchelt, D. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "864-870"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Borchelt,"

Phrase: "D."
Processing 00000000.tx.322: R., Thinakaran, G., Eckman, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.323: B., Lee, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.324: K., Davenport, F., Ratovitsky, T., Prada, C. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Davenport,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Ratovitsky,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Prada,"

Phrase: "C."
Processing 00000000.tx.325: M., Kim, G., Seekins, S., Yager, D., Slunt, H. 

Phrase: "M."

Phrase: ","

Phrase: "Kim,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Seekins,"

Phrase: "S."

Phrase: ","

Phrase: "Yager,"

Phrase: "D."

Phrase: ","

Phrase: "Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.326: H., Wang, R., Seeger, M., Levey, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wang,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Seeger,"

Phrase: "M."

Phrase: ","

Phrase: "Levey,"

Phrase: "A."
Processing 00000000.tx.327: I., Gandy, S. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.328: E., Copeland, N. 

Phrase: "E.,"

Phrase: "Copeland,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.329: G., Jenkins, N. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Jenkins,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.330: A., Price, D. 

Phrase: "A.,"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.331: L., Younkin, S. 

Phrase: "L., Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.332: G., and Sisodia, S. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.333: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.334: (1996) Neuron 17, 1005-1013[Medline] [OrderarticleviaInfotrieve] Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neuron 17,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "1005-1013"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Duff,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Zehr,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "X.,"

Phrase: "Prada,"

Phrase: "C."
Processing 00000000.tx.335: M., Perez-Tur, J., Hutton, M., Buee, L., Harigaya, Y., Yager, D., Morgan, D., Gordon, M. 

Phrase: "M."

Phrase: ","

Phrase: "Perez-Tur,"

Phrase: "J.,"

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Buee,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Harigaya,"

Phrase: "Y.,"

Phrase: "Yager,"

Phrase: "D."

Phrase: ","

Phrase: "Morgan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582521:morgan [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Gordon,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.336: N., Holcomb, L., Refolo, L., Zenk, B., Hardy, J., and Younkin, S. 

Phrase: "N., Holcomb,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Refolo,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Zenk,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.337: (1996) Nature 383, 710-713[CrossRef][Medline] [OrderarticleviaInfotrieve] Tomita, T., Maruyama, K., Saido, T. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nature 383,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "710-713"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Maruyama,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.338: C., Kume, H., Shinozaki, K., Tokuhiro, S., Capell, A., Walter, J., Grunberg, J., Haass, C., Iwatsubo, T., and Obata, K. 

Phrase: "C., Kume,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Shinozaki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tokuhiro,"

Phrase: "S."

Phrase: ","

Phrase: "Capell,"

Phrase: "A.,"

Phrase: "Walter,"

Phrase: "J.,"

Phrase: "Grunberg,"

Phrase: "J.,"

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Obata,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.339: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.340: Natl. 

Phrase: "Natl."
Processing 00000000.tx.341: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.342: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.343: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.344: 94, 2025-2030[Abstract/Free FullText] Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-Wood, K., Lee, M., Seubert, P., Davis, A., Kholodenko, D., Motter, R., Sherrington, R., Perry, B., Yao, H., Strome, R., Lieberburg, I., Rommens, J., Kim, S., Schenk, D., Fraser, P., St. 

Phrase: "94,"

Phrase: "2025-2030"

Phrase: "[Abstract/Free FullText"

Phrase: "] Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Westaway,"

Phrase: "D."

Phrase: ","

Phrase: "Xia,"

Phrase: "W.,"

Phrase: "Carlson,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Diehl,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Johnson-Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0043217:Wood [Substance]
   805 E C0144237:Sylvan [Organic Chemical]
   777 E C0442548:Woods [Geographic Area]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Davis,"

Phrase: "A.,"

Phrase: "Kholodenko,"

Phrase: "D."

Phrase: ","

Phrase: "Motter,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Perry,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Yao,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Strome,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Rommens,"

Phrase: "J.,"

Phrase: "Kim,"

Phrase: "S."

Phrase: ","

Phrase: "Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "Fraser,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.345: George Hyslop, P., and Selkoe, D. 

Phrase: "George Hyslop,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.346: J. 

Phrase: "J."
Processing 00000000.tx.347: (1997) Nat. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.348: Med. 

Phrase: "Med."
Processing 00000000.tx.349: 3, 67-72[Medline] [OrderarticleviaInfotrieve] Mehta, N. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "67-72"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mehta,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.350: D., Refolo, L. 

Phrase: "D."

Phrase: ","

Phrase: "Refolo,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.351: M., Eckman, C., Sanders, S., Yager, D., Perez-Tur, J., Younkin, S., Duff, K., Hardy, J., and Hutton, M. 

Phrase: "M."

Phrase: ","

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Sanders,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1504648:Sander [Fish]

Phrase: "S."

Phrase: ","

Phrase: "Yager,"

Phrase: "D."

Phrase: ","

Phrase: "Perez-Tur,"

Phrase: "J.,"

Phrase: "Younkin,"

Phrase: "S."

Phrase: ","

Phrase: "Duff,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Hutton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.352: (1998) Ann. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.353: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.354: 43, 256-258[Medline] [OrderarticleviaInfotrieve] De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., and Van Leuven, F. 

Phrase: "43,"

Phrase: "256-258"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Saftig,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Craessaerts,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Vanderstichele,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Guhde,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Annaert,"

Phrase: "W.,"

Phrase: "Von Figura,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Van Leuven,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.355: (1998) Nature 391, 387-390[CrossRef][Medline] [OrderarticleviaInfotrieve] Naruse, S., Thinakaran, G., Luo, J.-J., Kusiak, J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nature 391,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "387-390"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Naruse,"

Phrase: "S."

Phrase: ","

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "J.-J.,"

Phrase: "Kusiak,"

Phrase: "J."
Processing 00000000.tx.356: W., Tomiata, T., Iwatsubo, T., Qian, X., Ginty, D. 

Phrase: "W., Tomiata,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Qian,"

Phrase: "X.,"

Phrase: "Ginty,"

Phrase: "D."
Processing 00000000.tx.357: D., Price, D. 

Phrase: "D."

Phrase: ","

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.358: L., Borchelt, D. 

Phrase: "L., Borchelt,"

Phrase: "D."
Processing 00000000.tx.359: R., and Wong, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Wong,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.360: C. 

Phrase: "C."
Processing 00000000.tx.361: (1998) Neuron 21, 1213-1221[Medline] [OrderarticleviaInfotrieve] Doan, A., Thinakaran, G., Borchelt, D. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neuron 21,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "1213-1221"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Doan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0591397:Doan's [Organic Chemical,Pharmacologic Substance]

Phrase: "A.,"

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Borchelt,"

Phrase: "D."
Processing 00000000.tx.362: R., Slunt, H. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.363: H., Ratovitsky, T., Podlisny, M., Selkoe, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ratovitsky,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Podlisny,"

Phrase: "M."

Phrase: ","

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.364: J., Seeger, M., Gandy, S. 

Phrase: "J.,"

Phrase: "Seeger,"

Phrase: "M."

Phrase: ","

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.365: E., Price, D. 

Phrase: "E.,"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.366: L., and Sisodia, S. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.367: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.368: (1996) Neuron 17, 1023-1030[Medline] [OrderarticleviaInfotrieve] Thinakaran, G., Borchelt, D. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neuron 17,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "1023-1030"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Borchelt,"

Phrase: "D."
Processing 00000000.tx.369: R., Lee, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.370: K., Slunt, H. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.371: H., Spitzer, L., Kim, G., Ratovitsky, T., Davenport, F., Nordstedt, C., Seeger, M., Hardy, J., Levey, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Spitzer,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kim,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ratovitsky,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Davenport,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Nordstedt,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Seeger,"

Phrase: "M."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Levey,"

Phrase: "A."
Processing 00000000.tx.372: I., Gandy, S. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.373: E., Jenkins, N. 

Phrase: "E.,"

Phrase: "Jenkins,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.374: A., Copeland, N. 

Phrase: "A.,"

Phrase: "Copeland,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.375: G., Price, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.376: L., and Sisodia, S. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.377: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.378: (1996) Neuron 17, 181-190[Medline] [OrderarticleviaInfotrieve] Mercken, M., Takahashi, H., Honda, T., Sato, K., Murayama, M., Nakazato, Y., Noguchi, K., Imahori, K., and Takashima, A. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neuron 17,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "181-190"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mercken,"

Phrase: "M."

Phrase: ","

Phrase: "Takahashi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Honda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sato,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Murayama,"

Phrase: "M."

Phrase: ","

Phrase: "Nakazato,"

Phrase: "Y.,"

Phrase: "Noguchi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Imahori,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Takashima,"

Phrase: "A."
Processing 00000000.tx.379: (1996) FEBS Lett. 

Phrase: "(1996"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.380: 389, 297-303[CrossRef][Medline] [OrderarticleviaInfotrieve] Kim, T. 

Phrase: "389,"

Phrase: "297-303"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kim,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.381: W., Pettingell, W. 

Phrase: "W., Pettingell,"

Phrase: "W."
Processing 00000000.tx.382: H., Hallmark, O. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hallmark,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.383: G., Moir, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Moir,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.384: D., Wasco, W., and Tanzi, R. 

Phrase: "D."

Phrase: ","

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.385: E. 

Phrase: "E."
Processing 00000000.tx.386: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.387: Biol. 

Phrase: "Biol."
Processing 00000000.tx.388: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.389: 272, 11006-11010[Abstract/Free FullText] Thinakaran, G., Harris, C. 

Phrase: "272,"

Phrase: "11006-11010"

Phrase: "[Abstract/Free FullText"

Phrase: "] Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Harris,"

Phrase: "C."
Processing 00000000.tx.390: L., Ratovitski, T., Davenport, F., Slunt, H. 

Phrase: "L., Ratovitski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Davenport,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.391: H., Price, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.392: L., Borchelt, D. 

Phrase: "L., Borchelt,"

Phrase: "D."
Processing 00000000.tx.393: R., and Sisodia, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.394: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.395: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.396: Biol. 

Phrase: "Biol."
Processing 00000000.tx.397: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.398: 272, 28415-28422[Abstract/Free FullText] Ratovitski, T., Slunt, H. 

Phrase: "272,"

Phrase: "28415-28422"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ratovitski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.399: H., Thinakaran, G., Price, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.400: L., Sisodia, S. 

Phrase: "L., Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.401: S., and Borchelt, D. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Borchelt,"

Phrase: "D."
Processing 00000000.tx.402: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.403: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.404: Biol. 

Phrase: "Biol."
Processing 00000000.tx.405: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.406: 272, 24536-24541[Abstract/Free FullText] Podlisny, M. 

Phrase: "272,"

Phrase: "24536-24541"

Phrase: "[Abstract/Free FullText"

Phrase: "] Podlisny,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.407: B., Citron, M., Amarante, P., Sherrington, R., Xia, W., Zhang, J., Diehl, T., Levesque, G., Fraser, P., Haass, C., Koo, E. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Amarante,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Xia,"

Phrase: "W.,"

Phrase: "Zhang,"

Phrase: "J.,"

Phrase: "Diehl,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Fraser,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.408: H., Seubert, P., St. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.409: George-Hyslop, P., Teplow, D. 

Phrase: "George-Hyslop,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.410: B., and Selkoe, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.411: J. 

Phrase: "J."
Processing 00000000.tx.412: (1997) Neurobiol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.413: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.414: 3, 325-337[CrossRef][Medline] [OrderarticleviaInfotrieve] Zhang, J., Kang, D. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "325-337"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Zhang,"

Phrase: "J.,"

Phrase: "Kang,"

Phrase: "D."
Processing 00000000.tx.415: E., Xia, W., Okochi, M., Mori, H., Selkoe, D. 

Phrase: "E.,"

Phrase: "Xia,"

Phrase: "W.,"

Phrase: "Okochi,"

Phrase: "M."

Phrase: ","

Phrase: "Mori,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.416: J., and Koo, E. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.417: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.418: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.419: Biol. 

Phrase: "Biol."
Processing 00000000.tx.420: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.421: 273, 12436-12442[Abstract/Free FullText] Steiner, H., Capell, A., Pesold, B., Citron, M., Kloetzel, P. 

Phrase: "273,"

Phrase: "12436-12442"

Phrase: "[Abstract/Free FullText"

Phrase: "] Steiner,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Capell,"

Phrase: "A.,"

Phrase: "Pesold,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Kloetzel,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.422: M., Selkoe, D. 

Phrase: "M."

Phrase: ","

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.423: J., Romig, H., Mendla, K., and Haass, C. 

Phrase: "J.,"

Phrase: "Romig,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mendla,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.424: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.425: Biol. 

Phrase: "Biol."
Processing 00000000.tx.426: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.427: 273, 32322-32331[Abstract/Free FullText] Thinakaran, G., Regard, J. 

Phrase: "273,"

Phrase: "32322-32331"

Phrase: "[Abstract/Free FullText"

Phrase: "] Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Regard,"

Phrase: "J."
Processing 00000000.tx.428: B., Bouton, C. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Bouton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206181:bouton [Cell Component]

Phrase: "C."
Processing 00000000.tx.429: M.L., Harris, C. 

Phrase: "M.L., Harris,"

Phrase: "C."
Processing 00000000.tx.430: L., Price, D. 

Phrase: "L., Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.431: L., Borchelt, D. 

Phrase: "L., Borchelt,"

Phrase: "D."
Processing 00000000.tx.432: R., and Sisodia, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.433: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.434: (1998) Neurobiol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.435: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.436: 4, 438-453[CrossRef][Medline] [OrderarticleviaInfotrieve] Citron, M., Eckman, C. 

Phrase: "4,"

Phrase: "438-453"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.437: B., Diehl, T. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Diehl,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.438: S., Corcoran, C., Ostaszewski, B. 

Phrase: "S."

Phrase: ","

Phrase: "Corcoran,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Ostaszewski,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.439: L., Xia, W., Levesque, G., Hyslop, P., Younkin, S. 

Phrase: "L., Xia,"

Phrase: "W.,"

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hyslop,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.440: G., and Selkoe, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.441: J. 

Phrase: "J."
Processing 00000000.tx.442: (1998) Neurobiol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.443: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.444: 5, 107-116[CrossRef][Medline] [OrderarticleviaInfotrieve] Slunt, H. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "107-116"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.445: H., Thinakaran, G., Lee, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.446: K., and Sisodia, S. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.447: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.448: (1995) Amyloid Int. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Amyloid Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063789:INT [Organic Chemical]
   861   C3272375:INT [Intellectual Product]
Processing 00000000.tx.449: J.Exp. 

Phrase: "J.Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.450: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.451: Invest. 

Phrase: "Invest."
Processing 00000000.tx.452: 2, 188-190 Yu, G., Chen, F., Levesque, G., Nishimura, M., Zhang, D. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "188-190 Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1006780:yu [Plant]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Nishimura,"

Phrase: "M."

Phrase: ","

Phrase: "Zhang,"

Phrase: "D."
Processing 00000000.tx.453: M., Levesque, L., Rogaeva, E., Xu, D., Liang, Y., Duthie, M., St. 

Phrase: "M."

Phrase: ","

Phrase: "Levesque,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Rogaeva,"

Phrase: "E.,"

Phrase: "Xu,"

Phrase: "D."

Phrase: ","

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Duthie,"

Phrase: "M."

Phrase: ","

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.454: George-Hyslop, P. 

Phrase: "George-Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.455: H., and Fraser, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.456: E. 

Phrase: "E."
Processing 00000000.tx.457: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.458: Biol. 

Phrase: "Biol."
Processing 00000000.tx.459: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.460: 273, 16470-16475[Abstract/Free FullText] Lah, J. 

Phrase: "273,"

Phrase: "16470-16475"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lah,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0238705:LAH [Anatomical Abnormality,Disease or Syndrome]
  1000   C1427484:LAH [Gene or Genome]
  1000   C1842839:LAH [Disease or Syndrome]

Phrase: "J."
Processing 00000000.tx.461: J., Heilman, C. 

Phrase: "J.,"

Phrase: "Heilman,"

Phrase: "C."
Processing 00000000.tx.462: J., Nash, N. 

Phrase: "J.,"

Phrase: "Nash,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.463: R., Rees, H. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rees,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555622:Ree [Language]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.464: D., Yi, H., Counts, S. 

Phrase: "D."

Phrase: ","

Phrase: "Yi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Counts,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0439157:counts [Quantitative Concept]
   966 E C0750480:Count [Activity]
   966 E C1705566:Count [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.465: E., and Levey, A. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Levey,"

Phrase: "A."
Processing 00000000.tx.466: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.467: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.468: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.469: 17, 1971-1980[Abstract/Free FullText] Borchelt, D. 

Phrase: "17,"

Phrase: "1971-1980"

Phrase: "[Abstract/Free FullText"

Phrase: "] Borchelt,"

Phrase: "D."
Processing 00000000.tx.470: R., Lee, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.471: K., Slunt, H. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.472: S., Guarnieri, M., Xu, Z. 

Phrase: "S."

Phrase: ","

Phrase: "Guarnieri,"

Phrase: "M."

Phrase: ","

Phrase: "Xu,"

Phrase: "Z."
Processing 00000000.tx.473: S., Wong, P. 

Phrase: "S."

Phrase: ","

Phrase: "Wong,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.474: C., Brown, R. 

Phrase: "C., Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.475: H., Jr., Price, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.476: L., Sisodia, S. 

Phrase: "L., Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.477: S., and Cleveland, D. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "D."
Processing 00000000.tx.478: W. 

Phrase: "W."
Processing 00000000.tx.479: (1994) Proc. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.480: Natl. 

Phrase: "Natl."
Processing 00000000.tx.481: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.482: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.483: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.484: 91, 8292-8296[Abstract] Tomita, T., Tokuhiro, S., Hashimoto, T., Aiba, K., Saido, T. 

Phrase: "91,"

Phrase: "8292-8296"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tokuhiro,"

Phrase: "S."

Phrase: ","

Phrase: "Hashimoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Aiba,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.485: C., Maruyama, K., and Iwatsubo, T. 

Phrase: "C., Maruyama,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Iwatsubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.486: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.487: Biol. 

Phrase: "Biol."
Processing 00000000.tx.488: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.489: 273, 21153-21160[Abstract/Free FullText] Suzuki, N., Cheung, T. 

Phrase: "273,"

Phrase: "21153-21160"

Phrase: "[Abstract/Free FullText"

Phrase: "] Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Cheung,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.490: T., Cai, X. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X."
Processing 00000000.tx.491: D., Odaka, A., Otvos, L., Jr., Eckman, C., Golde, T. 

Phrase: "D."

Phrase: ","

Phrase: "Odaka,"

Phrase: "A.,"

Phrase: "Otvos,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.492: E., and Younkin, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.493: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.494: (1994) Science 264, 1336-1340[Medline] [OrderarticleviaInfotrieve] Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., and Ihara, Y. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Science 264,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1336-1340"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Odaka,"

Phrase: "A.,"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Mizusawa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nukina,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Ihara,"

Phrase: "Y."
Processing 00000000.tx.495: (1994) Neuron 13, 45-53[Medline] [OrderarticleviaInfotrieve] Asami-Odaka, A., Ishibashi, Y., Kikuchi, T., Kitada, C., and Suzuki, N. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Neuron 13,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "45-53"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Asami-Odaka,"

Phrase: "A.,"

Phrase: "Ishibashi,"

Phrase: "Y.,"

Phrase: "Kikuchi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kitada,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.496: (1995) Biochemistry 34, 10272-10278[Medline] [OrderarticleviaInfotrieve] Seeger, M., Nordstedt, C., Petanceska, S., Kovacs, D. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Biochemistry 34,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "10272-10278"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Seeger,"

Phrase: "M."

Phrase: ","

Phrase: "Nordstedt,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Petanceska,"

Phrase: "S."

Phrase: ","

Phrase: "Kovacs,"

Phrase: "D."
Processing 00000000.tx.497: M., Gouras, G. 

Phrase: "M."

Phrase: ","

Phrase: "Gouras,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.498: K., Hahne, S., Fraser, P., Levesque, L., Czernik, A. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hahne,"

Phrase: "S."

Phrase: ","

Phrase: "Fraser,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Levesque,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Czernik,"

Phrase: "A."
Processing 00000000.tx.499: J., St. 

Phrase: "J.,"

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.500: George-Hyslop, P., Sisodia, S. 

Phrase: "George-Hyslop,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.501: S., Thinakaran, G., Tanzi, R. 

Phrase: "S."

Phrase: ","

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.502: E., Greengard, P., and Gandy, S. 

Phrase: "E.,"

Phrase: "Greengard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.503: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.504: Natl. 

Phrase: "Natl."
Processing 00000000.tx.505: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.506: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.507: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.508: 94, 5090-5094[Abstract/Free FullText] Capell, A., Grunberg, J., Pesold, B., Diehlmann, A., Citron, M., Nixon, R., Beyreuther, K., Selkoe, D. 

Phrase: "94,"

Phrase: "5090-5094"

Phrase: "[Abstract/Free FullText"

Phrase: "] Capell,"

Phrase: "A.,"

Phrase: "Grunberg,"

Phrase: "J.,"

Phrase: "Pesold,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Diehlmann,"

Phrase: "A.,"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Nixon,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.509: J., and Haass, C. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.510: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.511: Biol. 

Phrase: "Biol."
Processing 00000000.tx.512: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.513: 273, 3205-3211[Abstract/Free FullText] Perez-Tur, J., Froelich, S., Prihar, G., Crook, R., Baker, M., Duff, K., Wragg, M., Busfield, F., Lendon, C., Clark, R. 

Phrase: "273,"

Phrase: "3205-3211"

Phrase: "[Abstract/Free FullText"

Phrase: "] Perez-Tur,"

Phrase: "J.,"

Phrase: "Froelich,"

Phrase: "S."

Phrase: ","

Phrase: "Prihar,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "Duff,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wragg,"

Phrase: "M."

Phrase: ","

Phrase: "Busfield,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Lendon,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Clark,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.514: F., Roques, P., Fuldner, R. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Roques,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Fuldner,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.515: A., Johnston, J., Cowburn, R., Forsell, C., Axelman, K., Lilius, L., Houlden, H., Karran, E., Roberts, G. 

Phrase: "A.,"

Phrase: "Johnston,"

Phrase: "J.,"

Phrase: "Cowburn,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Forsell,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Axelman,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lilius,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Houlden,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Karran,"

Phrase: "E.,"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.516: W., Rossor, M., Adams, M. 

Phrase: "W., Rossor,"

Phrase: "M."

Phrase: ","

Phrase: "Adams,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331762:Adams [Health Care Related Organization]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.517: D., Hardy, J., Goate, A., Lannfelt, L., and Hutton, M. 

Phrase: "D."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Goate,"

Phrase: "A.,"

Phrase: "Lannfelt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Hutton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.518: (1995) Neuroreport 7, 297-301[Medline] [OrderarticleviaInfotrieve] Herskowitz, I. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Neuroreport 7,"

Phrase: "297-301"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Herskowitz,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.519: (1987) Nature 329, 219-222[CrossRef][Medline] [OrderarticleviaInfotrieve] Verrall, S., and Hall, Z. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Nature 329,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "219-222"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Verrall,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Hall,"

Phrase: "Z."
Processing 00000000.tx.520: W. 

Phrase: "W."
Processing 00000000.tx.521: (1992) Cell 68, 23-31[Medline] [OrderarticleviaInfotrieve] Grosse, R., Schoneberg, T., Schultz, G., and Gudermann, T. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Cell 68,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0007634:Cell [Cell]
   861   C0450387:68 [Intellectual Product]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "23-31"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450348:23 [Quantitative Concept]
   861   C0450355:31 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Grosse,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Schoneberg,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Schultz,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Gudermann,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.522: (1997) Mol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.523: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.524: 11, 1305-1318[Abstract/Free FullText] Buxbaum, J. 

Phrase: "11,"

Phrase: "1305-1318"

Phrase: "[Abstract/Free FullText"

Phrase: "] Buxbaum,"

Phrase: "J."
Processing 00000000.tx.525: D., Choi, E. 

Phrase: "D."

Phrase: ","

Phrase: "Choi,"

Phrase: "E."
Processing 00000000.tx.526: K., Luo, Y., Lilliehook, C., Crowley, A. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "Y.,"

Phrase: "Lilliehook,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Crowley,"

Phrase: "A."
Processing 00000000.tx.527: C., Merriam, D. 

Phrase: "C., Merriam,"

Phrase: "D."
Processing 00000000.tx.528: E., and Wasco, W. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Wasco,"

Phrase: "W."
Processing 00000000.tx.529: (1998) Nat. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.530: Med. 

Phrase: "Med."
Processing 00000000.tx.531: 4, 1177-1181[CrossRef][Medline] [OrderarticleviaInfotrieve] Walter, J., Grunberg, J., Capell, A., Pesold, B., Schindzielorz, A., Citron, M., Mendla, K., George-Hyslop, P. 

Phrase: "4,"

Phrase: "1177-1181"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Walter,"

Phrase: "J.,"

Phrase: "Grunberg,"

Phrase: "J.,"

Phrase: "Capell,"

Phrase: "A.,"

Phrase: "Pesold,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Schindzielorz,"

Phrase: "A.,"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Mendla,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "George-Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.532: S., Multhaup, G., Selkoe, D. 

Phrase: "S."

Phrase: ","

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.533: J., and Haass, C. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.534: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.535: Natl. 

Phrase: "Natl."
Processing 00000000.tx.536: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.537: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.538: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.539: 94, 5349-5354[Abstract/Free FullText] Copyright  1999 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "94,"

Phrase: "5349-5354"

Phrase: "[Abstract/Free FullText"

Phrase: "] Copyright  1999 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

